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Abstract 
Neutrophil extracellular traps (NETs) are antimicrobial web-like structures whose release is 
mediated by reactive oxygen species (ROS) and purpose is to combat infections. Unbalanced 
NET production and clearance is, however, associated with auto-antibody production and 
disease. This thesis aimed to develop a High-Content-Analysis (HCA) approach to study human 
NETosis and its modulation. Initially, NET-related disease-relevant conditions were studied. 
Individual periodontal-bacteria generated substantial NET production compared with bacterial 
biofilms. Calcium or magnesium ions and increases in cell density enhanced NET responses. 
As part of this study the use of fixation and cell adherence procedures were explored and data 
indicated that addition of paraformaldehyde prior to centrifugation and the absence of poly-L-
lysine provided appropriate conditions for downstream cytological analysis. ‘Compartmental 
Analysis’ and ‘Tube Formation’ algorithms were initially assessed for HCA, however, it was 
determined that bespoke ‘NET Detection’ and ‘Nuclear Decondensation’ algorithms provided 
more accurate analysis of NETosis and peptidyl-arginine-deiminase-4 translocation. The 
optimised protocol employed for the high-content-screening of a 56-compound library 
identified 8 NETosis modulators. Further characterisation of compounds’ abilities to modulate 
ROS and NET production, identified roles for glutathione reductase, Src, molecular-target-of-
Rapamycin and mitogen-activated-protein-kinase signalling. These pathways may provide new 
therapeutic targets for treatment of NET-related inflammatory disorders including periodontitis. 
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 The innate immune response and neutrophils 
The innate immune system provides immediate defence against pathogens through the activity 
of leukocytes, macrophages and dendritic cells. Neutrophils are the most abundant cells of the 
innate immune system, they circulate in the blood stream and, subsequently, represent the first 
effectors at the site of infection, providing defence against invading microorganisms (Amulic 
et al., 2012). They were first described and termed neutrophilic polymorphonuclear leukocytes 
(PMNLs) by Paul Ehrlich and Elie Metchnikoff in the late nineteenth century (as reviewed in 
Kaufmann, 2008). They are characterised by a unique lobulated and segmented nucleus and by 
the presence of numerous storage organelles and granules which carry a range of antimicrobial 
proteins and signalling molecules ( Figure 1.1) (Borregaard & Cowland, 1997). Neutrophils are 
terminally differentiated leukocytes which patrol the peripheral vascular circulation and can act 
as primary effectors or can collaborate with other cells of the innate and adaptive immune 
systems to clear infection (Jaillon et al., 2013). During inflammation in response to infection, 
local tissue resident cells including epithelial cells, fibroblasts and dendritic cells secrete pro-
inflammatory cytokines, such as interleukin-8 and tumour-necrosis factor α (TNFα), which 
recruit neutrophils from the circulation to the site of infection where they become activated to 
enable pathogen clearance (Kolaczkowska & Kubes, 2013; Sadik et al., 2011). Pathogen 
detection occurs in a less specific manner compared with the adaptive immune response, with 
neutrophils identifying highly conserved foreign molecular patterns associated with pathogens 
via a diverse array of surface pattern recognition receptors ([PRRs]; Akira, 2011). Neutrophils, 
subsequently, coordinate the maturation and activities of other leukocytes and lymphocytes 
through cell-cell interaction and cytokine signalling (Jaillon et al., 2013). The neutrophil’s 
migratory activity and functionality are a fundamental pre-requisite for defending the human 
body against infections as demonstrated in both leukocyte adhesion diseases and chronic 
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granulomatous disease (CGD), where defective neutrophil functionality results in severe 
immunodeficiency (Bunting et al., 2002; Holland, 2010). 
 
 Figure 1.1: Micrographic image of a neutrophil. 
Image obtained by transmission electron microscopy. The multilobulated nucleus is visible in 
dark colouration in the central region of the cell surrounded by numerous granules visible in 
shades of grey (Fernandez et al., 2013).  
 
 From the bone marrow to the circulation 
Neutrophils are produced abundantly in the bone marrow at an estimated rate of 1-2x1011 
cells/day in a healthy adult human (Borregaard, 2010). Neutrophils originate from myeloid 
precursors in a process regulated by the cytokine granulocyte colony stimulating factor (G-
CSF) in order to compensate for the number of mature cells eliminated in the circulation and in 
tissues (Lieschke et al., 1994). Only fully mature neutrophils possess the characteristic granules 
and PRRs required for antimicrobial functions (Borregaard, 2010). Neutrophils mature in the 
bone marrow and are released into the circulation at a rate which in the presence of infection 
and inflammation, can increase up to 10-fold in only a few hours (Furze & Rankin, 2008). The 
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egress from the bone marrow is regulated by the expression of antagonist chemokine receptors, 
C-X-C motif receptor 4 (CXCR4) and C-X-C motif receptor 2 (CXCR2), which respond to the 
signals of retention and release (Strydom & Rankin, 2013). Neutrophil production and release 
is regulated by their rate of clearance and apoptosis in tissues. Tissue-resident macrophages and 
dendritic cells identify and phagocytose apoptotic neutrophils and can subsequently signal the 
recruitment of more neutrophils by down-regulation of interleukin 23 expression (IL-23) (Stark 
et al., 2005). Once in the circulation mature neutrophils patrol the human body in search of 
microbial invasion, however, ageing neutrophils are believed to be redirected for clearance back 
into the bone marrow by up-regulation of CXCR4 receptor expression at their surfaces (Eash 
et al., 2009).  
 Neutrophil activation, extravasation and chemotaxis 
The neutrophil mechanism of extravasation includes several strategies depending on the 
systemic organ in which the infection occurs (Nauseef & Borregaard, 2014). Migration from 
the vasculature to infected peripheral tissues largely takes place at post-capillary venules which 
have relatively thin vessel walls but are large enough for neutrophils to arrest and accumulate 
in without the risk of occlusion (Borregaard, 2010). In the transmigration process (Figure 1.2) 
the neutrophil functional state is re-programmed from a circulating cell to a tissue phagocyte 
capable of oxidative activity and pro-inflammatory cytokine production (Nauseef & 
Borregaard, 2014). 
2.1.2.1 Activation of endothelial cells and neutrophil tethering  
When infection occurs, resident tissue cells detect invading pathogens and release a range of 
pro-inflammatory mediators including TNFα, IL-8, -1β (IL-1β) and -17 (IL-17), which create, 
along with bacterial-derived components, a chemotactic gradient in the host tissues. This 
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gradient of inflammatory stimuli also activates blood vessel endothelial cells by inducing the 
expression of specific adhesion molecules including P-selectin, E-selectin and members of the 
immunoglobulin superfamily (Amulic et al., 2012). During circulation neutrophils randomly 
probe the endothelial wall and once P-selectin glycoprotein ligand-1 (PSGL1) and L-selectin 
(which are constitutively expressed on the neutrophil cell surface) interact with the P-selectin 
and E-selectin molecules on endothelial cells, the free-flowing neutrophils become tethered on 
the vessel wall (Kolaczkowska & Kubes, 2013). Following this interaction neutrophils roll 
along the endothelial wall by dynamic formation and dissociation of ligand binding adhesion 
molecules (Ramachandran et al., 2004).  
2.1.2.2 Neutrophil activation and extravasation 
The binding of PSGL1 and L-selectin triggers an intracellular cascade of kinases, including Src 
and Syk, which ultimately lead to neutrophil activation and commitment for pathogen killing 
(Ley et al., 2007). These intracellular signals, in turn, trigger the activation and clustering of 
integrin family protein members on the neutrophil surface, which interact with immunoglobulin 
superfamily members on the endothelial cells, namely intercellular adhesion molecules 
(ICAMs) and vascular cell-adhesion molecules (VCAMs), causing the arrest and firm adhesion 
of neutrophils to the vessel wall (Campbell et al., 1998). In this phase, cytoskeleton 
rearrangements define cellular reorganisation which polarise surface receptors for chemokines 
and phagocytosis at the forefront of the cell (Borregaard, 2010; Sperandio et al., 2012). Two 
pathways have been described for leukocyte extravasation: paracellular or transcellular 
(Phillipson et al., 2006). In the paracellular pathway neutrophils ‘squeeze’ between junctions 
of adjacent endothelial cells by interaction with integrins and their respective immunoglobulin 
ligands (Ley et al., 2007). For the transcellular pathway, neutrophils pass through the lumen of 
endothelial cells which form protrusions or transmigratory cups to cover and seal the leukocyte 
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away from the blood flow (Feng et al., 1998; Kolaczkowska & Kubes, 2013). Once past the 
endothelial wall neutrophil migration must occur through the pericyte sheath and the venular 
basal membrane before reaching infected tissues, however little is understood about these 
processes (Woodfin et al., 2010). 
2.1.2.3 Chemotaxis 
The directional migration of neutrophils towards, or opposite to, a chemotactic gradient is 
known as chemotaxis (Insall, 2010). Potentially, an initial chemotactic gradient produced by 
endothelial cells drives neutrophils from the circulation to the subluminal area while a second 
gradient, which overrides the first, directs neutrophils through the tissue to the infected site 
(Kolaczkowska & Kubes, 2013). The movement itself, and its orientation, are determined by 
cytoskeletal rearrangements which result in the formation of a pseudopod at the leading edge 
of the cell while retracting the rear (Friedl et al., 2001). Chemotaxis follows the concentration 
of endogenous or exogenous soluble mediators which act as chemoattractants including 
complement components, chemokines such as IL-8 and bacterial-derived N-formyl-methionyl-
leucyl-phenyalanine (fMLP) (Amulic et al., 2012; Sadik et al., 2011). The migration to the 
infected site, as represented in Figure 1.2, is coordinated by combinations of chemoattractants 
sensed by G-protein coupled receptors (GPCRs) on the neutrophil surface. Upon interaction, 
GPCRs trigger the activation of intracellular signalling pathways including those mediated by 
protein kinase C (PKC) and mitogen-activated protein kinases (MAPKs) (Selvatici et al., 2006). 
Downstream, these kinases activate the pathways responsible for neutrophil defence, including 
the oxidative burst and degranulation (Amulic et al., 2012).  
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Figure 1.2: Schematic representation of neutrophil extravasation and chemotaxis. 
Mature circulating neutrophils constitutively express on their surface PSGL1 and inactive integrin receptors. Once infection occurs in the peripheral 
tissue, bacterial and other pro-inflammatory signals induce the expression of selectin receptors on the endothelial cell surface. The interaction 
between selectin receptors and PSGL1 results in the tethering and slow rolling of the neutrophil along the endothelial wall. Integrin receptors 
become activated and interact with their respective ligands on endothelial cells resulting in the arrest and firm adhesion of neutrophils. Following 
adhesion, neutrophils cross the endothelial wall and transmigrate into the tissue (here represented by the paracellular pathway) where they migrate 
towards the infected site following chemoattractant gradients (image produced by I. J. Chicca). 
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 The neutrophil killing arsenal 
With the aim of killing or neutralising foreign microorganisms, neutrophils exhibit a range of 
microbicidal mechanisms at their disposal comprising phagocytosis, oxidative damage, release 
of antimicrobial peptides (AMPs) and extracellular killing (Amulic et al., 2012). The neutrophil 
cytoplasm is packed with granular organelles containing a wide range of AMPs which can cause 
damage and death to pathogens. In neutrophils three types of granules have been identified and 
categorised for their content (Branzk & Papayannopoulos, 2013) and these comprise: i) primary 
or azurophilic granules, which carry the serine protease neutrophil elastase (NE) and 
myeloperoxidase (MPO) amongst others, ii) secondary or specific granules, and iii) tertiary or 
gelatinase granules which store the majority of flavocytochrome b558 on their membranes 
(Amulic et al., 2012). Although the neutrophils primary function is to remove microorganisms 
and protect the human body, their antimicrobial strategies can also cause significant collateral 
host tissue damage as described in section 2.4 (Kruger et al., 2015).  
2.1.3.1 Reactive oxygen species and the oxidative burst  
The dominant mechanism neutrophils adopt for infection resolution is by causing oxidative 
damage to pathogens through the production of reactive oxygen species (ROS). The process, 
also called “the respiratory burst” (Figure 1.3), is initiated by the intracellular enzyme complex 
nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase which converts molecular 
oxygen (O2) into superoxide anions ([O"•-] Babior et al., 1973). The NADPH-oxidase (NOX) 
machinery is comprised of numerous components which are partially located in the cytoplasm 
and partially bound to granule membranes. Flavocytochrome b558 is the central enzyme required 
for the electron transfer activity and is composed of two membrane-bound subunits. Upon 
cellular activation the expression of flavocytochrome b558 increases and NOX-complex 
component assembly is induced (El-Benna et al., 2008). The electron transfer activity catalysed 
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by activated NOX-complexes produces O"•% which is transformed into hydrogen peroxide 
(H2O2) either spontaneously in the phagosome lumen or by the catalytic activity of superoxidase 
dismutases (SODs). The H2O2 produced at this stage can be converted by the enzyme MPO into 
hypochlorous acid (HOCl) which, in turn, is converted into hydroxyl radicals ([HO-⋅]; Chapple, 
1996). The production of ROS is fundamental for the neutrophils’ bactericidal activity as shown 
in the immunodeficiency syndrome CGD, in which patients with mutations in genes responsible 
for the NOX-complex compontents cannot generate ROS (Holland, 2010). The antimicrobial 
activity mediated by ROS operates following two paths: i) direct oxidation of pathogen 
membranes, proteins and nucleic acids, and ii) induction of membrane depolarisation and 
consequential mobilisation of cationic species, including potassium and calcium, which 
contribute to electrophysiological alterations and microbial killing (Hampton et al., 1998; Rada 
et al., 2004).  
 
Figure 1.3: Schematic representation of the respiratory burst. 
NOX complexes on the plasma or phagosomal membranes catalyse the conversion of NADPH 
into NADP+ and concomitantly convert O2 into O"•%, which in turn is converted into H2O2 by 
SOD. H2O2 acts as substrate for downstream reactions including i) the formation of HOCl by 
MPO; ii) the conversion into water (H2O) by catalase; iii) the oxidation of glutathione (GSH) 
to form its disulphide form (GSSG) by the enzyme glutathione peroxidase (schematic produced 
by I. J. Chicca). 
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2.1.3.2 Phagocytosis and intracellular killing 
Neutrophils are instructed to phagocytose bacteria encountered by host tissues and 
compartmentalise invading organisms. The process is mediated by specialised surface receptors 
which recognise highly conserved pathogen-associated molecular patterns (PAMPs) or 
opsonised pathogens coated with host-derived immunological proteins, such as 
immunoglobulins (IgGs) or complement components (Lee et al., 2003). Fc-gamma receptors 
(FcγR) or activated integrins can also trigger diverse phagocytic strategies. Bacterial 
components, including lipopolysaccharide (LPS) and peptidoglycans, are detected through 
PRRs, such as Toll-like receptors (TLRs) to clear pathogens and initiate the inflammatory 
response (Underhill & Ozinsky, 2002). This receptor-ligand binding activates an intracellular 
process leading to cytoskeletal rearrangements, plasma membrane extension and, finally, 
engulfment of the pathogen into phagocytic vacuoles (Lee et al., 2003). Once the phagosome 
is assembled the cytoplasmic granules fuse with its membrane and release their toxic materials 
into the intracellular compartment. Along with the granule contents the phagosome acquires 
flavocytochrome b558, which provides an anchor for NOX assembly and activation (Jesaitis et 
al., 1990). Once phagosomes are equipped with granules and the oxidative burst machinery, 
they are considered fully mature and can undertake microbial killing (Nunes et al., 2013). Some 
pathogens, however, have evolved strategies to interfere with phagosome assembly or its 
maturation and can escape this killing mechanism as described in section 2.2.4.1 (Amulic et al., 
2012).  
2.1.3.3 Degranulation and extracellular killing 
An alternative employ of granules is their release outside the cell which occurs when granules 
fuse with the outer plasma membrane rather than internally with the phagosome. This fusion 
results in the release of antimicrobial molecules into the extracellular space as well as the 
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assembly of NOX complexes on the plasma membrane and, therefore, creates a hostile 
environment for pathogens (Amulic et al., 2012). Release of granule proteins with non-specific 
proteolytic activity such as NE and the extracellular production of ROS can also cause damage 
to the surrounding tissue and lead to development of chronic inflammatory diseases such as 
periodontitis (Cooper et al., 2013; Matthews et al., 2007a). This degranulation, however, may 
provide a signalling gradient for the recruitment of other leukocytes or provide a signal for 
induction of alternative killing mechanisms such as the release of neutrophil extracellular traps 
(NETs) (Lacy, 2006; Soehnlein et al., 2009).  
 Neutrophil extracellular traps 
Among the many strategies neutrophils utilise for clearing infections in tissues is the release of 
neutrophil extracellular traps (NETs). The formation and physiological function of NETs were 
only first reported in 2004 and were described as a neutrophil strategy targeted against both 
Gram positive and Gram negative bacteria (Brinkmann et al., 2004). NETs comprise 
extracellular deoxyribonucleic acid (DNA)-fibres which form a web-like structure with the 
function of immobilising pathogens, arresting their spread within the tissue and, eventually, 
facilitating their death (Figure 1.4). Notably, NET components, which are mainly relaxed 
chromatin and granule proteins, have direct antimicrobial affects (Brinkmann & Zychlinsky, 
2007). Since their discovery more than 10 years ago, NETs have been the subject of intense 
research which has attempted to unravel the molecular pathways responsible for their 
production, release and functionality. Numerous microorganisms, chemical compounds and 
host-derived proteins, which are reviewed in more details in section 2.3, have been shown to 
activate NET release. The production of NETs is believed by some researchers to represent an 
ultimate sacrifice which neutrophils undergo as an alternative to phagocytosis, however, this 
cell death mechanism is distinct from necrosis and apoptosis (Fuchs et al., 2007). Conversely, 
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others maintain that neutrophils utilise their mitochondrial DNA to form NETs and remain 
viable in order to preserve their other antimicrobial strategies (Yousefi et al., 2009). Nucleic 
acid based extracellular traps (ETs) are not exclusive to neutrophils and they have been 
identified in other leukocytes including mast cells, macrophages, eosinophils and basophils 
(Boe et al., 2015; Möllerherm et al., 2016; Yousefi et al., 2015; Yousefi et al., 2012). Although 
molecular mechanisms leading to activation and formation of ETs differs between leukocytes 
(Goldmann & Medina, 2012), evidence suggests it represents an evolutionary conserved 
mechanism of anti-microbial and anti-fungal defence. Indeed, the formation of ET-like 
structures has been shown to act as defence mechanism in other mammals, birds, fish, 
invertebrates and also in plants (Brinkmann & Zychlinsky, 2012). Although NET release has 
been shown to be necessary for host immune defence, dysregulation of the process has been 
shown to play a pivotal role in the pathogenesis of auto-inflammatory and auto-immune 
diseases as is described in section 2.4.2 (Branzk & Papayannopoulos, 2013).  
 
Figure 1.4: Image of neutrophils and their NETs. 
Fluorescence visualisation of NETs (red arrows) following neutrophil (white arrows) 
stimulation with phorbol 12-myristate 13-acetate (PMA) and DNA staining with Sytox green®. 
Images were visualised using 20X magnification and the scale bar represents 100µm (image 
produced by I. J. Chicca).  
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 Requirements for NET formation 
NETosis is a complex process triggered by diverse signals and involving multiple transduction 
pathways including NOX activation, peptidylarginine deiminase 4 (PAD4) and NE esterase 
activities. Martinelli et al. (2004) demonstrated that the majority of molecular components 
required for signal transduction and neutrophil activation, in particular for NET release, are 
only generated in the late phase of neutrophil maturation, indicating that only mature circulating 
neutrophils are able to perform NET-mediated defence.  
2.2.1.1 The respiratory burst 
Neutrophils from CGD patients, which have mutations in the genes for NOX subunits (Seger, 
2008), are unable to initiate the respiratory burst cascade and have been shown to exhibit poor 
NET responses (Fuchs et al., 2007). Furthermore, patients with mutations in genes responsible 
for MPO activity, which can cause complete depletion of the enzyme, are more susceptible to 
infections compared with healthy individuals, partially due to defective NET formation 
(Metzler et al., 2011). These and other studies have identified the key role of the oxidative burst 
in NET production, and this has also been confirmed by our own research which demonstrated 
that HOCl, one of the final products of the ROS production cascade, can efficiently and directly 
induce NET release (Palmer et al., 2012a).  
2.2.1.2 Deimination and esterase activities 
The deimination activity of PAD enzymes has been shown to be important in chromatin 
decondensation, and is regarded as one of the early stages of NET formation (Neeli et al., 2008). 
PAD4 knockout mice have been generated and analysed for NET-mediated immune defence 
(Li et al., 2010), and data demonstrated that depletion of PAD4 activity is associated with 
increased susceptibility to bacterial infection, partially due to absent NET response. Similarly, 
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immunodeficiency has been shown in NE knockout mice as they were unable to produce NETs 
(Papayannopoulos et al., 2010). Although several publications have described a role for PAD4 
in NET formation, its involvement remains controversial as it has been suggested there is 
insufficient evidence for attributing the deimination activity to the PAD4 enzyme (Branzk & 
Papayannopoulos, 2013; Yousefi & Simon, 2016). 
2.2.1.3 Calcium influx 
Calcium flux has been reported to be involved in several stages of neutrophil activation 
(Tintinger et al., 2005). Firstly, treatment of neutrophils with calcium ionophores, which 
increase intracellular calcium influx in intact cells, induces rapid NET formation via a NOX-
independent pathway (Parker et al., 2012a; Douda et al., 2015). The effect of calcium on 
neutrophil function has been widely reported in the literature, showing a significant 
involvement in phagocytosis and migration (Alteraifi & Zhelev, 1997; Dewitt et al., 2003). 
Furthermore, calcium mobilisation has been linked to NET-inducing stimuli, such as IL-8 
(Gupta et al., 2014), and to the activation of processes involved in NETosis, including 
superoxide generation and histone citrullination (Vossenaar et al., 2003; Bréchard & Tschirhart, 
2008).  
 NET structure and content  
Since the early publications, NETs have been described as being highly orchestrated structures 
with a multifactorial composition. By atomic force microscopy, NETs appear as branching 2D 
meshworks organised in porous structures (Figure 1.5) (Pires et al., 2016). The scaffold of this 
intricate web is comprised of smooth filaments of double-stranded DNA which have been 
demonstrated to be sensitive to degradation by deoxyribonuclease (DNase) enzymatic activity 
(Brinkmann et al., 2004). Decorating the DNA strands are numerous neutrophilic proteins, 
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including histones and granule proteins, distributed and organised in globular domains of 30-
50nm (Brinkmann & Zychlinsky, 2012), a fundamental property which distinguishes NETs 
from DNA released due to necrosis (Cooper et al., 2013). Although proteolytic activity in vitro 
is not sufficient to eliminate NETs (Brinkmann et al., 2004), protein degradation does, however, 
significantly alter the structural organisation and spatial distribution of NETs (Pires et al., 
2016).  
 
Figure 1.5: Atomic force microscopy images of NETs. 
PMA-induced NET structures visualised using atomic force microscopy. NETs appear as a 
web-like structure composed of variable sized pores (Pires et al., 2016).  
 
2.2.2.1 DNA backbone and histones 
Although it is universally accepted that the main component of NETs is DNA, the source of the 
nucleic acid remains controversial (Yousefi & Simon, 2016). While nuclear DNA has been 
described as being released as NETs in Fuchs et al., (2007), Yousefi et al., (2009) identified 
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mitochondrial rather than genomic DNA in NETs. In general the two hypothesis are accepted 
by the scientific community as alternative pathways for NET release elicited by neutrophils 
following different inflammatory and infectious stimuli (Branzk & Papayannopoulos, 2013). 
Other key components of NETs are the histones which have been found to be associated as 
granular domains within the filaments and are the most abundant proteins present in NETs 
(Urban et al., 2009). As histones are known to form nucleosomes and to control the DNA 
condensation state in the nucleus, researchers have suggested they may operate the same 
function in NET assemblies (Pires et al., 2016). Indeed all four types of histones which form 
the nucleosome core, H2A, H2B, H3 and H4, together with the histone linker H1, have been 
identified within NETs (Brinkmann et al., 2004). However, their distribution, composition and 
post-translational modifications differ significantly from those found in the nuclear chromatin 
(Urban et al., 2009). In addition to a structural role, the presence of histones is believed to 
partially account for the antimicrobial function of NETs (Palmer, 2010). 
2.2.2.2 Granule proteins 
Numerous proteins that are usually found in neutrophil granules have also been associated with 
NETs (Urban et al., 2009). Among these is MPO, which has been shown to be released into the 
extracellular space and to actively produce ROS while bound to NET structures, an association 
which has been proposed to occur in the cytoplasm following neutrophil stimulation with PMA. 
MPO peroxidase activity is understood to represent another strategy NETs employ for creating 
a hostile environment for invading pathogens (Parker, et al., 2012b) along with the protease 
activity of other granule enzymes such as NE, which has also been associated with NETs 
(Brinkmann et al., 2004; Yousefi et al., 2009). NE, like other neutrophil proteases, has 
antimicrobial properties and causes damage to the outer membranes of bacteria and can degrade 
their virulence factors (Korkmaz et al., 2008).  
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Another class of granule proteins identified on NETs are the AMPs. LL-37 is part of the 
cathelicidin family which offers a wide range of host defence roles including regulation of the 
inflammatory response, immune cell chemoattraction and neutralisation of bacterial LPS (Dürr 
et al., 2006). LL-37 in NET structures is associated with two important functions: antibacterial 
activity and protection of the NET-DNA from nuclease digestion (Neumann et al., 2014). Its 
presence within NET-DNA complexes is also believed to propagate the auto-inflammatory 
activity which has been described for NETs (Kaplan & Radic, 2012).  
2.2.2.3 Cytoplasmic enzymes 
A wide range of neutrophilic proteins are non-granule-derived and have been identified in 
association with NETs. The majority of these have been described in Urban et al., (2009), who 
first demonstrated the presence of calprotectin in NETs. Calprotectin is a cytosolic protein with 
a strong antimicrobial activity generated by the chelation of metal ions which are fundamental 
for microbial growth (Weinberg, 1975). This mechanism was confirmed for the antifungal 
activity of NET-associated calprotectin on Candida albicans growth, which was restored with 
the enrichment of zinc and manganese in the media (Urban et al., 2009). Other cytosolic 
proteins reported by Urban et al. (2009) include cytoskeleton and glycolytic proteins, however, 
their function in NETs has not yet been described.  
 Events leading to NET formation 
The release of NETs as an antimicrobial strategy is a highly orchestrated process which has 
been shown to involve several neutrophilic proteins. To date, three main mechanisms have been 
described for the production of NETs and these are described below.  
i) Fuchs et al. (2007) described NET formation as a process dependent on NOX activity which 
leads to cell death following nuclear decondensation and rupture of nuclear and plasma 
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membranes. This mechanism has been supported by many other publications demonstrating 
that nuclear decondensation is regulated by the enzymatic activity of NE and MPO following 
their nuclear translocation (Metzler et al., 2011; Papayannopoulos et al., 2010).  
ii) An alternative oxidant-independent mechanism has been proposed whereby neutrophils 
release NETs in vesicles and remain vital upon stimulation with Staphylococcus aureus whilst 
losing their nuclei (Pilsczek et al., 2010).  
iii) A further mechanism of vital NET formation has been described as being ROS-dependent 
which does not result in cell death. This form of ETosis has been described in eosinophils, 
basophils and neutrophils and the NETs generated are composed of mitochondrial rather than 
nuclear DNA (Yousefi et al., 2015; Yousefi et al., 2009; Yousefi et al., 2008). Notably, only 
the nuclear-NET process has been extensively described and, subsequently, is schematically 
represented in Figure 1.6. 
Upon stimulation, the first upstream process required for NET assembly is the activation of 
NOX complexes and the consequential production of ROS. The cascade of oxidative events, 
described in section 2.1.3.1, has been identified as a major trigger for NET production. Notably, 
treatment of neutrophils with diphenylene iodonium (DPI), a potent inhibitor of NOX, was able 
to inhibit NET production following chemical and bacterial stimulation (Fuchs et al., 2007; 
Palmer et al., 2012a). Following ROS production, nuclear chromatin decondensation occurs as 
a result of the activity of two enzymes which operate in sequence. First, a deiminase enzyme 
catalyses the conversion of arginine amino acid residues into citrulline on histone tails (Wang 
et al., 2009). This conversion removes the positive charges on the arginine residues on histones 
which lose their interaction with the negatively charged DNA. The loss of electrostatic 
interactions relaxes the chromatin sufficiently for NE to then operate (Rohrbach et al., 2012). 
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NE is understood to translocate from its cytoplasmic granule location to the nucleus upon 
activation. The proteolytic activity of NE degrades the bond between the histones of the 
nucleosome and further relaxes the chromatin structure. At this stage, MPO, which follows NE 
into the nucleus, is believed to associate with the DNA (Papayannopoulos et al., 2010). The 
resulting relaxed chromatin is first released into the cytoplasm, following nuclear membrane 
dissociation, where it combines with a wide range of proteins deriving, for the most part, from 
disaggregated granules (Fuchs et al., 2007). The extracellular release of DNA/protein 
complexes in the extracellular space is understood to be, then, actively mediated by the 
cytoskeleton of the cell. In fact, treatment with cytochalasin D, an inhibitor of actin 
polymerisation, impedes the release of NETs but not their assembly (Cooper et al., 2013).  
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Figure 1.6: Schematic representation of neutrophil activation. 
Mature neutrophils are characterised by a multi-lobulated nucleus, intracellular granules and PRRs expressed on their surface. Stimulation occurs 
via receptor recognition for physiological stimuli, such as microorganisms, or intracellularly for non-physiological stimuli, such as PMA. Upon 
stimulation, intracellular signal transduction leads to ROS production and granule protein translocation to the nucleus where enzymatic activities 
mediate nuclear decondensation and loss of the multi-lobulated shape. At this stage the nuclear membrane disintegrates and the DNA mixes 
intracellularly with cytoplasmic and granule contents. DNA/protein complexes are then actively released into the extracellular space as NETs which 
can target, trap and kill microorganisms (image produced by I. J. Chicca).  
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 NET physiological functions 
Although the existence of NETs and their role in the immune system have been extensively 
described in the literature, their exact function and mechanism of action requires further 
investigation (Yipp & Kubes, 2013). The release of extracellular DNA has been widely 
identified in the animal and plant kingdom as a protection mechanism against bacterial and 
fungal infections. Since this defence strategy appears to be highly conserved in other more 
primitive species, it is likely that NETs accomplish the same function in humans (Cooper et al., 
2013). NET antimicrobial mechanisms can be categorised into two main roles: i) direct 
trapping/killing of microorganisms, and ii) clearing infections via cross-talk with other cells of 
the immune system.  
2.2.4.1 NET ensnaring and killing of microorganisms  
Considering their intricate mesh-like structure, the most obvious function of NETs is to 
physically interact with, and capture microorganisms. The direct adhesion to NET-DNA has 
been identified with a number of bacterial and fungal species (Abdallah et al., 2012; Brinkmann 
et al., 2004; Urban et al., 2009). Furthermore, NET entrapment functions by containing 
microorganism spread within the tissue and this may provide a strategy for their immobilisation 
while other antimicrobial effectors operate. A mechanism which has been proposed for the 
containment and killing of periodontal disease-associated bacteria (White, 2015). 
Subsequently, microorganisms have evolved virulence strategies which enable them to escape 
and survive NET killing. One of these mechanisms is the modification of the bacterial surface 
or structure, such as mimicking the expression of the host sialic acid on the external capsule in 
order to escape neutrophil recognition (Carlin et al., 2009). Another strategy employed by 
microorganisms is the production of degradative enzymes. DNase production in bacteria was 
previously reported by Hirsch, (1958), however, its degrading function has only been re-
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interpreted relatively recently since the discovery of NETs. Indeed, the bacterial production of 
DNase has been shown to degrade NETs and has also been related to increased virulence and 
disease severity (Beiter et al., 2006; Berends et al., 2010; Buchanan et al., 2006). A further 
component of NETs, however, can also be targeted by bacterial evasion strategies. Proteases 
from microorganisms may also enable their escape by disrupting NET architecture, altering 
NET mechanical strength and its binding abilities (Pires et al., 2016). 
2.2.4.2 NET interactions in the host response 
Besides their direct antimicrobial activity, NETs are believed to interact with other cells of the 
immune system. NETs have been proposed to collaborate with the phagocytic function of other 
‘non-NETosing’ neutrophils (Brinkmann et al., 2004). NET structures have been shown to bind 
complement component C1q which, in turn, initiates the host’s complement cascade and 
enhances infection clearance (Leffler et al., 2012). The interaction between platelets and NETs 
has also been proposed to play a role in disease pathogenesis. Platelets are able to induce NET 
production in their activated state and can be activated by NETs themselves (Cooper et al., 
2013). Numerous studies have proposed that NETs are also able to activate different types of 
lymphocytes and enable connections between the innate and adaptive immune response (Puga 
et al., 2011; Tillack et al., 2012).  
 Stimulation and regulation of NET release 
NET production has been reported in response to various stimuli which include host-immune 
system mediators, whole bacteria, their components and products, as well as chemical 
compounds. In the descriptions below, stimuli have been categorised into physiological and 
non-physiological in order to distinguish between their functions under in vivo and in in vitro 
conditions. Neutrophil responses to such stimuli, however, can be modulated for lesser or 
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greater NET production. In the past, the identification of modulatory compounds has led to the 
unravelling of NET regulatory intracellular pathways and has opened new perspectives for 
developing therapeutic approaches for NET-related diseases. Several compounds have been 
found to inhibit NETosis while others have the ability to priming neutrophils to increase their 
responsiveness for NET production. 
 Physiological stimulation 
Physiological stimuli are considered those related to the pathogenesis of diseases, including 
periodontitis, and are known to activate neutrophils through receptor-binding. These include 
foreign stimuli, such as bacteria, oral biofilms and LPS, and host-derived compounds, such as 
cytokines, AMPs and platelets (Cooper et al., 2013). Neutrophils utilise their surface receptors 
for the identification of foreign or host-derived molecules, which activate intracellular 
cascades, usually mediated by kinases, and ultimately lead to ROS and NET production.  
2.3.1.1 Microorganisms and microbial products 
A variety of Gram positive and Gram negative bacteria are known to induce NET production 
during in vitro and in in vivo models of diseases (Branzk & Papayannopoulos, 2013). Among 
these are periodontal disease-associated bacteria including Fusobacterium nucleatum (Figure 
1.7) and Porphyromonas gingivalis, which are two Gram negative bacteria (Delbosc et al., 
2011; Palmer et al., 2012a). These bacteria reportedly activate neutrophils through TLR-
binding (Kikkert et al., 2007) which, in turn, triggers intracellular cascades leading to ROS 
production and NET release (Prince et al., 2011). 
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Figure 1.7: Bacteria entrapped in NETs. 
Fluorescence micrographic image of F. nucleatum trapped (white arrows) in a NET filament 
(red arrow). Magnification of an image acquired with a 10X lens and scale bar is shown (image 
produced by I. J. Chicca). 
Although whole bacteria are reportedly more efficient in stimulating NETs, their components 
can also activate neutrophils (Fuchs et al., 2007). LPS is derived from the outer wall of Gram-
negative bacteria, and during infection it is released as a soluble particle which is recognised 
by the immune system. CD14 on the neutrophil surface binds LPS and acts as co-receptor for 
TLR4 activation. Previous studies indicate LPS-binding improves when the molecule forms 
complexes with the lipopolysaccharide-binding protein (LBP) abundant in human plasma 
(Luchi & Munford, 1993). Notably LPS is reported to induce NET formation in neutrophils 
following neutrophil priming with cytokines, such as granulocyte-macrophage colony-
stimulating factor (GM-CSF) (Yousefi et al., 2009) or via platelet-activation (Clark et al., 
2007).  
100µm
100µm
m
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A relatively unexplored area in NET biology is that of the anti-fungal functions of NETs, which 
is proposed to be similar to the activity identified in other mammals and plants. Fungal infection 
spreads systemically when the fungal organism switches to its hyphal growth phase, which 
generates a highly proliferative form with pathogenic filaments too large to be phagocytosed 
(Urban et al., 2006). Whole fungi and fungal hyphae, including Candida albicans and 
Aspergillus fumigatus, have been shown to induce the release of NETs, which then neutralise 
the microorganisms by employing the antifungal calprotectin (Bruns et al., 2010; Urban et al., 
2009). 
Relatively few studies have examined the role of NET formation in parasite and viral infections. 
Interestingly the promastigote, which is the parasitic component mediating the pathogenicity 
from Leishmania amazonensis, can also stimulate the formation of NETs (Descoteaux et al., 
2010; Guimarães-Costa et al., 2009). Furthermore, among viruses, the influenza A and human 
immunodeficiency virus-1 (HIV-1) have been shown to trigger neutrophil activation through 
TLR7 and TLR8 recognition and this has been associated with the production of NETs, which 
can capture and inactivate the virus by MPO and defensin activities (Narasaraju et al., 2011; 
Saitoh et al., 2012). 
2.3.1.2 Host-derived molecules 
Neutrophils are able to cross-talk with other cells of the immune system through the release of 
cytokines and other inflammatory mediators. NET production has been proposed to play a key 
role in mediating interactions between cells of the immune system, indeed, several host-
immune mediators have been found to induce NET release. Pro-inflammatory cytokines 
including TNF-α, IL-1β and IL-8, which are released by tissue structural cells and other 
leukocytes in response to invading microorganisms, have been reported to enhance ROS 
production and NET formation in neutrophils (Keshari et al., 2012a). A further inflammatory 
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mediator, nitric oxide (NO), has also been shown to be involved in the activation of NET 
pathways. Keshari et al. (2012b) utilised NONOates, a specific NO donor, in order to 
investigate NO-mediated NET release and found a high neutrophilic response following 
treatment in terms of ROS and NET production. Furthermore, LPS-activated platelets have 
been shown to interact in vivo with circulating neutrophils and mediate bacteria killing through 
NET formation (Clark et al., 2007).  
 Non-physiological/chemical stimulation 
Chemical stimuli frequently utilised in NET studies include HOCl, phorbol 12-myristate 13-
acetate (PMA) and ionomycin (Ermert et al., 2009; Gupta et al., 2014, 2005; Palmer et al., 
2012a). These molecules activate neutrophils by bypassing the interaction with surface 
receptors and, therefore, function relatively rapidly.  
HOCl, one of the key products of MPO activity and of the neutrophil ROS cascade, is required 
for efficient NET formation. In fact, chemical inhibition of MPO catalytic activity using 4-
aminobenzoic acid hydrazide resulted in decreased NET production, while treatment with 
exogenous HOCl was able to restore NET formation in CGD patients’ neutrophils. Moreover, 
suppression of HOCl by taurine was able to prevent NET formation and preserved neutrophil 
viability (Palmer et al., 2012a).  
PMA is extensively used by researchers to induce ROS and NET production. Its chemical 
structure resembles that of the host-derived diacylglycerol (DAG) which is a physiological lipid 
second messenger activator of the PKC pathway. PMA stimulation and its resulting 
intracellular kinase activity ultimately lead to NOX activation, ROS formation and NET release 
(Neeli & Radic, 2013). PMA stimulation in vitro has been reported by Fuchs et al. (2007) to 
stimulate NETs in approximately one-third of neutrophils that were assayed. Similar data were 
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provided by the research conducted by the Periodontal Research Group at the University of 
Birmingham (Palmer, 2010).  
Treatment with ionomycin, a lipid-soluble ionophore which transports calcium across the 
membrane, has also been shown to mediate NET production in an oxidant-independent pathway 
and this demonstrated calcium influx was required for NETosis (Gupta et al., 2014; Parker et 
al., 2012a).  
 Increased response in primed neutrophils 
Some agents have the effect of modulating neutrophil responsiveness to stimuli and have been 
used in studies of ROS and NET stimulation. The effect of cytokine priming on ROS production 
has been extensively described in neutrophils (El-Benna et al. 2008) and similar mechanisms 
have been proposed to enhance the response of neutrophils in terms of NET production (Kaplan 
& Radic, 2013). GM-CSF is an inflammatory cytokine which can function in recruiting 
neutrophils from the circulation as well as activating them at the site of infection (Sullivan, 
1992). Exposing neutrophils to GM-CSF prior to stimulation with LPS or complement 
molecules resulted in viable neutrophils releasing NETs comprised of mitochondrial DNA 
(Yousefi et al., 2009). Subsequently it has been proposed that different combinations of stimuli 
with cytokine priming affect the response and the fate of neutrophils (Dias et al., 2013; Kaplan 
& Radic, 2013). 
 Compound-mediated inhibition  
Several compounds which pharmacologically inhibit NET release have so far been identified. 
Most researchers focus on the inhibition of the ROS cascade utilising DPI, which blocks the 
activity of NOX complexes, or use specific MPO inhibitors to decrease NET formation (Palmer 
et al., 2012a). Recently, a potent inhibitor of NETosis has been described as a potential 
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treatment for NET-related auto-inflammatory diseases (Yu et al., 2015). Celastrol, also known 
as tripterine, is one of the active components in root extracts derived from Tripterygium 
wilfordii, or Thunder god vine, utilised in Chinese medicine. Celastrol treatment has been 
shown to down-regulate cytokine expression and to exhibit anti-inflammatory properties in 
several animal models of disease (Kannaiyan et al., 2011). Notably exposing neutrophils to 
celastrol prior to stimulation with TNF-α drastically reduced the percentage of cells undergoing 
NETosis (Yu et al., 2015).  
 NETs in the pathogenesis of disease 
Besides the beneficial antimicrobial function of NETs and the additional roles they exert upon 
the immune system in fighting infections, the presence of DNA/protein complexes in 
extracellular tissue has been associated with certain pathologies. Indeed, excessive production 
and/or delayed or defective removal of NETs are believed to play a role in the pathogenesis of 
several inflammatory diseases such as cystic fibrosis (CF) and systemic lupus erythematosus 
(SLE) (Brinkmann & Zychlinsky, 2012; Hakkim et al., 2010; Manzenreiter et al., 2012). 
Furthermore, NET structures have been implicated in thrombus formation in deep vein 
thrombosis (DVT) (Fuchs et al., 2012), in cancer development (Demers & Wagner, 2014) and, 
also, NETs may provide a source of auto-antigens in rheumatoid arthritis (RA) patients 
(Khandpur et al., 2013). Due to their contradictory functions in human biology, NETs have 
been described as being a “double-edged sword” and their homeostatic control may determine 
the difference between health and disease (Cooper et al., 2013). 
 Murine models of disease 
Over the past decades mice have been extensively used as model organisms in human disease 
research. Indeed, murine models have been developed for studying the immune-system and 
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immune-related diseases, in particular, they have been employed in studies focused on linking 
neutrophils with auto-inflammatory diseases (Németh et al., 2016). NET production has been 
successfully suppressed in PAD4 knockout mice, generated by deletion of exon II of the gene 
responsible for PAD4 transcription, resulting in the expression of a non-functional form of the 
enzyme (Li et al., 2010). Together with the increasing evidence recognising NETs as major 
source of auto-antigens, murine models have been developed for targeting NET cascade events 
in SLE, autoimmune arthritis, anti-neutrophilic cytoplasmic antibody-(ANCA)-associated 
vasculitis and gout. The subsequent data generated has supported a role for NETs in human 
disease pathogenesis (Knight et al., 2015; Willis et al., 2011; Kessenbrock et al., 2009; Schauer 
et al., 2014).  
 Aberrant NET formation & clearance  
Following efficient microbial entrapment in host tissue, NET removal is understood to 
comprise two steps. Initially, NETs are processed by either DNases, which can degrade the 
DNA backbone, or NETs are opsonised by C1q complement molecules. Subsequently, NETs 
are cleared by macrophage engulfment, a process known as efferocytosis in which NETs and 
other neutrophil remnants are degraded in intracellular lysosomal vacuoles (Farrera & Fadeel, 
2013). Notably the efferocytosis process must be efficient in order to prevent NET-derived 
cytotoxic components persisting in the host tissues and causing tissue injury or the induction of 
autoimmunity. Indeed ineffective macrophage-dependent efferocytosis, identified in the alveoli 
of patients with chronic lung diseases, has been proposed to contribute to persistent 
inflammation in CF (McCubbrey & Curtis, 2013). In CF patients with impaired antimicrobial 
neutrophil function excessive NET formation was identified and attributed to elevated levels of 
host-inflammatory molecules within the circulation. The extracellular filaments of DNA 
released as NETs are believed to accumulate in the mucus in the airways of CF patients and to 
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contribute to its viscosity (Cheng & Palaniyar, 2013). Another chronic condition in which 
impaired NET clearance has been identified is the autoimmune disease SLE. Patients affected 
by SLE present elevated serum levels of ANCA targeted against the major components of NETs 
including chromatin and granular proteins (Hakkim et al., 2010). Impaired NET clearance has 
been proposed as a primary source of auto-antigens (Munoz et al., 2005) and a subset of patients 
identified by Hakkim et al. (2010) presented defective DNase degradation of NET structures. 
Taken together, these findings suggest imbalanced NET formation and clearance processes 
represent suitable targets for the treatment of several diseases (White et al., 2016a).  
 NETs as a scaffold  
NETs are potentially a major source of extracellular DNA in fluid and tissues which may 
function as a scaffold for bacterial colonisation and biofilm development (Thornton et al., 
2013). Indeed, extracellular DNA (eDNA) has been shown to provide a functional structure for 
bacterial adhesion and biofilm formation, subsequently enabling antimicrobial resistance 
(Okshevsky & Meyer, 2015). Bacterial and host-derived eDNA are employed as scaffolds for 
forming and stabilising a pathogenic biofilm in the middle ear of children affected with otitis. 
One of the sources of host-derived eDNA, interestingly, was suggested to be the local 
production of NETs (Thornton et al., 2013). The structural function of NETs as a scaffold for 
bacterial colonisation was also suggested for chronic infections identified in CF patients (Cheng 
& Palaniyar, 2013). This structural function is not limited to bacterial colonisation, indeed 
NETs can also provide a scaffold for the development of thrombi as well as activating their 
formation in an experimental model of DVT (Fuchs et al., 2012). In sepsis, NET release occurs 
inside the vasculature and can activate platelets with the DNA/protein structures being 
associated with platelet adhesion (shown in Figure 1.8). Their aggregation with red blood cells 
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and other coagulation factors subsequently results in the formation of clots and thrombotic 
complications (Kaplan & Radic, 2012).  
 
Figure 1.8: Micrograph images of platelets adhering to NET structures. 
a) Fluorescence images of platelets, visible in green, attached to NET structures, visible in blue 
and indicated by arrows, while no interactions are identified with neutrophils, out of focus and 
indicated by arrowheads. b) Electron micrograph of platelets (Pts) aggregated with NET 
filaments (Fuchs et al., 2010). 
 
 NETs as a source of auto-antigens  
RA is a chronic disease characterised by the production of antibodies against self-antigens, 
leading to joint inflammation and swelling (Koch, 2007). Similar to SLE patients, RA patients 
produce elevated levels of autoantibodies directed against NET components, in this specific 
case against citrullinated proteins, which are known as anticitrullinated protein antibodies 
(ACPAs). Indeed, serum and synovial fluid from inflamed joints of RA patients have been 
shown to trigger NET production in neutrophils from healthy individuals (Branzk & 
Papayannopoulos, 2013). Subsequently, aberrant NETosis has been demonstrated in the 
synovial fluid of RA patients providing a source of autoantigens and enhancing the 
inflammation; a positive feedback mechanism has also been described to perpetuate this 
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pathogenicity in RA (Khandpur et al., 2013). Recently, citrullination and PAD4 activity have 
been identified in the synovial fluid associated with the release of NETs, and this has been 
linked to the elevated production of ACPAs in serum from the same patients and to disease 
progression in RA pathogenesis (Spengler et al., 2015).  
 NET function in cancer 
Over recent years NET pathogenicity has also been associated with cancer progression, with 
extracellular release of neutrophil chromatin being shown to contribute to tumour development, 
angiogenesis and metastasis (Demers & Wagner, 2014). NET-like structures have been 
identified in sections of tumours by two independent studies (Berger-Achituv et al., 2013; Ho-
Tin-Noé et al., 2009), and recently Cools-Lartigue et al. (2013) demonstrated in vitro and in an 
in vivo murine model that NET release can result in the capture of circulating tumour cells, 
promoting their adhesion in distant organs and thereby mediating metastatic disease. 
Subsequently, the presence of NETs in tumours and in the blood of patients affected by cancer 
has provided new information on the potential use of NET-associated biomarkers for diagnostic 
and therapeutic approaches (Demers & Wagner, 2014).  
 Neutrophils and NETs in the pathogenesis of Periodontitis 
The interaction between oral bacteria and the host immune response has been extensively 
investigated. While oral commensal bacteria, usually colonising the tooth surface, are known 
to positively balance the recruitment and the activity of immune cells in healthy periodontal 
tissue, when this homeostasis is lost, inflammation can occur (Devine et al., 2015). Periodontitis 
is a well characterised chronic inflammatory disease affecting the supporting tissues of the tooth 
and its progression can be modulated by many factors, such as smoking and stress. Moreover 
it has been demonstrated that diabetes and genetic predisposition also represent significant risk 
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factors for periodontal diseases (Figure 1.9). The chronic, non-resolving inflammation in 
response to the bacterial plaque biofilm, if left untreated, results in damage to the tooth’s 
supporting tissues, identified in patients as loss of bone and connective tissues, and ultimately 
disease progression can lead to tooth loss (White et al., 2016a). Salivary calcium has also been 
shown to play a major role in sub-gingival plaque accumulation and contributes to calculus 
formation (Miller et al., 2006). The level of calcium in saliva from periodontitis patients has 
been analysed in several studies and this has demonstrated levels to be elevated in patients 
compared with healthy individuals. Subsequently calcium saliva levels have been reported as a 
biomarker for periodontal disease (Sewón et al., 1995; Sewón et al., 1998; Kambalyal et al., 
2015). Notably, increased levels of salivary calcium mirrors the fluctuations occurring at a 
systemic level following disease progression (Greabu et al., 2009) and, interestingly, 
extracellular calcium flux is involved in several stages of NETosis, as previously described in 
section 2.2.1.3. Neutrophils are known to play a significant role in the inflammatory process in 
periodontal disease and previous studies have shown the presence of NETs in purulent exudates 
from inflamed gingiva. It is therefore, reasonable to speculate that NETs may be important in 
periodontitis pathogenesis, as previously reported for other chronic inflammatory diseases 
(Cooper et al., 2013). Notably, chronic periodontitis is associated with systemic diseases 
including RA. Interestingly, the periodontal disease-associated bacteria, P. gingivalis, which is 
the only bacteria expressing its own PAD enzyme, is reportedly involved in the production of 
citrullinated host-peptides which may act as auto-antigens in RA pathogenesis (de Pablo et al., 
2009). 
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Figure 1.9: Diagram of key factors involved in the aetiology of periodontitis. 
Periodontitis occurs due to a dysbiosis between the plaque biofilm at the gingival margin and 
the host immune response. Several risk factors, such as poor oral hygiene, plaque retention, 
increased salivary calcium levels, smoking or systemic conditions, can influence disease 
progression and lead to chronicity (image produced by I. J. Chicca).  
 
 Characteristic phenotype of neutrophils from periodontitis patients 
The immune response plays a fundamental role in the pathogenesis of chronic periodontitis, 
indeed, disease development is understood to occur in predisposed individuals which present 
an exaggerated inflammatory response (Matthews et al., 2007a). Recently, neutrophils from 
periodontitis patients have been shown to exhibit chemotactic anomalies in response to certain 
chemoattractants, such as fMLP, and in particular they move relatively slower and with 
compromised directionality compared with healthy neutrophils (Roberts et al., 2015). This 
prolonged tissue transit time has been hypothesised to contribute to collateral host tissue 
damage and is associated with the neutrophil’s tissue extravasation process and their release of 
an arsenal of cytotoxic molecules (Roberts et al., 2015). Indeed, neutrophils isolated from 
chronic periodontitis patients have been shown to exhibit an abnormal phenotype in respect to 
pathogen interaction and ROS production. In response to bacterial stimulation, periodontitis 
RISK FACTORS 
HOST RESPONSE PLAQUE BIOFILM 
LOCAL  
(e.g. poor oral hygiene, plaque-retentive 
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SYSTEMIC  
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patients’ neutrophils have been shown to generate increased levels of extracellular oxygen 
radical release compared with neutrophils derived from healthy control individuals. The 
baseline ROS activity, in the absence of any exogenous stimulation, was also higher than in 
control neutrophils. Taken together these findings highlight the characteristic hyper-
responsiveness and -reactivity of neutrophils derived from chronic periodontitis patients (Ling 
et al., 2015; Matthews et al., 2007b). Notably however, although ROS production directly 
correlates with NET formation, neutrophils from chronic periodontitis exhibit similar levels of 
NET release compared with healthy control (White et al., 2016b).  
 Periodontal pathogens and NETs 
Periodontitis is characterised by the accumulation of bacteria and biofilm formation at the 
gingival margin. A wide range and variety of bacterial species have been identified and 
categorised based on their association with disease stages. Key periodontal bacteria include F. 
nucleatum and P. gingivalis which are strongly associated with disease pathogenesis 
(Socransky et al., 1998). Exposing neutrophils to these periodontal bacteria induces the release 
of tissue-degrading molecules and cytokines which may exacerbate local tissue inflammation 
(Scott & Krauss, 2012). Several periodontal pathogens have also been shown to differentially 
activate ROS and NET responses in neutrophils from healthy volunteers and this has indicated 
that, although NETs entrap bacteria, they are not necessarily capable of killing them (White, 
2015). It is reasonable to speculate that the function of NETs at the periodontal site is to provide 
a source of extracellular DNA, which functions to provide a scaffold for biofilm formation, 
rather than acting antimicrobially, and subsequently this could contribute to disease 
development, as described in section 2.4.3. In addition, this may provide a source of, eDNA 
which has been shown to provide a suitable substrate for oral bacterial adhesion, protection 
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from antimicrobial agents and a source of nutrients which can enable oral biofilm progression 
and development (Jakubovics & Grant Burgess, 2015).  
 NETs in periodontal tissues  
During periodontal inflammation neutrophils migrate to the infected gingival tissues where they 
undertake antimicrobial functions. Neutrophils are also constantly released through the gingival 
crevicular fluid (GCF) around the tooth to provide a tissue defence mechanism. Once GCF is 
enriched with neutrophils it is clinically considered a purulent exudate. Notably, exudates and 
biopsies of the gingival epithelium collected from chronic periodontitis patients have been 
shown to exhibit elevated levels of NETs which were identified by NE immunostaining (Vitkov 
et al., 2009). Similar results were presented in Cooper et al. (2013) who reported for the first 
time increased MPO-positive NET structures in the gingival connective tissue following 
inflammation compared with healthy tissue (Figure 1.10).  
 
Figure 1.10: Evidence of NETs in inflamed periodontal tissue. 
Confocal microscopy of MPO-stained NETs in healthy and diseased gingival tissues. An 
increased amount of DNA is visible in red and co-localising with extracellular MPO, visible in 
green, in the diseased tissue (Cooper et al., 2013).  
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 Current methods used for NET analysis 
Following evidence demonstrating the association of NETs with several inflammatory diseases 
there is now a growing need to develop a better understanding of the NETosis process. Current 
approaches for the analysis of NETs in biological samples or tissues are based on the 
identification of their components and include DNA quantification, NET-related protein 
immunostaining and immunoblotting or enzyme-linked immunosorbent assays (ELISA) 
(Palmer et al., 2012a; Urban et al., 2009; Wang et al., 2009). These methods can be relatively 
low-throughput, expensive and there has been lack of consistency between findings since 
different approaches are applied, and results can be prone to bias. Only relatively recently have 
efforts focused on improving the analytical method for NETs by developing objective semi-
automated and high-throughput solutions (Brinkmann et al., 2012; Zhao et al., 2015).  
 Microscopy analysis  
The most frequently published methods used for the analysis of NETs in vitro and in tissues 
utilise microscopic approaches. These approaches, in general, utilise fluorescence, such as in 
confocal laser microscopy, or electrons such as in transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM) (de Buhr & von Köckritz-Blickwede, 2016). Although 
microscopic approaches are generally the preferred method utilised by many researchers, as 
NETs are fragile structures their careful handling and preparation is paramount to ensuring that 
artefacts are not introduced during their analysis (Brinkmann & Zychlinsky, 2012). Since the 
major component of NETs is DNA, visualisation by fluorescence microscopy is achieved by 
using cell impermeable DNA dyes which highlight the extracellular filaments (Brinkmann et 
al., 2004; Urban et al., 2009). DNA staining is often performed alongside immunostaining 
targeted at NET-related proteins such as histones, MPO or NE (Brinkmann et al., 2004; Hakkim 
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et al., 2010; Metzler et al., 2011). While fluorescence microscopy is employed for the analysis 
of NET components, electron microscopy allows structural investigations. Indeed, SEM and 
TEM were employed for the initial characterisation of the NETosis process (Brinkmann et al., 
2004; Fuchs et al., 2007) as shown in Figure 1.11. SEM has demonstrated the structural 
properties of NET filaments and, TEM has been used to determine the characteristic cell 
morphology assumed by neutrophils during NETosis, such as nuclear decondensation and 
nuclear membrane disintegration. However, observation of NETs by microscopy has two main 
disadvantages: first, the detection of NET structures is prone to lack of objectivity and bias 
which is introduced by the operator who must search and identify DNA/protein complexes in 
the detection area; second, these techniques are performed on microscopy slides which allow 
only a limited number of cells and samples to be analysed over a relatively long time period (de 
Buhr & von Köckritz-Blickwede, 2016).  
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Figure 1.11: Electron micrographs of neutrophils and NETs. 
SEM images of unstimulated neutrophils (a) and PMA-induced NETs (indicated by arrows in 
b & e). TEM images of unstimulated (c) and PMA stimulated (d) neutrophil morphology, and 
NET filaments (f). Scale bars represent 10µm in a) to d) and 500µm in e) and f) (from 
Brinkmann et al., 2004). 
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 NET-DNA analysis using fluorescence spectroscopy 
Besides visualisation by microscopy, NETs can also be quantified based on the amount of 
extracellular DNA detected in samples in vivo and in vitro in culture media. This method 
routinely utilises the partial digestion of NET structures in order to isolate the DNA component 
from the rest of the cell, and is followed by its fluorometric quantification using a multiwell 
plate reader (Köckritz-Blickwede et al., 2010; Palmer et al., 2012a). The main advantage of 
this procedure is the possibility of analysing a greater number of samples compared with 
microscopy approaches (de Buhr & von Köckritz-Blickwede, 2016). Furthermore, this 
approach allows NET analysis without requiring sample processing, such as fixation and 
washing passages, which may affect outcomes. However, care is necessary when performing 
this procedure in order to avoid artefacts caused by DNA released due to other types of cell 
death (Brinkmann & Zychlinsky, 2012).  
 Immunoassays for NET-related protein detection 
Although NET components can be observed by fluorescence microscopy following 
immunostaining, a more qualitative characterisation can be performed using other 
immunoassay approaches. For this purpose, NET structures are partially digested in order to 
isolate DNA/protein complexes from the samples and then antibodies specifically targeted for 
NETs are applied (Masuda et al., 2016). The immuno-based assays developed for NETs include 
ELISA and western blotting (Keshari et al., 2012b; Kessenbrock et al., 2009; Papayannopoulos 
et al., 2010). Immunoassay applications are not limited to NET components, but have been 
extended for the quantification of NET-bound enzyme activity. For instance, antibody-based 
immunoassays have been developed for quantifying the citrullination activity of PAD4 during 
the NETosis process (Spengler et al., 2015). Although this approach offers the possibility of 
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quantifying NET-related proteins, accurate standardisation is required for relative data 
comparison in unstimulated neutrophils and only a limited number of parameters can by 
analysed for each readout.  
  High-throughput and automated methods for NET quantification 
It is only recently that alternative approaches have been proposed for the high-throughput 
analysis of NETs. These solutions were developed for the quantification of NET-related 
features in a relatively short-time scale and with the aim of minimising operator bias. Two 
recent publications in the same year have proposed flow cytometry-based approaches for the 
detection of NETs. The method developed by Zhao et al. (2015) is based on the analysis and 
identification of nuclear decondensation in stimulated neutrophils, which has been shown to 
represent the initial stage of NETosis (as previously described in section 2.2.3). The method 
employs Multispectral Imaging Flow Cytometry which integrates the advantages of 
fluorescence microscopy with those of flow cytometry (Figure 1.12). The technique is 
morphologically-based and was developed to analyse nuclear shape, DNA staining intensity 
and co-localisation of the MPO signal in order to differentiate vital NETosis from non-vital 
NETosis. Conversely, the method proposed by Gavillet et al. (2015) aimed at directly 
quantifying NET levels in blood samples employing citrullinated-H3 and MPO biomarkers 
using a fluorescent-activated cell sorting (FACS)-mediated approach. The main disadvantage 
of this technique, however, was the limitation to the analysis of citrullinate-H3 positive NETotic 
events which, whilst being suggested to represent the majority of NETotic events, may not 
represent them all (de Buhr & von Köckritz-Blickwede, 2016; Li et al., 2010). Following the 
need for automation of NET analysis, Brinkmann et al. (2012) developed a technique for 
automated image analysis of NETosing cells. This method was based on monitoring the 
fluorescent signal associated with H2a-H2b-DNA complexes, which become exposed during 
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chromatin relaxation, and utilised a computer algorithm for the automatic analysis of NETosing 
cells. The software quantified the NETosing rate based on the ratio between chromatin 
relaxation and DNA staining. However, in this approach neutrophils were prepared on a glass 
slide, processed for immunostaining and only 5 random images were selected for analysis, and 
this approach remains somewhat subjective. An additional semi-automated method was 
recently proposed for screening compound libraries of inhibitors in order to identify novel NET 
regulatory molecules and associated pathways. This method eliminated operator bias related to 
image acquisition by utilising automated microscopy for the identification of NETosing cells. 
Indeed using this approach the author identified that inhibition of the Raf-MEK-ERK pathway 
was sufficient to block NET formation (Hakkim et al., 2011).  
 
Figure 1.12: Flow-cytometry based high-throughput approach for the identification of 
neutrophils undergoing NETosis. 
Nuclear features of unstimulated and stimulated neutrophils are analysed by flow-cytometry. 
a) Images obtained with brightfield (BF), side-scatter for granular content (SSC) and nuclear 
staining (Nuc) are shown. b) The portion of NETosing cells is quantified in scatterplots and 
gated in red (Zhao et al., 2015).  
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 High-Content Analysis  
As described above, the majority of studies on neutrophils and NETs have allowed only 
relatively small scale analysis. Now, with the introduction of automated tools for image 
acquisition and data analysis, high-throughput analyses have become a reality for the study of 
biological samples (Abraham et al., 2004). High-content analysis (HCA) is a high-throughput 
imaging approach which integrates automated cell image acquisition with automated data 
analysis. A comprehensive definition has been provided by Shariff et al. (2010) which 
described HCA as a combination of “image processing, computer vision, and machine learning 
to provide fast and objective methods for analysing large amounts of bioimage data”. This 
technology has broad application in the pharmaceutical industry with an increasing number of 
biological assays now being performed with HCA. Using this automated imaging system major 
breakthroughs have been achieved in the field of neuroscience and in the screening of small-
inhibitory ribonucleic-acid (siRNA) (Daub et al., 2009; Dragunow, 2008; Drake et al., 2009). 
The main advantages of HCA compared with low-throughput analyses are: i) quantification of 
protein staining intensity and molecular subcellular localisation, ii) obtaining independent cell 
information, and iii) rapid acquisition of multiparametric data, such as information on spatial 
and temporal variables (Drake et al., 2009). The image analysis aspect is performed using 
bioinformatics software with built-in algorithms for diversified biological applications, with 
examples including cell death investigations, measurement of oxidative stress and analysis of 
protein-related parameters (Ghosh et al.; Mandavilli; Miller et al.). HCA is a completely 
automated platform for the investigation of biological features in high-resolution images 
captured by an automated fluorescence microscope capable of reading 96-, 384-, 1536-well 
plate formats, which dramatically increases the number of conditions which can be analysed 
simultaneously (Mayr & Bojanic, 2009). Furthermore, cell-based HCA has been extensively 
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employed for the screening of compound libraries, often referred to as high-content screening 
(HCS), which aims to identify novel therapeutic leads (Korn & Krausz, 2007). 
 From its early origins to today’s HCA technology 
Since its introduction to scientific research in the 17th century, the microscope has provided a 
powerful tool for studying cells. Its technological evolution has so far contributed to notable 
improvements in our research approach and the quality of results generated (Bardell, 2004). A 
major breakthrough leading to the development of HCA was the introduction of the 
fluorescence microscope in the 1950s which integrated the accuracy of fluorescence 
investigation with the specificity of targeted antibodies (Coons & Kaplan, 1950). Successively, 
the introduction in the early 1990s of optimised fluorescent dyes with different ranges of 
excitation and emission wavelengths made possible the simultaneous investigation of multiple 
parameters in the same cell, as is shown in Figure 1.13 (DeBiasio et al., 1987). Inspired by the 
flow cytometry system and early forms of automated microscopy, the biotechnological 
company Cellomics introduced, in 1997, a high-throughput automated fluorescence platform 
for the analysis of large biological samples (Giuliano et al., 1997; Taylor, 2007). This 
automated transition represented both time-saving as well as cost-saving improvements due to 
the reduced amount of reagents and personnel time required for the screening approach whilst 
maintaining high-sensitivity readouts (Drake et al., 2008). Subsequently, HCA merged with 
confluent innovations in probe technology, automated image instrumentation, image analysis 
and bioinformatics.  
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Figure 1.13: Multiple combined fluorescent staining for the analysis of acetylation 
modifications of the cytoskeleton provides powerful multi-parametric data. 
Images of colorectal cells fixed and stained for nuclear DNA (blue), keratin proteins (green) 
and acetylation modifications (red). Different patterns of acetylation are shown for the different 
cytokeratin domains A) K10, B) K471 and C) 482 (Drake et al., 2009). 
 
 Application of HCA for large-scale biology 
With low-throughput imaging technologies, cell-based biology can only be investigated in 
relatively small sample sizes with the image produced as a relevant output. However, automated 
HCA has application for the study of thousands to millions of cells simultaneously and focuses 
on the translation of imaging data to digital output (Taylor, 2007). Low- and high-throughput 
imaging approaches are often integrated for accurate identification of functional parameters 
(Abraham et al., 2004). In the past, HCA has been successfully applied for the identification of 
genes or cellular/molecular activities involved in a wide range of biological processes 
(Mattiazzi Usaj et al., 2016). For example, using HCA researchers have screened RNA inhibitor 
libraries and have identified numerous genes involved in differentiation and proliferation 
processes of several organism systems including zebrafish and human embryonic stem cells 
(Chia et al., 2010; Huang et al., 2012). Other applications of HCA for large-scale biology have 
monitored the expression of sensitive reporters which lead to the identification of pathways 
involved in the pathogenesis of several neurological diseases including Huntington’s and 
Alzheimer diseases (Honarnejad et al., 2013; Schulte et al., 2011). Furthermore, HCA has been 
applied for genome-wide screening and the analysis of protein suppression or amplification. 
A B C 
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This approach has facilitated the identification of pathways and their temporal sequence 
enabling identification of molecular targets for possible therapeutic interventions (Abraham et 
al., 2004).  
 High-Content Screening of compound libraries 
Intracellular signal transduction pathways are often involved in the pathogenesis of diseases 
such as cancer, inflammatory disease and metabolic disorders. Frequent therapeutic approaches 
for such diseases are, therefore, targeted to regulate abnormalities in signalling including 
modulation of receptor activation and kinase activities. Indeed HCA has been applied for the 
screening of modulatory compound libraries targeting a wide range of intracellular processes 
(Korn & Krausz, 2007). With HCA, protein translocation and subcellular compartmentalisation 
can be monitored by fluorescently labelling the protein target and compound libraries can be 
screened for the identification of protein translocation inhibitors. Utilising this approach 
researchers have discovered inhibitors for the translocation of Akt1 and phosphoinositide-3-
kinase, pathways involved in cell survival and cancer cell growth (Lundholt et al., 2005; Wolff 
et al., 2006). Fluorescent fusion proteins have also now been developed for investigating 
intracellular protein trafficking including receptor activation and internalisation mechanisms. 
More than 700,000 compounds have been screened using HCA to investigate the activation and 
internalisation of GPCRs in metabolic and obesity diseases (Garippa et al., 2006). Numerous 
compound libraries are routinely screened in cell viability assays in order to determine the level 
of cytotoxicity of potential drug candidates and assess their potential clinical safety. With HCA, 
multiple cytotoxic parameters, including mitochondrial integrity, nuclear area and plasma 
membrane integrity can be evaluated simultaneously (O’Brien et al., 2006).  
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NET formation is a complex process which is regulated by an intricate modulation of 
intracellular pathways. The numerous parameters associated with NETosis have the potential 
for being investigated by HCA. With the potential of monitoring multiple conditions 
simultaneously, HCA can be applied for screening compound libraries for regulating NETosis 
to enable: i) identification of the molecular mechanisms leading to NET formation, ii) 
understand the role of NETs in the pathogenesis of inflammatory disorders, and iii) identify 
modulators of NETosis with possible therapeutic application. However, a detailed protocol for 
the HCA of neutrophils and NETosis has yet to be proposed.  
 Aims and objectives 
In the last decade, NETs have been extensively studied in order to identify the molecular 
pathways mediating their formation, to try to understand their involvement in disease 
pathogenesis and, ultimately, develop appropriate therapeutic approaches. However, the 
screening methods currently utilised for NET analysis are generally low-throughput, are subject 
to operator biases and often lack consistency and reproducibility. NETs have the potential for 
being investigated by high-throughput and automated methods, and several studies have begun 
to propose different techniques to do this (Brinkmann et al., 2012; Gavillet et al., 2015; 
Moussavi-Harami et al., 2016; Zhao et al., 2015).  
• The initial aim of this study was to develop and optimise a protocol for the investigation 
of neutrophil activation and NET formation using the automated high-throughput 
platform of HCA. In order to address this aim three main objectives were considered: 
- The evaluation of suitable experimental conditions and stimuli which could be applied 
for the development of a HCA method for NETosis investigation. 
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- The development of an appropriate fixation protocol for preservation of neutrophil 
and NET sample integrity. 
- The validation of HCA algorithms and the optimisation of algorithm parameters for 
the correct identification of neutrophils and NET-related features.  
Maintaining the homeostasis between NET formation and clearance may determine the 
difference between health and disease conditions. Several studies are now focusing on the 
identification of compounds able to pharmacologically modulate NETosis and with possible 
application for the treatment of NET-related diseases (Lapponi et al., 2013; Mcinturff et al., 
2013; Yu et al., 2015). Screening modulatory compounds on NETosis activity has the potential 
for being investigated by HCA. 
• The second aim of this study was to apply HCA for screening (HCS) a pharmaceutically-
derived compound library and identify those with the ability to induce or inhibit the 
process of NETosis. In order to address this second aim two main objectives were 
considered: 
- Perform HCS using a 56 member compound library for the modulation of NETosis 
activity.  
- Characterise and validate the compound ‘hits’ selected by HCS for their effects on 
unstimulated and PMA-stimulated neutrophils in term of ROS and NET production 
using specific targeted approaches.  
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3 CHAPTER 2: MATERIALS & METHODS 
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2.1 Isolation of human peripheral blood neutrophils 
For experiments using human peripheral blood neutrophils, cells were isolated from human 
venous whole blood from orally and systemically healthy volunteers using a discontinuous 
Percoll gradient, erythrocyte lysis and sedimentation processes as previously described 
(Matthews et al., 2007a). On average ~2-million cells per ml of whole blood were obtained, 
purity was assayed by flow cytometry as described below in section 2.1.8.  
2.1.1 Discontinuous Percoll gradient 
Neutrophil isolation was performed using Percoll solutions as there is a low grade of toxicity 
associated with polyvinylpyrrolidone (PVP)-coated silica particles which constitute the Percoll 
solution (Pertoft et al., 1978) and previous research performed at the School of Dentistry 
Laboratories has demonstrated the lowest levels of neutrophil activation using this method 
compared with Ficoll or Dextran (Chapter 3 of White, 2015). Two distinct densities were 
prepared combining Percoll (GE Healthcare 17-0891-01), distilled sterile water and sterile 
1.5M NaCl (Sigma S7653) in distilled water (Table 2.1). 
                             Gradient densities (g/ml) 
Components (ml) 
1.079 1.098 
Percoll 19.708 24.823 
Water 11.792 6.677 
1.5M NaCl 3.5 3.5 
Total volume (ml) 35 35 
Table 2.1: Composition of Percoll density gradients.  
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Resulting solutions were stored at 4°C for no longer than 7 days prior to use. To create the 
discontinuous density gradient 8ml of 1.098 was slowly layered under 8ml of 1.079 Percoll 
solutions using a 3ml plastic Pasteur pipette in 25ml or 30ml centrifuge tubes (Fisher 
Scientific).  
2.1.2 Venous blood collection  
Peripheral venous blood was collected from healthy volunteers in 6ml Vacutainers (Greiner, 
Bio-One Ltd.) coated with lithium heparin, anticoagulant suitable for cell isolation purposes.   
2.1.3 Erythrocyte lysis buffer 
To remove erythrocyte contamination and increase the purity of isolated neutrophils, samples 
were treated with a buffer solution to generate osmotic disequilibrium and induce erythrocyte 
cell lysis. The buffer was prepared by dissolving 8.3g NH4Cl (Sigma A9434), 1g KHCO3 
(Sigma P9144), 0.04g Na2 EDTA 2H2O (Sigma E5134), 2.5g bovine serum albumin ([BSA]; 
Sigma A7906) in 1L distilled water and stored at 4°C prior to use. 
2.1.4 Phosphate Buffered Saline (PBS) 
A buffer solution to maintain neutrophils in osmotic and pH conditions similar to that of the 
human body was generated by dissolving 7.75g NaCl (Sigma S7653), 0.2g KH2PO4 (Sigma 
P5655), 1.5g K2HPO4 (Sigma P3786) in 1L distilled water, autoclaved and stored at 4°C prior 
to use.  
2.1.5 Neutrophil isolation method 
Venous blood was carefully layered above the discontinuous Percoll density gradient using the 
9ml volume of blood within each gradient tube, then centrifuged (Rotina 380R or Universal 
320R, Hettich Zentrifugen) for 8 minutes at 150 relative centrifugal force (rcf) followed by 10 
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minutes at 1200 rcf. Sedimentation through the discontinuous gradient results in the 
stratification of blood as shown in Figure 2.1.  
The upper layers containing plasma (see Figure 2.1), leukocytes and monocytes were removed 
from centrifuge tubes and discarded using a 3ml plastic Pasteur pipette. The neutrophil layer 
was carefully transferred in 30ml erythrocyte lysis buffer to a 50ml centrifuge tube and mixed 
by inversion. The cell suspension was incubated for 5 - 10 minutes at room temperature until 
the solution became clear and then centrifuged for 6 minutes at 500 rcf to pellet the neutrophils. 
The supernatant was discarded and the pellet suspended in an additional 3ml of erythrocyte 
lysis buffer. Following a further 5 minutes of incubation at room temperature, the cell 
suspension was re-centrifuged for 6 minutes at 500 rcf. The supernatant was discarded and the 
pellet was washed in 5ml of PBS, centrifuged once more for 6 minutes at 500 rcf and re-
suspended in 5ml of PBS after the supernatant was discarded.  
 
Figure 2.1: Venous blood layered in Percoll gradient. 
Labelled layers of stratified blood through the Percoll gradient.  
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2.1.6 Neutrophil count  
The haemocytometer chamber is divided into 9 squares, the central square area measures 1mm2 
and is subdivided in 25 squares of 0.04mm2 surrounded by triple lines. The chamber depth is 
0.1mm, therefore the volume of the central square is 0.1mm3 (1mm2 x 0.1mm). Cells were 
counted in 9 of the 25 squares and those within the triple lines on the left margin and above the 
central square, but cells were not counted if they were on or beyond the the right margin and 
below the bottom margin as shown in Figure 2.2. 
 
Figure 2.2: Representation of the haemocytometer chamber used for cell counting. 
Dimensions of a standard haemocytometer chamber are shown in the left image. Centre and 
right figures show a schematic representation used for cell counting. Barred circles represent 
cells excluded from the counting process (adapted from ProSciTech SV520-N product 
information sheet).  
 
Number of neutrophils within cell suspension was calculated using the equation:  
!"#$%×25×10000	9 = .#/012	"3	$1#%2"4ℎ678	6$	19:ℎ	/7	"3	:177	8#841$86"$ 
Where 25 refers to the number of small squares, 10,000 is the correction factor to convert 
0.1mm3 into 1cm3 (equal in volume to 1ml) and 9 is the number of small squares used.  
Following counting, the suspension was diluted with the appropriate amount of buffer to give 
a final concentration of 1x106 neutrophils per ml of suspension.  
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2.1.7 Neutrophil viability assessment 
Neutrophil viability was assessed using the Trypan Blue exclusion assay or, alternatively, 
compound-induced cytotoxicity was determined by measurement of lactate dehydrogenase 
(LDH) cell release where specified and as described below.   
2.1.7.1 Trypan Blue exclusion 
Neutrophil suspensions were routinely analysed for cell viability by light microscopy (Leitz 
Laborlux S) under 20X magnification. Ten-µl of cell suspension was combined with 10µl of 
Trypan Blue dye (Sigma T8154) and 10µl of the solution was loaded into a haemocytometer 
(Neubauer, Reichert) chamber. Viability was determined using the Trypan Blue exclusion assay 
which identifies the fraction of cells with an intact outer membrane not permeable to the blue 
dye as being viable. Cells stained blue were considered dead or dying due to outer membrane 
damage. Viable cells were counted as described in 2.1.6 and multiplied two fold in order to 
account for the dilution factor. 
2.1.7.2 Lactate dehydrogenase (LDH) leakage assay 
LDH is a cytosolic enzyme which catalyses the conversion of lactate to pyruvic acid and vice 
versa. Upon damages of the plasma membrane its enzymatic activity can be measured in the 
extracellular medium and is therefore used as a sensitive and precise indication of cytotoxicity 
(Korzeniewski & Callewaert, 1983). Compound-mediated cytotoxicity assays were performed 
using the Pierce LDH Cytotoxicity Assay Kit (Thermo Scientific 88953). A couple of 
enzymatic reactions are involved in the assay. Initially, the enzyme LDH catalyses the 
conversion of lactate to pyruvate and concomitantly the reduction of NAD+ in NADH. 
Subsequently, the Diaphorase enzyme utilises the NADH to catalyse the conversion of a 
tetrazolium salt into a formazan product which can be measured by absorbance at 490nm (as 
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described in the manufacturer’s instructions of Pierce LDH Cytotoxicity Assay Kit). All reagent 
preparations and storage instructions were provided by the manufacturer. The Reaction Mixture 
was prepared by combining 0.6ml of Assay Buffer with 11.4ml of Substrate Mix dissolved in 
ultrapure water. Besides compound-induced LDH, spontaneous LDH activity was determined 
by incubating neutrophils with 10µl sterile ultrapure water, while the maximum LDH activity 
was achieved by incubation with 10µl Lysis Buffer (provided in the Pierce LDH Cytotoxicity 
Assay Kit). The LDH Positive Control solution was used in triplicate in the 96-well plate in 
order to verify the assay effectiveness. Upon incubation, 50µl of the supernatant was transferred 
into a new clear 96-well plate and were gently mixed with 50µl of Reaction Mixture. After 30 
minutes incubation at room temperature and protected from light, 50µl Stop Reaction were 
added to each well and gently mixed. Absorbance was measured at 490nm and 680nm using a 
microplate reader (BioTek ELx800). The absorbance measured at 680nm was subtracted by the 
readings at 490nm in order to correct values for the background. The percentage of compound-
induced cytotoxicity was calculated using the formula:  
(!"/4"#$< − %219%1<	>?@	9:%6A6%B)	– (E4"$%9$1"#8	>?@	9:%6A6%B)(F9G6/#/	>?@	9:%6A6%B)	– (E4"$%9$1"#8	>?@	9:%6A6%B) ×100 
2.1.8 Neutrophil purity determination by flow cytometry 
Neutrophil purity was assessed in samples by Flow Cytometry targeting the cell marker cluster 
of differentiation 66b (CD66b) expressed on the human neutrophil surface (Schmidt et al., 
2012). Flow cytometry experiments were performed at the laboratories of the School of Life & 
Health Sciences at Aston University, unless differently specified. Once isolated as described 
above, cells were diluted to 1x106 cells per ml of suspension, 100µl of sample were combined 
with 5µl anti-human CD66b with a phycoerythrin tag antibody (clone G10F5, eBioscience 12-
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0666-41) for positive identification or with 1µl mouse IgG1 K isotype with a phycoerythrin tag 
immunoglobulin (clone P3.6.2.8.1, eBioscience 12-4714-42) for the negative control. For 
comparison, 50µl of whole blood were treated with 450µl OptiLyse C (Beckman Coulter) for 
2 hours for erythrocyte lysis, then 100µl of this was analysed as a control. Samples were 
incubated on ice for 30 minutes with the antibodies and transferred to flow cytometry tubes 
(Sarstedt 55476005) for analysis on a Cytomics FC 500 flow cytometer (Beckman Coulter, 
CXP software, FL3 wavelength). Upon Percoll gradient isolation, neutrophil isolations were 
shown to contain greater than 95% neutrophils (Figure 2.3).  
a)                                                                         b) 
         
Figure 2.3: Representative scatter plots of neutrophil population. 
Flow Cytometry scatter plots of CD66b positive events in a) isolated neutrophil samples and b) 
whole blood. The population of neutrophils in the gated area represents 97% in a) and 24% of 
the total cells in b), respectively.  
 
2.2 Derivation of murine bone marrow neutrophils 
Long bones obtained from C57 black 6 wild-type and PAD4 knockout (PADi4-/-) mice were 
kindly donated by the Infection and Immunity Research Group at the University of Glasgow, 
UK. Murine bone marrow was extracted by flushing RPMI-1640 throughout tibias and femurs 
of wild-type and knockout mice and filtered through a 70µm mesh cell strainer (Fisher 
Scientific 22363548) to eliminate debris and cell aggregates. Neutrophil purification was 
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performed using the MACS® Cell Isolation kit for murine application (Miltenyi Biotec 130-
097-658). Cell suspensions were treated as per manufacturer instructions. The bone marrow 
suspension was centrifuged at 300 rcf for 10 minutes at 20°C, the supernatant was carefully 
removed and the cell pellet was re-suspended in 200µl (per 5x107 total cells) of MACS buffer 
(solution 1:20 of MACS BSA Stock Solution [130-091376] with autoMACS® Rinsing 
Solution [130091222]), following addition of 50µl (per 5x107 total cells) of biotin-
conjugated monoclonal antibody cocktail against non-neutrophil antigens. After 10 minutes 
incubation at 4°C cells were washed with 10ml (per 5x107 total cells) of MACS buffer and 
centrifuged at 300 rcf for 10 minutes at 20°C. The supernatant was carefully removed and the 
pellet was re-suspended in 400µl (per 5x107 total cells) of MACS buffer. Cells were incubated 
with 100µl (per 5x107 total cells) of anti-biotin MicroBeads for 15 minutes at 4°C and then 
washed with 10ml (per 5x107 total cells) of MACS buffer. The solution was centrifuged as 
before and up to 1x108 cells were re-suspended with 500µl of MACS buffer. Magnetic 
separation was performed with a MidiMACS™ Separator (Miltenyi Biotec 130-042-302). The 
LS column (Miltenyi Biotec 130-041-306) was rinsed with 3ml of MACS buffer before use, 
subsequently, the cell suspension was loaded into the column and topped with 9ml of MACS 
buffer. The flushed unlabeled neutrophils were collected in a fresh 15ml conical tube (Fisher 
Scientific 14-959-53A). The cell count was determined as in section 2.1.6 and bone marrow 
neutrophils were re-suspended in RPMI (Roswell Park Memorial Institute)-1640 (Sigma 
R7509) at the desired concentration. Sample purity and neutrophil viability were assessed by 
flow cytometry as described in section 2.1.8 upon staining for Ly6G (GR-1) (eBioscience 12-
5931-81), CD11b (eBioscience 17-0112-81) and Fixable Viability Dye eFluor® 450 
(eBioscience 65-0863-14). Flow cytometry demonstrated more than 97% of cells were CD11b 
and Ly6G (GR-1) positive (Figure 2.4). 
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a)                                                                  b) 
Figure 2.4: Representative scatter plots of murine neutrophils. 
Flow cytometry scatter plot of murine bone marrow neutrophils indicating the population of 
neutrophils in the gated area represent a) the 95% of isolated cells and b) >99% of the 
population is comprised of viable cells. 
  
2.3 Culture of Oral Epithelial Cells  
Experiments were performed with cultured human oral epithelial cells (OECs). The OEC line 
was a kind donation of Prof S. Prime at Bristol University, UK. The immortal cell line was 
derived from oral squamous cells isolated from a carcinoma of the alveolar process at stage 2 
from a 55 year old female patient. Cultured cell biological behaviour and similarity to oral 
epithelial cells were previously determined and published by (Prime et al., 1990). H400 cells 
have previously been identified as a suitable model for in vitro studies in OEC inflammatory 
processes (Milward et al., 2007; Milward et al., 2013).  
2.3.1 Culture media and reagents 
Media and reagents for H400 cell culture were maintained in sterile conditions and pre-warmed 
at 37°C in a water bath prior to use. Aliquots were regularly tested for infections at 37°C and 
5% CO2 for 24h and observed for changes in turbidity.   
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2.3.1.1 Storage medium  
For long term storage at -80°C, cells were suspended in Dulbecco’s modified Eagle’s medium 
and Ham’s F-12 (DMEM/F-12) 1:1 solution (Invitrogen 21331-020) supplemented with 20% 
foetal calf serum (Labtech FB-1001T/500) and 10% dimethyl sulfoxide (DMSO) (Sigma 
D8418). 
2.3.1.2 Growth medium 
For H400 culture, DMEM/F-12 was supplemented with 2% L-glutamine (Sigma G7513), 
0.005% hydrocortisone (Sigma H0888) and 10% foetal calf serum (Labtech FB-1001T/500) 
prior to use. Supplemented media were stored at 4°C until use. 
2.3.1.3 Trypsin-Ethylenediaminetetraacetic Acid (T-EDTA) solution 
In order to disaggregate the H400 cell monolayer and therefore release cells into suspensions, 
cell cultures required treatment with a solution of 0.0025% trypsin and 0.01% 
Ethylenediaminetetraacetic Acid (EDTA) in Hank’s balanced salt buffer (Invitrogen R-001-
100). Aliquots of this solution were stored at -20°C until needed.   
2.3.2 H400 cell storage and recovery  
H400 cells were preserved in 1ml storage medium (section 2.3.1.1) and archived in liquid 
nitrogen until needed. For recovery, cells were defrosted in a water bath at 37°C and diluted in 
9ml growth medium (section 2.3.1.2). Following 10 minutes centrifugation at 150 rcf, the cell 
pellet was re-suspended in 10ml growth medium (section 2.3.1.2), seeded in 75cm2 cell culture 
flask (Thermo Scientific 174952) and incubated at 37°C 5% CO2 for 3-4 days (Galaxy S CO2 
Incubator, New Brunswick). Cell growth was monitored by microscopy (Light microscope, 
Leitz Laborlux s) and 10ml media was replaced every 2-3 days of incubation. Once the 
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monolayer reached approximately 90-100% confluence, cells were passaged as described 
below.     
2.3.3 H400 cell passage and culture  
To maintain H400 cultures, cells were re-seeded in new culture flasks with fresh media once 
the monolayer reached 90-100% confluence. The exhausted growth media was removed and 
cell cultures were washed with 10ml Dulbecco’s PBS (Invitrogen 14190). Adherent cells were 
then treated with 4ml T-EDTA (section 2.3.1.3) at 37°C, 5% CO2 until the dissolution of the 
monolayer was microscopically confirmed. The cell suspension was then diluted with 6ml 
growth medium (section 2.3.1.2) and cells were collected and pelleted by centrifugation for 10 
minutes at 150 rcf. Cells were re-suspended in fresh growth medium (section 2.3.1.2) and the 
concentration (cells per ml of solution) was determined by counting cells within 4x1cm2 
quadrants of a haemocytometer (described in section 2.1.6). Cells were suspended in fresh 
growth medium (section 2.3.1.2) and seeded at 5x105 cells/10ml per 75cm2 culture flask, 1x105 
cells/1ml per well of a 24-well plate or 1x103 cells/100µl per well of a 96-well plate. For 
immunocytochemistry analysis H400 cells were cultured on heat-sterilised (100°C overnight) 
multi-well glass slides (Hendley-Essex PH005). Glass slides were placed in petri dishes 
(Appleton Woods AB260) and seeded with 4x105 cells in 14ml growth medium (section 
2.3.1.2).  
2.4 Neutrophil stimulation 
The following section describes all types of stimuli employed for in vitro induction of ROS and 
NETs. Stimuli were categorised as physiological or non-physiological for their different 
interactions with neutrophils and the different intracellular pathways involved in cellular 
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activation as described in section 2.3. Neutrophil stimulation can also be chemically modulated 
by blocking the activation cascade or priming cells with cytokines for increased responsivity.  
2.4.1 Physiological stimuli  
Bacteria and related stimuli were considered physiological due to their in vivo relevance and 
association with inflammation. Bacterial stimulation usually occurs via surface receptor 
recognition as described in section 2.3.1 and are known to trigger a variety of neutrophil 
responses including ROS and NET production (Hayashi et al., 2003; White, 2015).  
2.4.1.1 Bacteria  
F. nucleatum and P. gingivalis are two Gram negative anaerobic bacteria known to have 
pathogenic activity and to trigger inflammatory responses in immune-cells. They are both 
strongly associated with periodontitis pathogenesis (Socransky et al., 1998) and interact with 
neutrophils via TLR-2 and -4 binding (Darveau et al., 1997; Kikkert et al., 2007). 
2.4.1.1.1 Bacterial growth  
F. nucleatum sp. Nucleatum (ATCC number 25586) was grown anaerobically on blood agar 
plates (Oxoid PB0114) followed by planktonic growth in Brain hearth infusion broth (Oxoid 
CM1135) prepared as per manufacturer’s instructions. P. gingivalis (Strain W83) was grown 
anaerobically on neomycin supplemented blood agar plates (Oxoid PB0112) followed by 
planktonic growth in Fastidious anaerobe broth (Lab M LAB071) prepared as per 
manufacturer’s instructions.  
3.1.1.1.1 Strain validation by Gram staining 
Bacterial species were identified by colony observation and Gram staining. Following 
appropriate staining procedures Gram positive bacteria appear blue or purple while Gram 
negative exhibit a red or pink coloration. A single representative colony was emulsified with 
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saline solution on a glass slide and heat fixed over a Bunsen burner. The bacterial sample was 
covered with few drops of Crystal violet (solution 1:1 of crystal violet [Sigma C0775] diluted 
in ethanol and 1% ammonium oxalate [Sigma A8545] water) for 30 seconds and rinsed with 
distilled water. Lugol’s iodine (Sigma L6146) was, then, applied for 30 seconds followed by 
rinsing with distilled water and application of carbon fuchsin (BDH 351874U diluted 1:10 with 
water) for further 30 seconds. After rinsing and drying, colonies on glass slides were observed 
with a light microscope (Leitz Dialux 22) using an oil immersion objective X100 lens and 
images were captured with a digital camera (Nikon Coolpix 1990). Gram stained bacterial 
suspensions showed Gram negative rods consistent with the colonial morphology and 
suggestive of P. gingivalis and F. nucleatum. 
2.4.1.1.2 Bacterial stock preparation  
Planktonic bacterial growth was estimated by optical density measurements 
(Spectrophotometer Jenway 6300) at 600nm wavelength (OD600) and sterile broth was used to 
correct values for media changes in absorbance. Values (F. nucleatum 1OD600=1.62x109; P. 
gingivalis 1OD600=1.69x109) used for calculating bacterial growth were pre-determined by the 
Forsyth Institute, Boston and are published in Roberts et al. (2002). Bacterial suspensions were 
centrifuged (Harrier 18/80) three times for 15 minutes at 1800 rcf and 4°C, followed by 
resuspension in sterile PBS. Bacterial concentrations were determined as before and solutions 
were diluted to obtain a final stock suspension of 4x109 cells/ml. Bacteria were heat-killed by 
incubation in a Hot Air Oven (LTE OP30) at 80°C for 1 hour prior to solutions being aliquoted 
and stored at -20°C prior to use. To confirm bacterial death 1ml heat-killed stock solutions were 
plated on blood agar plates and incubated anaerobically for several days.  
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2.4.1.2 Multispecies biofilms 
Three-, 7- and 10-species biofilms were developed on Termanox™ coverslips (13mm diameter; 
Fisher 174950) as described in Millhouse et al. (2014), and kindly donated by the Infection and 
Immunity Research Group at the University of Glasgow, UK. Fully mature biofilms, had 
compositions as described in Table 2.2, and were deprived of media and stored at -80°C until 
use. For biofilm regeneration, coverslips were placed in 24-well plate (Costar 3526) and 
incubated overnight in sterile artificial saliva (composition for 1l: 2.5g porcine stomach mucins, 
3.5g NaCl, 0.2g KCl, 0.2g CaCl2•2H2O, 2g yeast extract, 1g lab lemco powder, 5g proteose 
peptone, 1.25ml urea) in anaerobic conditions. After 24 hours incubation, the supernatant was 
carefully removed, aliquoted and stored at -20°C until use. Twenty-five-µl of each type of 
biofilm supernatant was used in 200µl microwells for ROS and NET experiments.  
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Biofilm type 
Model/Disease 
status 
Bacterial Species Composition 
3-species Health 
Streptococcus mitis 
Streptococcus intermedius 
Streptococcus oralis 
7-species Gingivitis 
Streptococcus mitis 
Streptococcus intermedius 
Streptococcus oralis 
Veillonella dispar 
Actinomyces naeslundii 
Fusobacterium nucleatum 
Fusobacterium nucleatum spp. Vincentii 
10-species Periodontitis 
Streptococcus mitis 
Streptococcus intermedius 
Streptococcus oralis 
Veillonella dispar 
Actinomyces naeslundii 
Fusobacterium nucleatum 
Fusobacterium nucleatum spp. Vincentii 
Aggregatibacter actinomycetemcomitans 
Porphyromonas gingivalis 
Prevotella intermedia 
Table 2.2: Multispecies biofilm composition and association with disease status. 
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2.4.1.3 Oral epithelial cell co-culture with multispecies biofilms 
OECs were cultured as described in section 2.3 in 24-well plates. After 24 hours incubation at 
37°C 5% CO2, H400 cells reached 70-80% confluency, as assessed visually by optical 
microscopy (Leitz Laborlux s), subsequently growth media was removed and replaced with 
sterile pre-warmed media. Three-, 7- and 10-species biofilms on coverslips (section 2.4.1.2), 
after 24 hours incubation in artificial saliva, were removed from the plate, inverted and mounted 
with Vaseline® to hanging cell culture inserts for 24-well plates (Greiner Bio-one ThinCert™ 
662630). Inserts with attached biofilms were placed in H400 cell cultures in 24-well plates 
leaving a space between the biofilm and cell culture layer of ~0.5mm (Figure 2.5) and placed 
in a humidified incubator (Galaxy S, New Brunswick). After 24 hours incubation, biofilms 
were carefully removed, culture media was collected, aliquoted and stored at -20°C until use.   
 
Figure 2.5: Schematic representation of H400 cell co-culture with biofilms. 
Multispecies biofilms grown on coverslip were mounted on a cell culture insert and placed in 
incubation with H400 cells (Millhouse et al., 2014).  
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2.4.1.4 Lipopolysaccharide  
One-mg/ml Escherichia coli O26:B6 LPS solution (Sigma L8274) was diluted in desired buffer 
or media supplemented with 10% and 20% sterile human plasma (Sigma H4522) or 10% BSA 
(Sigma A4503) to generate solutions of 8µg/ml and 20µg/ml. LPS solutions were aspirated 
with siliconised tips, aliquoted in siliconised centrifuge tubes and stored at -20°C until used.  
2.4.2 Non-physiological stimuli  
Those stimuli which activate neutrophils by bypassing the interaction with surface receptors 
and are not bacterial components were classified as being non-physiological. PMA is a well 
characterised neutrophil activator and mimics the role of the physiological mediator DAG in 
activating the PKC pathway (Fuchs et al., 2007), and HOCl, is a downstream product of the 
ROS cascade and has been established to induce rapid formation of NETs (L. J. Palmer, Cooper, 
et al., 2012).  
2.4.2.1 Phorbol 12-myristate, 13-acetate  
One-mg PMA powder (Sigma P8139) was dissolved in DMSO to prepare a stock solution of 
1.62mM equivalent to 1mg/ml. Further dilutions were prepared with PBS to obtain a range of 
concentrations of between 5.6nM and 400nM working solutions. PMA solutions were 
aliquoted, stored at -20°C and protected from light by wrapping in aluminium foil.   
2.4.2.2 Hypochlorous acid 
HOCl was obtained by diluting sodium hypochlorite solution (Sigma 425044) with PBS. 
Hypochlorite ions in solution were previously estimated by Palmer et al. (2012a) by measuring 
the OD at 290nm of pH 12 solutions with an extinction coefficient of 350M/cm. Solutions used 
in neutrophil experiments had an equivalent pH and acid dissociation constant (pKa) of 7.5, 
therefore assuming that hypochlorite ions in solutions exist as HOCl and as OCl- in a 1:1 ratio. 
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HOCl solutions were diluted to a 0.75mM final concentration (which is physiologically 
relevant) for neutrophil experiments and prepared fresh when required.  
2.4.3 Modulators of neutrophil response 
GM-CSF has been previously used in neutrophil assays to prime the cells before LPS exposure 
and, therefore, increase their stimulation (Matthews et al., 2007a). Celastrol is a triterpenoid 
compound extracted from the Chinese Thunder of God Vine (Tripterygium wilfordii) and has 
been used for the treatment of inflammatory disorders due to its antioxidant properties. 
Celastrol acts as inhibitor of the inflammatory response and has multiple targets, such as nuclear 
factor-κB (NF-κB), the molecular-target-of-Rapamycin (mTOR) pathway and the MAPK 
cascade (Kannaiyan et al., 2011). The compound has also been shown to block NET formation 
upon neutrophil stimulation and was used in experiments as a control for neutrophil inhibition 
(Yu et al., 2015).  
2.4.3.1 Granulocyte-macrophage colony stimulating factor  
A total of 20 µg of GM-CSF powder (Sigma SRP3050) were dissolved in sterile water to obtain 
an initial 100µg/ml solution and further diluted in PBS 0.1% BSA (Sigma A4503) to prepare 
1.25ng/ml working solutions. Once aliquoted, GM-CSF solution was stored at -20°C until used.  
2.4.3.2 Celastrol  
Celastrol 5mg powder (Cayman 70950) was dissolved in DMSO to obtain a 1mg/ml stock 
solution (2.219mM), aliquoted and stored at -20°C protected from light. Working solutions 
were prepared immediately before use by diluting the 2.219mM stock with PBS to a 74µM 
solution and used at 10µM final concentration.  
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2.5 H400 stimulation  
H400 cells were cultured in black, clear bottom 96-well plates (Greiner Bio-one 655096) or on 
multi-well glass slides (section 2.3.3) for 2 to 4 days until the monolayer reached 90-100% 
confluence. NF-κB translocation from the cytoplasm to the nucleus was induced by incubation 
with 20µl/ml LPS (section 2.4.1.4) for 1 hour at 37°C and 5% CO2. H400 were pre-treated with 
10µM celastrol (section 2.4.3.2) for 30 minutes before LPS stimulation as a negative control 
and left unstimulated as a media control in order to ensure staining specificity of NF-κB and its 
LPS-induced nuclear translocation. 
2.6 Neutrophil assays 
Neutrophil metabolism and activity can be measured using a wide range of assays, including 
the quantification of ROS produced by the oxidative burst cascade and the analysis of NET 
release. ROS were quantified using a well characterised chemiluminescence assay, a technique 
established within the Periodontal Research Group (Matthews et al., 2007a). NET analysis was 
performed by fluorometric quantification of extracellular NET-DNA, qualitative observation 
by fluorescence microscopy ( Palmer et al., 2012a), and high-throughput investigation by HCA. 
All experiments were performed in triplicate and repeated using neutrophils from 3 different 
healthy donors.  
2.6.1 Pre-treatment of cultureware with blocking buffer   
To prevent cell adhesion or non-specific activation, cultureware used for neutrophil incubation 
were pre-treated with PBS 1% BSA or “blocking buffer”. The solution was made by dissolving 
10g BSA (Sigma A4503) in 1l standard PBS, filter sterilised (pore size 0.22µm) and stored at -
20°C in 20ml aliquots. Each well was filled with 200µl blocking buffer and incubated overnight 
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at 4°C. Subsequently plates were washed 5 times with standard PBS before being used in 
neutrophil assays.  
2.6.2 Pre-treatment of cultureware with poly-L-lysine 
To facilitate cell adhesion on cultureware, multiwell plates were pre-treated with an adhesive 
agent. A thin layer of 0.1% of poly-L-lysine in water (Sigma P8920) was aliquoted to cover the 
bottom surface of each well. After 10 minutes incubation at room temperature, wells were 
decanted using a vacuum pump and washed with PBS to remove excess adhesive agent.    
2.6.3 Chemiluminescent quantification of ROS 
For the quantification of intra- and extra-cellular ROS, neutrophils were exposed to the 
chemiluminescent substrate luminol, a substrate able to cross the cell membrane and to detect 
the presence of ROS. Luminol reacts with ROS generated by MPO catalytic activity and the 
interaction changes the oxidative status of luminol molecules which emit a light signal once 
excited (Lundqvist et al., 1995). Light output is monitored by a microplate luminometer and 
translated in relative light units (RLU) which are used as a measure of ROS generation 
(Bergström & Asman, 1993; Matthews et al., 2007a).  
2.6.3.1 Glucose-supplemented PBS 
Standard PBS buffer was supplemented with glucose for optimal superoxide production in 
neutrophils (Tan et al., 1998). Glucose-PBS (gPBS) was prepared by mixing 1.8g glucose 
(Sigma G8270), 0.15g CaCl2 (BDH 10070) and 1.5ml MgCl2 (BDH 22093) in 1l sterile PBS 
(section 2.1.4). The solution was filter-sterilised (pore size 0.22µm), aliquoted and stored at -
20°C until used.    
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2.6.3.2 Luminol   
A 30mM stock solution was prepared by dissolving 0.5g luminol (Sigma A8511) in 94.05ml of 
1mM NaOH and stored at 4°C for 6 months protected from light. To prepare the working 
solution, 1ml of stock solution was diluted with 9ml PBS and the pH was adjusted when 
necessary to 7.3 with the addition of HCl or NaOH.  
2.6.3.3 ROS assay    
Neutrophils were diluted in gPBS (section 2.6.3.1) and seeded at 1x105 cells/well in white 96-
well plates (Costar 3912), pre-treated overnight with blocking buffer (section 2.6.1) unless 
otherwise specified. To analyse the production of total ROS, cells were incubated with 30µl 
luminol (section 2.6.3.2) in the luminometer (Berthold Tristar2 LB942) for an initial 30 minutes 
to obtain a baseline reading, prior to addiction of modulators to selected wells and obtaining 
readings for a further 30 minutes. Subsequently, neutrophils were incubated with 25µl of 
selected stimuli in the luminometer for the required incubation time. All readings were obtained 
at 37°C, recorded by MikroWin2000 software (Mikrotek version 4) and expressed in RLU. The 
maximum production of ROS, or peak ROS, was identified using Excel software (Microsoft, 
US) as the highest RLU value registered within the stimulation time.  
2.6.4 Induction of NETosis 
Neutrophils were diluted in RPMI-1640 and seeded as indicated in Table 2.3 in multi-well 
plates pre-treated overnight with blocking buffer (section 2.6.1), unless otherwise specified. 
After an initial 30 minutes incubation period at 37°C and 5% CO2, modulators were added to 
selected wells followed by further incubation for 30 minutes. Subsequently, 25µl stimuli were 
added to each well and neutrophils were incubated for the appropriate stimulation time. 
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NET assay Multi-well plate formats Cell seeding (cells/well) 
Fluorometric Quantification 
Clear 96-well plate 
(Costar 3370) 
1x105 
Visualisation  
Clear 24-well plate 
(Costar 3524) 
1x105 
Clear 48-well plate 
(Costar 3548) 
1x105 
Clear 96-well plate 
(Costar 3370) 
1x105 
High-Content Analysis 
Black, clear bottom 96-well plate 
(Greiner Bio-one 655096) 
1x105 
Black, clear bottom 384-well plate 
(Greiner Bio-one 781096) 
5x103 
Table 2.3: Neutrophil seeding details for assays and plate format. 
 
2.6.5 Fluorometric quantification of NETs 
During the NETosis process, NET filaments are released in the extracellular space as a result 
of pro-inflammatory stimulation. NET filaments are predominantly made of DNA that can be 
easily isolated from intact cells and quantified following appropriate staining. A quantitative 
method for the analysis of NETs was developed in the School of Dentistry Laboratories (Palmer 
et al., 2012a). For reliable quantification, samples were initially treated with micrococcal 
nuclease to detach NET structures from cells and, subsequently a fluorescent DNA dye, Sytox 
green®, was added to the supernatant. Cell free NET-DNA was quantified using a multiplate 
fluorescence reader (Berthold Twinkle2 LB970) and data recorded as arbitrary fluorescence 
units (AFU).  
2.6.5.1 Micrococcal nuclease 
A stock solution of 2136.3U/ml was prepared by dissolving micrococcal nuclease powder 
([MNase]; Worthington 4789) in 10ml sterile water. The 311.3µl stock solution was diluted in 
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50ml sterile PBS to obtain a working solution of 13.3U/ml. This solution was divided into 1ml 
aliquots and stored at -20°C until used.  
2.6.5.2 Sytox green® 
Syotx green® stock solution was supplied by Invitrogen (S7020) and 10µl was diluted in 5 ml 
RPMI-1640 to generate a working solution of 10µM. The working solution was foil-covered 
and stored at -20°C.      
2.6.5.3 Method for NET quantification 
Neutrophils were isolated as described in sections 2.1.5 and NETs were induced as per section 
2.6.4. Post-incubation, samples were treated with 15µl of MNase (section 2.6.5.1) for 15 
minutes at room temperature. Afterwards, plates were centrifuged for 10 minutes at 1800rcf 
(Hettich Universal 320R) and 150µl of supernatant was carefully transferred from each well to 
a black 96-well plate (Costar 3915). The supernatant was stained with 15µl of Sytox green® 
(section 2.6.5.2) and the fluorescence emission was read 5 times using a multiplate fluorometer 
(Berthold Twinkle2 LB970) with an excitation wavelength of 485nm and emission wavelength 
525nm. All readings were obtained at 37°C, recorded using MikroWin2000 software and 
expressed in AFU. 
2.6.6 NET visualisation  
Neutrophils were isolated as described in sections 2.1.5 and NETs were induced as for section 
2.6.4. Since DNA is the major component of NETs their structures can be visualised following 
DNA staining. NET visualisation was, therefore, performed following fluorescence staining of 
DNA and using a fluorescence microscope (CoolLed pE excitation system). 
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2.6.6.1 Paraformaldehyde solution 
Paraformaldehyde (PFA) powder was supplied by Sigma (P6148) and stored at 4°C until use. 
A 20% PFA stock solution was prepared by dissolving 4g powder in 20ml PBS with gentle 
agitation and heating to 60°C. After cooling at room temperature for several minutes the 
solution was filter sterilised and stored at 4°C until used. The 20% PFA solution was further 
diluted with PBS to obtain a working solution of 4%.  
2.6.6.2 PFA fixation 
The 20% PFA solution was added to neutrophil culture medium to give a final concentration of 
4% and samples were incubated at room temperature for 10 minutes. Unless otherwise 
specified, plates were then centrifuged for 10 minutes at 1800rcf (Hettich Universal 320R), 
media was carefully removed from each well and samples were washed twice with PBS.  
2.6.6.3 Visualisation using epifluorescence microscopy 
Post-incubation samples were fixed with PFA (section 2.6.6.2) when specified. Sytox green® 
(section 2.6.5.2) was added and neutrophils were visualised using an epifluorescence 
microscope (Nikon Eclipse TE300) with excitation wavelength of 472nm and emission 
wavelength 520nm (CoolLed pE excitation system). Images were captured with a Nikon D5100 
camera and adjusted for brightness and colour using Fiji software (Image J version 2; 
Schindelin et al., 2012). 
2.7 Immunocytochemical analysis of NF-κB translocation in H400 cells 
Immunocytochemistry (ICC) is a histological technique based on antibody-recognition of 
specific intracellular or extracellular antigens of interest, the visualization is then achieved 
using a secondary labelling system which comprises enzymatic colorimetric reaction or 
fluorophore conjugation (Ordronneau et al., 1981).  
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The translocation of NF-κB from the cytoplasm to nuclei in H400 cells was qualitatively 
assessed using an indirect biotin-streptavidin amplification system (Milward et al., 2013). The 
intracellular NF-κB bound to primary antibody is targeted by a secondary antibody conjugated 
with biotin which has strong affinity for the labelling streptavidin, which is in turn conjugated 
with peroxidase. NF-κB location sites assume a brown colouration due to a change in the 
oxidative state of diaminobenzidene (DAB) activated by the peroxidase.   
2.7.1 Staining technique  
H400 cells were cultured and stimulated on multi-well glass slides as described in sections 2.3.3 
and 2.5. Upon stimulation the glass slides were washed 3 times in PBS followed by fixation in 
dry acetone for 15 minutes. Samples were then air dried for a further 15 minutes. All the 
following staining procedures were performed with the Super Sensitive™ Link-Label IHC 
Detection System kit (BioGenex QD470-60K) and incubation were performed in a dark 
humidifier box set at room temperature. Each well of the glass slide was covered with 100µl 
solution of the anti-NF-κB primary antibody (described in section 2.8.2.2) 1:100 solution in 
PBS 1% BSA (as prepare in section 2.6.1) and washed 3 times in PBS after 1 hour incubation. 
Subsequently each well was covered with Link, a pre-diluted biotinylated anti-mouse IgG 
secondary antibody solution in PBS, and incubated for 20 minutes. Slides were washed 3 times 
in PBS and the Label component (horseradish peroxidase-conjugated streptavidin solution in 
PBS) was applied for further 20 minutes. After washing 3 times with PBS, slides were overlaid 
with DAB reagent previously prepared by diluting 38µl of 3,3'-DAB chromogen solution in 1 
vial of Substrate Buffer. After 5 minutes incubation slides were washed under running water 
and Mayer’s Haematoxylin (BioGenex HK100-5K) was applied for a further 5 minutes. Slides 
were rinsed with deionised water and dehydrated in graded alcohols passages (90%, 100%, 
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100%), cleared in xylene and mounted in XAM neutral medium (BDH Laboratory supplies 
36119).  
2.7.2 Image acquisition, processing and cell count 
Images of stained H400 cells were visualised and acquired using a light microscope (Leitz 
Laborlux s) with 20X lens. Five randomly selected image areas for each experimental condition 
were analysed for NF-κB staining. An image with no cells was used for background correction 
and staining enhancement performed with Fiji software equipped with the “calculator plus” 
plug in (Landini, 2012). The number of cells positive or negative for NF-κB translocation to 
the nucleus were counted in the 5 images with the Fiji software plug in “Cell counter” (De Vos 
& Sheetz, 2007). The percentage of positive cells were determined using the formula:  
.#/012	"3	4"86%6A1	:1778(.#/012	"3	4"86%6A1	:1778) + (.#/012	"3	$#I9%6A1	:1778)×100 
2.8 High-Content Analysis  
The HCA technique utilises automated high-resolution fluorescence imaging to allow rapid 
qualitative and quantitative measurement of multiple parameters (Shariff et al., 2010). Images 
are analysed through a bioinformatics software approach which translates biologically-related 
features in numbers, tables and graphs. The HCA platform has been designed for the analysis 
of biological samples in micro-well plate formats such as 96-, 384- and 1536-well plates, and 
for the simultaneous visualisation of multiple fluorescent staining (Mayr & Bojanic, 2009). 
Therefore, in order to perform HCA, neutrophils and H400 cells were processed for 
immunofluorescence staining in conjunction with a DNA fluorescent counterstaining 
application based on previously published protocols (Corfe et al., 2013).   
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HCA was performed using the platform located at the laboratory of Imagen Therapeutics Ltd 
(Manchester, UK) as summarised in Figure 2.6 and as described below in more detail. 
 
Figure 2.6: Flow diagram of the HCA process for neutrophil analysis.  
Steps involved in sample preparation and HCA application are subdivided into 4 main 
categories and are described within the flow diagram.   
Immunostaining	
(optional)
•Digitonin	to	permeabilise the	outer	cell	wall	
•Primary	antibodies	bind	to	proteins	of	interest
•Fluorescent	secondary	antibodies	bind	to	primary	antibodies	
DNA	staining	
•Hoechst	33342	for	nuclear	staining
•Sytox	green	for	extracellular	DNA	staining
Image	acquisition	
with	ArrayScan	
•Autofocus	and	autoexposure	setting	adjustment
•Fluorescent	lasers	excitation
•Images	captured	with	high-resolution	camera
Image	analysis	
•Cell	identification	in	images	based	on	nuclear	staining
•Cell	rejection	process	based	on	cell	size	and	staining	intensity	
•Identification	of	secondary	intracellular	immunofluorescence	or	extracellular	DNA	
areas
•Validation	of	secondary	fluorescent staining
•Quantification	of	features	of	interest	
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2.8.1 Fluorescent DNA staining 
To visualise neutrophil nuclei and NET structures, two DNA fluorescent dyes were used for 
sample staining. Syotx green® was used as the primary DNA-NET stain as reported in section 
2.6.5.2, while a working solution 20µg/ml Hoechst 33342 (Sigma 14533) was prepared by 
diluting 10µl stock solution in 5ml of sterile PBS and used to highlight neutrophil nuclei.  
2.8.2 Protein immunofluorescence staining   
For the identification and the localisation of protein through the HCA technology, samples were 
processed to allow targeted antibodies, intracellular binding and their fluorescent identification.  
2.8.2.1 0.05% Digitonin  
A 500µg/ml solution (0.05%) of Digitonin was prepared by dissolving 15g of powder 
(Calbiochem, 300410) in 30ml PBS. The solution was heated and boiled in order to dissolve 
the powder for a maximum of 20 seconds and incubated at room temperature until cooled. The 
solution was prepared fresh before every application and stored at room temperature for a 
maximum of 2 hours.   
2.8.2.2 Primary antibodies  
Primary antibodies were carefully selected for specific protein targeting and stock solutions 
were stored at 4°C until used. For cell immunostaining, primary antibodies were diluted as 
indicated in Table 2.4 in 0.05% Digitonin (see section 2.8.2.1). Antibody solutions were 
prepared immediately before use and made fresh prior to application.   
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Target Species Manufacturer Dilution 
PAD4 Mouse Abcam (ab128086) 1:150 
Citrullinated histone 3 Rabbit Abcam (ab5103) 1:150 
MPO Mouse Abcam (ab25989) 1:150 
NE Rabbit Abcam (ab131260) 1:150 
NF-κB Mouse Abcam (ab13594) 1:200 
Table 2.4: Targets and primary antibodies for immunostaining application. 
 
2.8.2.3 Secondary antibodies  
Combination of secondary antibodies were selected from Table 2.5 for simultaneous 
applications. Selected secondary antibodies were diluted 1:500 in Hoechst 33342 solution 
(section 2.1.1) immediately before use and prepared fresh prior to application. 
Table 2.5: Targets and secondary antibodies for immunostaining application. 
Target Species Colour 
Wavelength 
(Ex/Em) 
Manufacturer 
Rabbit IgG Goat 
Alexa Fluor® 
594 
(red) 
590/617nm ThermoFisher Scientific A-11037 
Mouse IgG Goat Alexa Fluor® 488 (green) 495/519nm 
ThermoFisher 
Scientific A-11001 
Mouse IgG Goat 
Alexa Fluor® 
594 
(red) 
590/617nm ThermoFisher Scientific A-11005 
Rabbit IgG Goat 
Alexa Fluor® 
680 
(far red) 
679/702nm ThermoFisher Scientific A-21109 
Mouse IgG Goat 
Alexa Fluor® 
680 
(far red) 
679/702nm ThermoFisher Scientific A-21057 
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2.8.2.4 Method for immunofluorescent staining   
Cultures were incubated with 50µl primary antibodies in 0.05% Digitonin (section 2.8.2.2) at 
room temperature for 1 hour. Following the incubation time, cells were washed twice with PBS 
and further incubated at room temperature with secondary antibodies diluted in Hoechst 33342 
solution (section 2.8.1) for 30 minutes. Subsequently, cells were washed twice with PBS, sealed 
with adhesive film (Greiner A5596-100EA) and stored in the dark prior to image acquisition.    
2.8.3 High-Content Analysis of NETs 
Neutrophils were isolated as described in sections 2.1.5 and NETs were induced as described 
in section 2.6.4 in a black, clear bottom 96-well plate (Greiner Bio-one 655096). Following 
PFA fixation (section 2.6.6.2), neutrophil samples were sealed with an adhesive film to avoid 
evaporation and were transported to the laboratory of Imagen Therapeutics Ltd (Manchester, 
UK) for staining procedures (sections 2.1.1 & 2.8.2) and analysis.   
2.8.4 High-Content Analysis of NF-κB translocation in H400 cells 
H400 cells were cultured and stimulated in a black, clear-bottomed 96-well plate as described 
in sections 2.3.3 and 2.5. Following PFA fixation (section 2.6.6.2), plates were washed 3 times 
with PBS and were sealed with an adhesive film to avoid evaporation during transport to the 
laboratory of Imagen Therapeutics Ltd. NF-κB immunostaining was performed as described in 
section 2.8.2 and H400 cell nuclei were stained with 20µg/ml Hoechst 33342 prepared as des 
cribed in section 2.1.1. HCA was employed to quantify NF-κB nuclear translocation in 
stimulated H400 cells and compared with unstimulated and celastrol treated cells.  
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2.8.5 High-throughput screening of NETosis modulation 
A 56-compound library (Table 2.6.) pre-established by the team at Imagen Therapeutics Ltd 
for ovarian cancer treatment were screened for modulatory effects on neutrophils activation and 
NET release using the HCA technology. The HCS was performed in 384-well plates as is 
described below.  
2.8.5.1 Robotic benchtop workstation  
Compound library preparation and neutrophil handling in 384-well plate was performed with 
Microlab STAR Line robotic benchtop workstation (Hamilton Star) shown in Figure 2.7. The 
automatic seeding was performed with an air-based advanced pipetting Total Aspiration and 
Dispensing Monitoring (TADM) system for a real time supervising of any error that could occur 
during all pipetting steps. The Air-Droplet Control (ADC) system eliminated dripping by 
compensating the pressure changes in the channels. The system uses the CO-RE Technology 
to avoid build-up of aerosols due to forceless tip pick-up and ejection. The automatic 
workstation was programmed and controlled through the VENUS software (Hamilton). 
 
Figure 2.7: Hamilton Star robotic benchtop workstation. 
Illustration of the Hamilton Star automatic benchtop operating on biological samples in a 384-
well plate. 
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2.8.5.2 56-compound library preparation  
All compounds were diluted in DMSO as per manufacturer instructions. Master plates with 
compounds 1000 times concentrated were prepared in advance, sealed with adhesive film and 
stored at -20° until application. Compounds were combined and diluted in PBS to obtain 5 
concentrations ranging between 0.025nM and 250000nM. Twenty-µl of each concentration 
were then added to 30µl of neutrophils to obtain compound concentrations ranging between 
0.01nM and 100000nM as recommended by the team of Imagen Therapeutics Ltd and as 
specified in Table 2.6.  
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Compound name Dosage Manufacturer 
Benzethonium Chloride 100nM Selleckchem S4162 
Axitinib 1-10000nM Selleckchem S1005 
BEP (Bleomycin, Etoposide, Cisplatin)* 0.1-1000nM 
Bleomycin Sulfate 1-10000nM Selleckchem S1214 
Bortezomib (PS-341) 0.1-1000nM Selleckchem S1013 
Bosutinib (SKI-606) 1-10000nM Selleckchem S1014 
Cabozantinib (XL184, BMS-907351) 0.1-1000nM Selleckchem S1119 
Capecitabine 1-10000nM Selleckchem S1156 
Carboplatin 1-10000nM Selleckchem S1215 
Carboplatin & Gemcitabine* 0.1-1000nM 
Carboplatin & Taxol* 0.1-1000nM 
Carfilzomib (PR-171) 0.1-1000nM Selleckchem S2853 
Carmustine 1-10000nM Sigma C0400 
Cisplatin 1-10000nM Selleckchem S1166 
Cladribine 1-10000nM Selleckchem S1199 
Clofarabine 1-10000nM Selleckchem S1218 
Crizotinib (PF-02341066) 1-10000nM Selleckchem S1068 
Dabrafenib (GSK2118436) 1-10000nM Selleckchem S2807 
Dacarbazine 1-10000nM Selleckchem S1221 
Dasatinib 1-10000nM Selleckchem S1021 
Docetaxel 0.1-1000nM Selleckchem S1148 
Doxorubicin & Topotecan* 0.1-1000nM 
Doxorubicin (Adriamycin) 1-10000nM Selleckchem S1208 
Epothilone B (EPO906, Patupilone) 1-10000nM Selleckchem S1364 
Erlotinib HCl (OSI-744) 1-10000nM Selleckchem S1023 
Etoposide 1-10000nM Selleckchem S1225 
Everolimus (RAD001) 0.1-1000nM Selleckchem S1120 
Gefinitib (ZD-1839, Iressa) 1-10000nM Selleckchem S1025 
Gemcitabine & Cisplatin 0.1-1000nM 
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Gemcitabine 0.1-1000nM Selleckchem S1714 
Imatinib (STI571, Gleevec) 1-10000nM Selleckchem S2475 
Irinotecan 0.1-1000nM Selleckchem S1198 
Lapatinib 1-10000nM Selleckchem S2111 
Lomustine 10-100000nM Selleckchem S1840 
Methotrexate 1-10000nM Selleckchem S1210 
Mitoxantrone 0.1-1000nM Selleckchem S1889 
Nilotinib (AMN-107) 1-10000nM Selleckchem S1033 
Olaparib (AZD2281, KU0059436) 1-10000nM Selleckchem S1060 
Oxaliplatin 1-10000nM Selleckchem S1224 
Paclitaxel (Taxol) 0.1-1000nM Selleckchem S1150 
Pazopanib 1-10000nM Selleckchem S3012 
Ponatinib (AP24534) 1-10000nM Selleckchem S1490 
Rapamycin (Sirolimus) 0.1-1000nM Selleckchem S1039 
Regorafenib (BAY 73-4506) 1-10000nM Selleckchem S1178 
Ruxolitinib (INCB018424) 1-10000nM Selleckchem S1378 
Sorafenib Tosylate 1-10000nM Selleckchem S1040 
Staurosporine 0.01-100nM Selleckchem S1421 
Sunitinib 1-10000nM Selleckchem S7781 
Teniposide 1-10000nM Selleckchem S1787 
Temozolomide (TMZ ) 1-10000nM Selleckchem S1237 
Topotecan HCl 1-10000nM Selleckchem S1231 
Trametinib (GSK1120212) 1-10000nM Selleckchem S2673 
Vandetanib (ZD6474) 1-10000nM Selleckchem S1046 
Vemurafenib (PLX4032, RG7204) 1-10000nM Selleckchem S1267 
Vinorelbine Tartrate 1-10000nM Selleckchem S4269 
Vismodegib (GDC-0449) 1-10000nM Selleckchem S1082 
Vorinostat (SAHA, MK0683) 1-10000nM Selleckchem S1047 
Table 2.6: Compound library composition. 
*Combination of equal proportions of specified compounds.  
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2.8.5.3 Application of the compound library for neutrophil analysis  
Neutrophils were isolated as described in section 2.1.5 and seeded at 30µl/well in a black, clear 
bottom 384-well plate. The 56-compound library (described in section 2.8.5.2) was applied to 
neutrophils followed by 30 minutes incubation at 37°C and 5% CO2. Subsequently, NETs were 
induced with PMA as for section 2.6.4, neutrophils were fixed with PFA (section 2.6.6.2) and 
plates were sealed with an adhesive film to minimise evaporation.  
2.8.6 Image acquisition  
Plates for HCA and HCS were sequentially loaded onto the Cellomics™ ArrayScan™ reader 
(ThermoFisher Scientific, VTI) using a computer driven Thermo Catalyst express robotic arm. 
Samples were visualised with the ArrayScan™ automated Observer Z1 inverted microscope 
(Zeiss) with transmitted light and fluorescence and high-resolution images of up to 30 fields 
per well were acquired and captured using a CCD camera (Hamamatsu Orca ER) equipped with 
5X/0.25 Fluar, 10X/0.3 Plan Neofluar and 20X/0.4 Epi Plan objectives (Zeiss). Visualisation 
of fluorescence staining was achieved using an automated excitation filter wheel and automated 
dichroic/emission cube turret for efficient automated imaging of combinations of dyes covering 
blues, greens, reds, and long reds. All operations were driven by the HCS Studio™ 2.0 Client 
software (Cellomics, ThermoFisher Scientific) with features for autofocus, autoexposure and 
cell subpopulation settings.  
2.8.7 Image analysis 
Quantitative analysis of images obtained with the ArrayScan™ (section 2.8.6) were performed 
using the ArrayScan HCS Reader software (Cellomics, ThermoFisher) provided with built-in 
algorithms for biological analysis. Settings of pre-determined algorithms were modified and 
adjusted for the correct identification of individual cells or subdivision into sub-populations as 
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for features of interest. The software automatically identified cells in each image based on their 
nuclear size and staining intensity (Figure 2.8a). Rejection thresholds were adjusted as required 
to exclude objects exceeding a minimum or maximum size or intensity which did not relate to 
cellular features (Figure 2.8b). Afterwards, the software analysed pixels of any staining area 
associated with the previously identified nuclei (Figure 2.8c) and translated image outputs in 
numbers which, in turn, were statistically analysed. The algorithms employed in this thesis 
comprise built-in Compartmental Analysis and Tube Formation algorithms, and custom built 
NET Detection and Nuclear Decondensation algorithms.  
a)  
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b) 
 
c) 
 
Figure 2.8: Images of screenshots of the operating ArrayScan HCS software. 
Screenshot of the ArrayScan HCS software acquired during NET image processing using the 
Compartmental Algorithm. a) Setting adjustment for cell identification. b) Setting adjustment 
for the validation of cell recognition shown in a). c) Quantification of pixels of florescence 
staining within the area surrounding those cells selected in a) and b). 
  88 
2.9 Statistical analysis  
Statistical analysis and graph presentation of data was performed with Prism version 6 and 7 
(GraphPad). Data are expressed as mean values and error bars indicate standard error of the 
mean (SEM). Analysis of normal distribution was run with the D’Agostino-Pearson omnibus 
normality test which determined whether the dataset followed a normal or non-normal 
distribution, therefore data were treated as appropriate. Statistical tests were considered valid 
exclusively with P values ≤ 0.05. N number, statistical tests and significance are expressed for 
each dataset.  
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5 CHAPTER 3: CHARACTERISATION OF 
CONDITIONS FOR NET ANALYSIS 
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  Background 
During microbial infections, neutrophils are recruited to diseased sites from the capillary 
circulation (Kolaczkowska & Kubes, 2013). Once neutrophils localize and reach the colonising 
microorganisms, they become activated and initiate their antimicrobial strategies (as described 
in section 2.1.3) (Chapple & Matthews, 2007). Periodontitis is a well characterised 
inflammatory disease and the events occurring at the site of infection, including neutrophils 
interacting with periodontal pathogens, can be modelled in vitro (Serhan et al., 2008). In order 
to reproduce the in vivo conditions implicated in inflammation, human neutrophils were isolated 
from peripheral venous blood for in vitro analysis. Infectious conditions were mimicked by 
exposing cells to physiologically or chemically relevant stimuli. Since NETosis has been 
previously demonstrated to depend upon NOX activity and ROS generation (Palmer et al., 
2012a; Remijsen et al., 2010), neutrophil activation state in response to stimulation and 
experimental conditions applied was evaluated through the measurement of two parameters, 
the release of NETs and the production of intracellular and extracellular ROS. Notably, 
variation in type and duration of stimulation often results in qualitative and quantitative 
differences in NET release (Brinkmann et al., 2004). Therefore, for the analysis of neutrophil 
activation status, current techniques focus on monitoring ROS production and quantifying 
extracellular NET-DNA using fluorometric assays (described in section 2.6.2) in time-course 
studies. NET quantification assays have the potential to be performed using HCA, however, 
analytical conditions required optimisation for this purpose. The aim of this chapter was 
therefore to test and identify appropriate conditions for NET release which could be applied for 
neutrophil investigations using a HCA platform. Research areas covered in this chapter include: 
i) the effect of physiological and non-physiological (chemical) stimuli on neutrophil activation; 
ii) analysis of stimulation threshold; iii) effect of temperature and CO2 conditions on NET 
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production; iv) effect of ion-supplemented media on neutrophil activation; and v) the 
comparison between human and murine bone marrow neutrophils and their responses.  
 Stimuli selection  
Stimuli tested for neutrophil activation were divided into the two categories of “physiological” 
and “non-physiological” (chemical). Physiological stimuli were considered those that have 
been previously related to periodontitis pathogenesis and are known to activate neutrophils 
through surface receptor-binding, and include single species oral pathogens, oral biofilms and 
E. coli LPS (described in section 2.3.1). Chemical stimuli utilised for the following experiments 
were HOCl and PMA as they are well characterised stimuli of NET production (Palmer et al., 
2012a; Ermert et al., 2009; Gupta et al., 2005). Data on stimulation obtained for both ROS and 
NET production were compared with unstimulated basal levels.  
 PMA stimulation 
PMA is a cell permeable compound that simulates DAG upstream of the activation of the PKC 
pathway, thereby bypassing the surface receptor binding process necessary for NET stimulation 
(Fuchs et al., 2007). Previous publications on neutrophil stimulation have used concentrations 
of PMA between 10-50nM (Fuchs et al., 2007;Brinkmann et al., 2004). In order to characterise 
the PMA dose dependency response, a range of concentrations between 0 and 50nM were 
assayed for ROS and NET production.  
Time-course analysis of total ROS was evaluated for up to 4 hours following exposure to PMA 
using a chemiluminescence assay (section 2.6.3) in which oxygen radicals are quantified as 
relative light units (RLU) emitted by oxidised luminol. Data demonstrated that the ROS signal 
increased with the time of exposure to PMA (Figure 3.1a), reached its maximum production 
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between 60 and 100 minutes after stimulation and, subsequently decreased. Higher PMA 
dosages reduced the time period required for stimulation of the maximum level of ROS 
production (Figure 3.1a). The minimal concentration of PMA necessary to induce a detectable 
ROS response was 6nM, while concentrations above this resulted in a dose-dependent increase 
in ROS signal as confirmed by the analysis of peak ROS release (Figure 3.1b). Dose-response 
data indicated detectable amounts of ROS were generated only following exposure to 
concentrations of 25nM PMA and above. NET analysis was performed by exposing neutrophils 
to the same range of PMA concentrations for up to 4 hours and was quantified fluorometrically 
(section 2.6.5). Data presented in Figure 3.1c indicated a dose-response release of NETs of a 
similar profile to that observed for ROS production (Figure 3.1b). Similar to ROS production, 
PMA-induced NET release required a minimum concentration of 6nM or above for detection, 
and significant levels of NET-DNA were detected only after stimulation with 50nM PMA 
compared with unstimulated neutrophils.     
a) Time-course PMA dose-response ROS production 
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b) Peaks of ROS production: PMA dose-response 
 
c) PMA dose-response NET release  
 
Figure 3.1:PMA dose-response for stimulation of ROS and NETs. 
Stimulation of neutrophils with a range of PMA dosages (0 – 50nM) and its effect on a) time-
course production of total ROS; b) peak ROS production, and c) NET production at 4 hours. 
Values are expressed as relative light units (RLU) or arbitrary fluorescence units (AFU) and as 
mean ± SEM. Statistical significance calculated with Dunnett’s multiple comparison test (n= 
5; *p<0.05, ****p<0.0001). 
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Ex vivo NET studies are routinely performed at 37°C in 5% CO2 throughout the stimulation to 
provide physiologically relevant conditions. However, performing real-time HCA of NET 
formation would require incubation of neutrophils for extended time periods in the Arrayscan 
Cellomics equipment, which operates at room temperature and provides no CO2 
supplementation. Due to these logistic limitations, NET release was evaluated by fluorometric 
assay (section 2.6.5) in equivalent environmental conditions and compared with tissue culture 
incubation (37°C in 5% CO2). For the following experiment, neutrophils were incubated with 
50nM PMA for up to 3 hours at room temperature, 37°C, or 37°C in 5% CO2 (section 2.6.4); 
and NETs quantified throughout the stimulation interval. Time-course analysis of NET 
formation (Figure 3.2a) indicated that incubation performed at 37°C in 5% CO2 resulted in the 
highest amount of NET-DNA release in response to PMA, whereas in the absence of 5% CO2 
the levels of NETs decreased. Incubation at room temperature, however, considerably reduced 
the amount NET-DNA released and NETs remained at significantly lower levels throughout 
the entire stimulation period (Figure 3.2b).  
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a) Time-course of NET quantification  
 
b) NET production: room temperature (RT), 37°C/atmospheric CO2, and standard 
incubator 37°C/5% CO2 
 
Figure 3.2: Time-course analysis of NET release following PMA stimulation under 
different environmental conditions. 
PMA stimulated NET-DNA quantification over 3h incubation at room temperature (RT), at 
37°C/atmospheric CO2, and standard 37°C/5% CO2. a) Time-course analysis of NET 
production and b) comparison between the different environmental conditions applied. Values 
are expressed as arbitrary fluorescence units (AFU) and as mean ± SEM. Statistical 
significance calculated with Tukey’s multiple comparison test (n= 4; *p<0.05, ***p<0.001). 
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 NET production following stimulation with periodontally relevant bacteria  
To mimic the in vivo activity of neutrophils combatting a periodontal infection, two well 
characterised periodontal pathogens were assayed for neutrophil activation, namely F. 
nucleatum and P. gingivalis. Both periodontally-associated Gram negative bacteria trigger 
receptor-induced intracellular signalling cascades leading to ROS production and subsequent 
NET release (Prince et al., 2011). Subsequently single-strain bacterial cultures were heat-killed 
and employed in time-course studies for total ROS production and NET release. Bacteria were 
used at a MOI of 100:1 according to previous studies which report the numbers of bacteria 
associated with periodontal pocket epithelium during active disease (Dierickx et al., 2002). 
Real-time total ROS production was recorded using the chemiluminescence assay (section 
2.6.3) before and after stimulation for up to 10 hours. Neutrophil responses to F. nucleatum 
(MOI 100:1) were compared with PMA (50nM) exposure, which was used as a positive control 
and also with unstimulated cells as negative control. Figure 3.3a displays the differences in 
profiles generated between these two types of stimulation. The reaction to PMA began within 
30 minutes of initial exposure to the stimulus and resulted in a sudden relatively high peak that 
slowly decreased up to 5 hours post-stimulation. Conversely, F. nucleatum stimulation resulted 
in a different curve profile and relatively slowly reached peak levels after approximately 4 hours 
exposure to bacteria, gradually decreasing to basal levels by 9 hours. Peak levels of ROS 
production are compared in Figure 3.3b. Consistent with the time-course data, peaks for both 
stimulations were significantly higher compared with basal levels of unstimulated cells, 
however, the difference between the two types of stimuli was not significant.  
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a) Time-course ROS production in response to PMA and F. nucleatum 
 
b) Peaks of ROS production in response to PMA and F. nucleatum 
 
Figure 3.3: Analysis of ROS production by neutrophils in response to PMA and F. 
nucleatum. 
Representative plots of total ROS production over 10h stimulation with PMA and F. nucleatum 
(Fn) are presented. a) Time-course quantification of ROS in response to PMA (green) and F. 
nucleatum (blue) compared with unstimulated neutrophils (red). b) Analysis of peak ROS 
production in response to PMA and F. nucleatum compared with unstimulated neutrophils 
(n=3). Values are expressed as relative light units (RLU) and as mean ± SEM.  
To investigate differences between periodontally-pathogenic bacteria, neutrophils were 
exposed to P. gingivalis (MOI 100:1) for 4 hours. Neutrophil activation was quantified in terms 
of ROS production and NET release respectively using chemiluminescence and fluorometric 
assays. Peak levels of ROS were compared with F. nucleatum which was used as a positive 
control and unstimulated neutrophils were used as negative control. Data from P. gingivalis 
stimulation indicated a significant amount of ROS were produced compared with basal 
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unstimulated levels, however, significantly lower levels were detected compared with F. 
nucleatum stimulation (Figure 3.4a). Conversely, data on NET release indicated that 
stimulation with P. gingivalis induced a higher amount NET-DNA compared with F. nucleatum 
stimulation (Figure 3.4b).  
a) Peaks of ROS production in response to F. nucleatum and P. gingivalis 
 
b) NET production in response to F. nucleatum and P. gingivalis exposure 
 
Figure 3.4: Total ROS and NET production in response to different bacterial stimuli. 
Neutrophil responses to F. nucleatum (Fn) and P. gingivalis (Pg) stimulation over 4h. Analysis 
of a) peaks of total ROS and b) NET production. Values are expressed as relative light units 
(RLU) or arbitrary fluorescence units (AFU) and as mean ± SEM. Statistical significance 
calculated with Dunnett’s multiple comparison test (n= 3 individuals; ns=non significant, 
*p<0.05, **p<0.01). 
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Activation of neutrophils in response to bacterial stimuli is driven by receptor-binding 
processes which involve simultaneous activation of multiple receptors present on the cell 
surface as described by Futosi et al. (2013) and in section 2.3.1.1 of the Introduction. The 
concentration of bacteria required to trigger the activation of NOX complexes was determined 
using a range of F. nucleatum dosages. In order to test dose-response activation and mimic the 
immune response occurring in different stages of infection, neutrophils were stimulated with 
concentrations of F. nucleatum ranging between 0.1 and 100 bacteria per neutrophil. Data on 
time-course analysis indicated that the maximum level of ROS production occurred relatively 
early (at ~60 minutes) following stimulation with the highest F. nucleatum dosage (MOI 100:1) 
(Figure 3.5a). Concurrently, comparison of peak ROS production showed a dose-dependent 
increase in activation (Figure 3.5b).  
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b) Peaks of ROS production  
 
Figure 3.5: F. nucleatum dose-response stimulation of total ROS production. 
Dose-response F. nucleatum induction of ROS production at 150 min stimulation (MOI 1:10, 
5:10, 1:1, 5:1, 10:1, 50:1, 100:1). Data for a) time-course production and b) total ROS peak. 
Values are normalised to control and expressed as relative light units (RLU). Statistical 
significance calculated with two-way ANOVA and Tukey’s multiple comparison test (n=3; 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).   
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Bacterial and chemical stimuli differentially activate neutrophils and responses vary in time and 
magnitude (Parker et al., 2012a). In order to identify at what stage of the stimulation NET-DNA 
is first identified in neutrophils, samples were stimulated with F. nucleatum, PMA and HOCl 
for a 4 hour time-course and NETs were fluorometrically quantified at the time-points of 0, 30, 
60, 120, 180 and 240 minutes post-exposure. Figure 3.6a represents an overview of all 
stimulations analysed along with differences in timing and relative amounts of NETs produced. 
Of the three stimuli tested, HOCl initiated NET release earlier than the other stimuli, data that 
is consistent with that previously described by Palmer et al. (2012a). The levels of HOCl-
induced NET-DNA release were significantly higher compared with controls, and occurred as 
early as 30 minutes post-stimulation and increased up to four times by 240 minutes post-
exposure. PMA resulted in delayed stimulation with significant levels of NET-DNA not being 
detected until 180 minutes post-exposure. Analysis of F. nucleatum stimulated NETs showed 
detectable NET-DNA induction at a later time-point compared with the other stimuli applied 
(Figure 3.6b). 
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a) NET production using three stimuli           
 
b) F. nucleatum stimulation (re-plotted from above graph) 
 
Figure 3.6: Time-course analysis of NET production in response to three different stimuli. 
NET quantification over 240 min stimulation with a) F. nucleatum, PMA and HOCl compared 
to unstimulated neutrophils; b) re-plotted data from graph presented in a) showing detailed F. 
nucleatum stimulation. Values are expressed as arbitrary fluorescence units (AFU) and as mean ± SEM. Statistical significance calculated with Tukey’s multiple comparison test (n= 3; 
*p<0.05, ***p<0.001, ****p<0.0001). 
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Neutrophil exposure to F. nucleatum was also observed using a fluorescence microscope to 
determine the feasibility of using bacterial stimulation for further analysis by HCA. 
Subsequently, unstimulated and F. nucleatum-stimulated neutrophil preparations were stained 
with Sytox green® and analysed by epifluorescence microscopy. Images presented in Figure 
3.7 demonstrate that bacterial cells were also stained by the DNA dye and created a notable 
background noise that may impact upon NET quantification using HCA image analysis 
techniques.  
Control                                                              F. nucleatum  
  
Figure 3.7: Fluorescence microscopy images of neutrophil co-localisation with F. 
nucleatum. 
Neutrophils and F. nucleatum bacteria (heat-killed) were visible after staining with Sytox green 
and with fluorescence microscopy observation. Unstimulated cells on the left panel and bacteria 
stimulation on the right panel. Neutrophils are indicated by white arrows and F. nucleatum by 
red arrows. Scale bar represents 200µm. Images are representative of 3 independent 
experiments.  
 
 Lipopolysaccharide stimulation of NETs 
Neutrophil stimulation is reportedly more rapid when triggered by multiple receptor being 
activated and bacterial components are also effective activators of several cell surface receptors, 
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as described in section 2.3.1.1. The advantages of using single bacterial components compared 
with using whole bacteria, is the absence of bacterial DNA and the possibility that the use of 
DNA dyes will subsequently not generate background noise which may interfere with future 
HCA. The following experiments aimed to identify optimal conditions for LPS stimulation of 
neutrophils.   
LPS was diluted in standard PBS or PBS supplemented with 10% human plasma, 20% human 
plasma or 10% BSA; and used for neutrophil stimulation at 1µg/ml final concentration in order 
to verify whether these media would affect LPS stimulation. Production of ROS was evaluated 
using the chemiluminescence assay for up to 4 hours and ROS peak signals were compared. 
Figure 3.8a shows levels of ROS stimulation were similar with all four PBS buffer solutions 
used, however, LPS dilution in PBS supplemented with 10% BSA resulted in slightly lower, 
although non-significant, levels of ROS. Compared with unstimulated neutrophils, 1µg/ml 
LPS-stimulation resulted in increased ROS production although this was non-significant for all 
four tested buffer solutions used (Figure 3.8b).  
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a) LPS-stimulated total ROS production  
 
b) Peak total ROS production: LPS vs control 
  
Figure 3.8: LPS-stimulated ROS production in different buffers. 
LPS-induced total ROS formation, with peak analysis in a) standard PBS, 10% plasma 
supplemented PBS, 20% plasma supplemented PBS and 10% BSA supplemented PBS, and b) 
in comparison with unstimulated neutrophils. Values are expressed as relative light units (RLU) 
and as mean ± SEM. Statistical significance calculated with Tukey’s multiple comparison test 
(n=3; ns= non significant).   
PB
S
PB
S 1
0%
 pl
as
ma
PB
S 2
0%
 pl
as
ma
PB
S 1
0%
 BS
A
0
5000
10000
15000
20000
Media conditions
R
LU
ns
PB
S
PB
S 1
0%
 pl
as
ma
PB
S 2
0%
 pl
as
ma
PB
S 1
0%
 BS
A
0
5000
10000
15000
20000
Media conditions
R
LU
Control 
LPS
ns
  107 
The stimulation triggered by LPS in supplemented buffers was additionally tested for inducing 
NET formation at 4 hours post-exposure. Consistent with ROS data, addition of plasma or BSA 
to the standard PBS resulted in similar values of LPS-induced NETs as shown in Figure 3.9a. 
Similarly, compared with basal levels of unstimulated cells shown in Figure 3.9b, LPS was able 
to induce NET production although data were not statistically different from those in 
unstimulated cells. This result was consistent with the ROS data, nevertheless, for further 
experiments LPS was diluted in PBS buffer supplemented with 10% human plasma in order to 
facilitate receptor binding (Luchi & Munford, 1993). 
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a) LPS-stimulated NET production  
 
b) NET production: LPS vs control 
 
Figure 3.9: LPS-stimulated NET production in different buffers. 
LPS-induced NET formation a) analysed in standard PBS, 10% plasma supplemented PBS, 
20% plasma supplemented PBS and 10% BSA supplemented PBS, and b) in comparison with 
unstimulated neutrophils. Values are expressed as arbitrary fluorescence units (AFU) and as 
mean ± SEM. Statistical significance calculated with Tukey’s multiple comparison test (n=3; 
ns= non significant).   
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As demonstrated above, 1µg/ml LPS did not induce significantly higher ROS or NET responses 
whether it was diluted in plasma or in standard PBS. Therefore, different dosages of LPS were 
tested as stimuli for both ROS and NET production. LPS was tested in a range of concentrations 
between 0.5 to 10µg/ml and neutrophil responses were analysed up to 4 hours exposure. Results 
presented in Figure 3.10a indicate all four concentrations induced a dose-dependent release of 
ROS compared with unstimulated neutrophils and the highest amount was registered upon 
stimulation with 10µg/ml LPS. Interestingly, NET quantification (shown in Figure 3.10b) 
indicated all four concentrations were ineffective in inducing significant NET release and, 
interestingly, stimulation with 10µg/ml LPS resulted in a significantly lower amount of NETs 
compared with unstimulated neutrophils. The high concentration of LPS may, actually, be 
associated with cell death do to the overwhelming signal or may activate an alternative killing 
mechanism such as phagocytosis.  
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a) LPS dose-response stimulation of total ROS  
 
b) LPS dose-response of NET production  
 
Figure 3.10: Dosage analysis for LPS stimulation of neutrophils. 
LPS dose-response (0.5 - 10µg/ml) stimulation of a) peak total ROS production and b) NET 
production 4 hours post-stimulation. Values are expressed as relative light units (RLU) or 
arbitrary fluorescence units (AFU) and as mean ± SEM. Statistical significance calculated with 
Dunnett’s multiple comparison test (n= 3; *p<0.05, **p<0.01, ***p<0.001). 
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 Multi-species biofilms as stimulants for NET release 
In periodontitis pathogenesis excess inflammation is driven by the dysregulation of the host 
immune response following microbial challenge ( Darveau, 2010). More than 400 bacterial 
species have been identified within the oral biofilm to form the subgingival plaque (Xiao et al., 
2016) and subdivided into categories based on their association with the disease (Socransky et 
al., 1998). To study the complex interaction between the host immune-inflammatory response 
and microbial plaque, Millhouse et al. (2014) developed a simplified model of oral multi-
species biofilms and analysed the ability of these bacterial complexes to induce inflammatory 
responses in oral epithelial cells. This study identified that the co-culturing of oral epithelial 
cells with a disease-associated biofilm resulted in elevated expression of pro-inflammatory 
cytokines, such as IL-8 and TNF-α. Therefore, in the following experiments neutrophils were 
exposed to supernatants from 3-, 7- and 10-species biofilms which represents model for the 
healthy or disease-associated plaque as described in section 2.4.1.2 of the Materials and 
Methods. Additionally, supernatants from co-cultures of oral epithelial cells with biofilm 
models were used to stimulate neutrophils to mimic the local immune-response occurring 
during periodontal inflammation. 
To analyse neutrophil responses to pathogenic and non-pathogenic biofilms directly, cells were 
incubated with supernatants from the culture of 3-, 7-, 10-species biofilms and compared with 
PMA induction as a positive control, the carrier diluent artificial saliva or unstimulated 
neutrophils were used as negative controls. Time-course ROS release was monitored by 
chemiluminescence assay, while NET production was fluorometrically evaluated following 4 
hours of incubation. Data presented in Figure 3.11a indicate ROS production was elevated after 
exposure to all three types of biofilms, the highest response was obtained with the 3-species 
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biofilm stimulation, however, sterile artificial saliva was also able to induce significant ROS 
production. Conversely, data shown in Figure 3.11b indicated all three multispecies biofilm 
supernatants were insufficient to stimulate significant NET production after 4 hours.     
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a) Peak ROS production 
 
b) NET production 
 
Figure 3.11: Neutrophil response to multi-species biofilms. 
Stimulation with 3-, 7-, and 10-species biofilm supernatants compared with PMA, artificial 
saliva and unstimulated neutrophils. a) Effect on ROS production and b) quantification of NET-
DNA release. Values are expressed as relative light units (RLU) or arbitrary fluorescence units 
(AFU) and as mean ± SEM. Statistical significance calculated using the Dunnett’s multiple 
comparison test (n= 3; *p<0.05, **p<0.01). 
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In order to study neutrophil responses to pro-inflammatory stimuli released by oral epithelial 
cells when exposed to multispecies biofilms, supernatants from 24 hour co-cultures were used 
to stimulate ROS and NET-DNA release. Time-course ROS production was evaluated by real-
time chemiluminescence quantification and compared with unstimulated oral epithelial cell 
supernatant, unstimulated neutrophils and PMA-stimulation. The analysis of peak ROS levels 
for each condition showed an increased and significant signal in response to the supernatants 
from oral epithelial cells co-cultured with 7- and 10-species biofilms (Figure 3.12a). However, 
fluorometric quantification of NET production after 4 hours stimulation showed minimal 
increase of NET-DNA (Figure 3.12b).  
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a) ROS production following exposure to epithelial cell supernatants 
 
b) NET production following exposure to epithelial cell supernatants 
 
Figure 3.12: Neutrophil responses to supernatants obtained from co-cultures of oral 
epithelial cells with multi-species biofilms. 
Stimulation with the supernatant from oral epithelial cell cultures (Oral Ep cells) or co-cultured 
with 3-, 7-, and 10-species biofilms (Oral Ep+3sp-, 7sp-, 10sp-biofilm) compared with PMA 
and unstimulated neutrophils. a) Effect on ROS production and b) quantification of NET-DNA 
release. Values are expressed as relative light units (RLU) or arbitrary fluorescence units (AFU) 
and as mean ± SEM. Statistical significance calculated using the Dunnett’s multiple 
comparison test (n= 3; *p<0.05, ***p<0.001, ****p<0.0001). 
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 Ion supplemented media as stimuli for NETs 
Increased levels of salivary calcium have been related to oral diseases and extracellular calcium 
flux has a major role in neutrophil activation as described in section 2.2.1.3 of Introduction. 
Although salivary ionic levels differ from serum levels, alterations in saliva components mirror 
the fluctuations occurring in the human blood following disease progression (Greabu et al., 
2009). Therefore, the following experiments were performed to determine whether increased 
levels of serum extracellular calcium, as a salivary mimic for periodontitis, affect ROS 
generation and NET production in peripheral blood neutrophils.     
 Effects of calcium and magnesium ions on ROS production          
CaCl2 and MgCl2 at a final concentration of 1mM were used to supplement PBS in order to 
represent ionic levels found in serum (Sullivan et al., 1979) and neutrophil activity was 
compared with glucose-supplemented PBS (gPBS) and non-supplemented PBS. Neutrophils 
were seeded in supplemented PBS and stimulated with PMA to analyse ROS production in the 
presence of these cations. Figure 3.13a shows how supplementation of PBS with cations 
modified the profile of ROS release over time. Calcium supplementation resulted in a reduction 
in the peak signal detected at 60 minutes after exposure to non-supplemented media, however, 
at 100 minutes levels of ROS were equivalent. Conversely, the magnesium supplementation 
resulted in similar ROS levels over time to those of the non-supplemented conditions, however 
levels of ROS were marginally reduced. Supplementation with both calcium and magnesium 
compared with non-supplemented PBS resulted in an overall reduced level of ROS production. 
PMA stimulation, in both supplemented and non-supplemented media resulted in a significant 
increase in ROS compared with unstimulated neutrophils (Figure 3.13b).  
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a) Time-course of total ROS production in response to PMA 
 
b) Peak ROS production: control vs PMA 
 
Figure 3.13: PMA induced ROS production in ion-supplemented PBS. 
Neutrophils were stimulated with PMA in standard PBS (-/-), Ca+2 PBS (+/-), Mg+2 PBS (-/+), 
Ca+2/Mg+2 PBS (+/+) and gPBS. a) Time-course analysis of total ROS production and b) 
analysis of peak ROS production in comparison with unstimulated neutrophils. Values are 
expressed as relative light units (RLU) and as mean ± SEM. Statistical significance was 
calculated with Tukey’s multiple comparison test (n= 3; ****p<0.0001).   
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Following analysis of peak ROS production with supplemented and non-supplemented media 
in unstimulated neutrophils, the amount of ROS quantified was found to be significantly higher 
in the presence of calcium alone or when supplemented with both calcium and magnesium, 
while magnesium supplementation alone resulted in similar levels of peak ROS production 
compared with non-supplemented and glucose supplemented PBS (Figure 3.14a). However, in 
PMA-stimulated neutrophils, all supplementations resulted in lower levels of ROS release 
compared with non-supplemented PBS, while calcium supplemented PBS resulted in a 
significant reduction compared with non-supplemented PBS and gPBS (Figure 3.14b).  
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a) Unstimulated neutrophils 
 
b) PMA stimulated neutrophils 
 
Figure 3.14: Effect of ion supplementation on ROS production.  
Analysis of peak ROS production in a) unstimulated and b) PMA stimulated neutrophils in 
standard PBS (-/-), Ca+2 PBS (+/-), Mg+2 PBS (-/+), and Ca+2/Mg+2 PBS (+/+) compared with 
gPBS. Values are expressed as relative light units (RLU) and as mean ± SEM. Statistical 
significance was calculated using Tukey’s multiple comparison test (n= 3; *p<0.05, **p<0.01, 
***p<0.001). 
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 Effect of calcium and magnesium supplementation on NET production 
Calcium and magnesium supplemented PBS was also assayed for NET production upon 
stimulation with PMA. Figure 3.15 shows levels of NETs produced in response to PMA. In 
enriched media with magnesium or both elements, PMA stimulation resulted in significantly 
higher levels of NETs compared with unstimulated cells, however, with calcium alone the 
difference was not significant.  
 
Figure 3.15: PMA stimulated NET production in ion-supplemented media. 
PMA stimulation compared to unstimulated neutrophils in standard PBS (-/-), Ca+2 PBS (+/-), 
Mg+2 PBS (-/+), and Ca+2/Mg+2 PBS (+/+). Values are expressed as arbitrary fluorescence units 
(AFU) and as mean ± SEM. Statistical significance was calculated with Tukey’s multiple 
comparison test (n= 3; ns= non significant, ***p<0.001, ****p<0.0001). 
Supplementation of PBS with both calcium and magnesium resulted in significantly higher 
levels of basal NET production in unstimulated neutrophils compared with the other conditions 
assayed (Figure 3.16a). Similarly, upon PMA stimulation, cells produced a significantly higher 
amount of NETs in the presence of magnesium alone or with both elements added, while 
significantly lower NETs were quantified in the presence of calcium supplementation (Figure 
3.16b).   
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a) Unstimulated neutrophils 
 
b) PMA stimulated neutrophils 
 
Figure 3.16: Effect of calcium and magnesium on NET production. 
Analysis of NET production by a) unstimulated and b) PMA stimulated neutrophils in standard 
PBS (-/-), Ca+2 PBS (+/-), Mg+2 PBS (-/+), and Ca+2/Mg+2 PBS (+/+). Values are expressed as 
relative light units (RLU) or arbitrary fluorescence units (AFU) and as mean ± SEM. Statistical 
significance calculated with Tukey’s multiple comparison test (n= 3; *p<0.05, ***p<0.001, 
****p<0.0001). 
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 Behavioural analysis of murine bone marrow-derived neutrophils 
Murine models have been extensively used for research on inflammatory processes as reviewed 
in section 2.4.1 of the Introduction. In the section below PAD4 knockout and wild-type bone 
marrow murine neutrophils were compared with healthy peripheral blood human neutrophils 
with the aim of validating murine models for NET studies and to evaluate the possibility of 
using murine derived neutrophils for HCA studies.    
 Validation of murine models for ROS production  
To determine the ability of human and bone marrow murine neutrophils to produce ROS in 
response to non-physiological stimuli, cells were incubated for up to 18 hours with PMA, and 
ROS were measured using the chemiluminescence assay. Human neutrophils produced a 
considerably higher amount of ROS in response to PMA compared with murine neutrophils 
(Figure 3.17a). However, both types of murine neutrophils responded to PMA stimulation 
producing significantly higher amounts of ROS compared with unstimulated cells (Figure 
3.17b).  
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a) ROS production: human vs murine neutrophils 
 
b) ROS production: wild type vs knockout  
 
Figure 3.17: ROS production by bone-marrow derived murine neutrophils. 
Analysis of peak ROS production by unstimulated and PMA-stimulated a) bone-marrow 
murine compared to human neutrophils and b) wild type (WT) compared with PAD4-knockout 
(KO) bone-marrow murine neutrophils. Values are expressed as relative light units (RLU) and 
as mean ± SEM. Statistical significance was calculated with Tukey’s multiple comparison test 
(n= 3; *p<0.05, ****p<0.0001). 
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Although the difference with human and murine neutrophil responses was substantial, the bone 
marrow derived murine cells still exhibited a significant level of activation as a result of PMA 
stimulation. Such a differential response between the human and murine neutrophils may be 
due to the relatively immature nature of the murine bone marrow cells which are still in a naïve 
state compare with mature human peripheral blood neutrophils. In order to test this hypothesis, 
cells were exposed to the cytokine GM-CSF for 30 minutes before being stimulated with PMA 
in order to prime cells (section 2.3.3). Figure 3.18 shows there was no significant differences 
in term of ROS production between GM-CSF-treated and untreated cells for both human and 
mouse neutrophils.   
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a) ROS production: human vs murine neutrophils 
 
b) ROS production: wild type vs knockout  
 
Figure 3.18: Primed ROS production in bone-marrow murine neutrophils. 
Analysis of peak ROS production by PMA-stimulated and GM-CSF primed a) bone-marrow 
murine neutrophils compared with human and b) wild type (WT) compared with PAD4-
knockout (KO) bone-marrow murine neutrophils. Values are expressed as relative light units 
(RLU) and as mean ± SEM. Statistical significance calculated with Tukey’s multiple 
comparison test (n= 3; ns=non significant). 
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 Identification of NET structures produced by bone marrow-derived murine neutrophils  
Alongside ROS production, NET release by human and murine neutrophils was observed using 
fluorescence microscopy. Cells were exposed to PMA or were unstimulated for up to 5 hours 
and then stained with Sytox green prior to microscopic observation. Unstimulated neutrophils 
from both human and murine sources did not show the presence of NET structures at any time 
point (Figure 3.19 top row panel) and were therefore used as negative controls. PMA-stimulated 
human neutrophils presented few NET structures after 1 hour of exposure, while the amount of 
visible NETs notably increased at 3 and 5 hour time-points (Figure 3.19 left column). PAD4 
knockout murine neutrophils presented a similar visual profile as compared with unstimulated 
cells up to 5 hours post-exposure to PMA (Figure 3.19 right column). In addition, relatively 
few NETs were visible in wild-type murine samples after 3 hours exposure to PMA and this 
number appeared to marginally increased at 5 hours post-stimulation (Figure 3.19 central 
column). 
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                                Human                       Wild type mouse                 PAD4 KO mouse 
PBS          
PMA 1h    
PMA 3h    
PMA 5h    
Figure 3.19: NET visualisation in human and murine neutrophils. 
Images of neutrophils from human wild-type and PAD4 knockout (KO) mice were stimulated 
up to 5h with PMA or were unstimulated (PBS). NETs were stained with Sytox green® and 
visualised (X20 magnification) with an epifluorescence microscope. Images are representative 
of two independent experiments. Scale bar represents 100µm. 
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 Discussion 
HCA offers a powerful platform for observing NETs, their characteristic structures and all those 
features related to their formation, including nuclear decondensation and protein localisation; 
and provides a faster and more effective quantification technology for future studies of NET 
biology. Before applying HCA for neutrophil investigation, however, a reliable protocol needed 
to be developed. Several conditions and stimuli were therefore tested in the above experiments 
and results were considered for further protocol optimization.  
PMA is the most commonly used stimulus in NET studies and the dose-response analysis 
reported here confirmed that concentrations above 6nM are required for activation of 
neutrophils. This suggests that concentrations below 6nM are not sufficient for triggering the 
PKC inflammatory pathway, which is in agreement with previous publications (Brinkmann et 
al., 2004). However, exposure to 50nM PMA resulted in the most robust response for NET 
investigation and development of a HCA protocol. The highest PMA concentration was 
therefore used for subsequent analysis and for the evaluation of different environmental 
conditions on neutrophil responses.  
NET production was negatively affected by decreased incubation temperature and decreased 
CO2 levels, conditions which have been also identified in the subgingival environment in 
periodontitis patients. These data may indicate a possible failure of in vivo responses at 
epithelial or mucosal surfaces exposed to pathogen invasion and infection at the gingival 
margin. Lack of response by the immune system may allow microbial proliferation and the 
infection to disseminate more widely, representing a potential link to associated systemic 
diseases (Seymour et al., 2007). Interestingly, the periodontal bacteria, F. nucleatum and P. 
gingivalis, induced a significant response in neutrophils in terms of ROS production. Both ROS 
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and NET production required longer exposure to bacteria compared with PMA and HOCl 
stimulation, however, this analysis is consistent with pathways usually triggered in neutrophils 
by bacteria (Prince et al., 2011). This finding confirms that the accumulation and persistence 
of microbial plaque resulting from poor oral hygiene (Dahlén et al., 1992) has the potential to 
trigger an inflammatory response. In this case ROS and NET production could contribute to 
periodontal tissue damage, as previously shown by our group (Matthews et al., 2007b). 
Although F. nucleatum represents a good example of a physiological stimulus and is able to 
induce a notable response in term of ROS and NET production, bacterial DNA interferes with 
neutrophil staining and causes an elevated background in NET microscopic images potentially 
affecting future HCA results. Therefore, stimulation of neutrophils with bacterial components 
rather than whole bacteria may represent a solution for HCA. LPS extracted from E. coli was 
tested under different conditions and concentrations, notably the stimulation was effective for 
ROS production but, ineffective in inducing a significant amount of NET release despite 
numerous papers (Brinkmann et al., 2004; Fuchs et al., 2007; Yousefi et al., 2009) publishing 
different findings. Concomitant dilutions of LPS in human plasma or bovine albumin failed to 
improve these neutrophil responses. The lack of NET production in neutrophils stimulated with 
E. coli-derived LPS may be attributed to the non-pathogenicity of the strain, however similar 
responses were identified upon stimulation with LPS from P. gingivalis (Figure 3.20).  
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Figure 3.20: Neutrophil stimulation with P. gingivalis-derived LPS. 
NET formation induced by P. gingivalis derived LPS (LPS Pg) and compared with unstimulated 
(PBS) and PMA-stimulated conditions. Values are expressed as arbitrary fluorescence units 
(AFU) and as mean ± SEM. Statistical significance calculated with Tukey’s multiple 
comparison test (n= 3; ****p<0.0001). 
 
Dental plaque is a complex bacterial biofilm which is able to trigger a substantial and sustained 
immune system response in humans (Peyyala & Ebersole, 2013). Therefore, to better mimic 
the in vivo situation, biofilm models developed by Millhouse et al., (2014) were used here to 
invistigate the interaction between neutrophils and dental plaque. Both health and diseases 
relevant biofilm models were able to induce an inflammatory response in neutrophils in regard 
to ROS production, supporting previous study findings on the association between periodontal 
bacteria and neutrophil activation (White et al., 2016a). The 7- and 10-species biofilms also 
demonstrated ability to induce NET release, although only at relatively low levels, indicating a 
possible NET degradation by bacterial DNase release, a well know virulence strategy used by 
bacteria in order to evade NET killing (Palmer et al., 2012b).  
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Interaction between pathogenic biofilms and oral epithelial cells simulates local inflammation 
and cytokine release within the gingiva (Millhouse et al., 2014; Peyyala et al., 2012), the 
exposure of neutrophils to such an inflammatory environment was sufficient to trigger ROS 
production, although resulted in relatively low levels of NET formation. Results suggest NET 
activation may require a more complex pattern of stimulation or extended periods of 
stimulation. These data indicate in vivo NET production may act as a secondary antimicrobial 
strategy once other processes have failed.  
Neutrophil exposure to elevated levels of calcium resulted in partial cell activation and 
increased basal levels of ROS production suggesting a possible role for ion levels present in 
periodontal pockets (Sewón et al., 1995) in priming the immune system during periodontal 
inflammation. Surprisingly, magnesium supplementation had a priming effect on neutrophils 
which resulted in the release of an increased amount of NET-DNA in response to PMA. These 
results indicate a possible role for magnesium in neutrophil biology which requires further 
characterisation since altered magnesium levels have been associated with chronic diseases 
(Swaminathan, 2000). 
Murine models are convenient and informative for studying disease pathogenesis and 
identifying new therapeutic approaches (Németh et al., 2016), however, neutrophil biology 
differs between humans and mice. These differences were also identified in ROS production as 
described above. Priming bone marrow-derived murine neutrophils with growth 
factors/cytokines was also ineffective in inducing an adequate response to PMA as compared 
with human neutrophils. NET visualisation confirmed a considerably lower amount of DNA 
structures being released in response to PMA. This finding suggests the bone marrow 
neutrophils are unable to produce NETs as previously concluded by Martinelli et al. (2004) and 
their maturation requires a more complex combination of cytokines which has not been 
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determined yet. Notably, PAD4 knockout mouse were unable to produce NETs however 
prolonged the stimulation with PMA was. These data support previous findings which indicate 
that the activity of PAD4 is necessary for PMA-induced NET formation (Li et al., 2010; Wang 
et al., 2009). Murine models may help in better understanding intracellular pathways involved 
in neutrophil activation, however, currently they remain unsuitable for HCA application due to 
their different activation processes.    
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7 CHAPTER 4: PROTOCOL OPTIMISATION 
FOR HIGH-CONTENT ANALYSIS OF NETs 
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 Background  
Investigating biological samples using High Content Analysis (HCA) requires cell imaging for 
accurate and rapid examination. A key advantage of HCA is the ability to simultaneously 
observe thousands of cells, multiple samples and different conditions in a relatively short time 
span (Shariff et al., 2010). However, imaging biological samples requires their fixation and 
appropriate staining to preserve their characteristic features (Corfe et al., 2013). Neutrophils, 
and in particular NETs, have the potential to be studied using high-throughout analysis as 
previously discussed in section 2.6.4 of the Introduction, however, careful processing is 
required before imaging. Fixation protocols available for neutrophils currently involve several 
washing stages which may damage and alter the relatively fragile NET structures. This chapter 
aimed to establish the effects of different fixation protocols on NET samples and to identify 
optimal conditions to allow sample conservation while preserving NET-DNA structure 
integrity. The overall goal was to develop a suitable protocol for the application of HCA to 
NET samples.  
 Neutrophil cell densities for use in multi-well plate formats 
Neutrophils are routinely imaged on glass slides by confocal microscopy. However, HCA 
technology requires the image acquisition from samples in microplate formats, therefore it was 
necessary to establish a suitable protocol to allow visualisation of cell and component using a 
96-well plate format. Initially, neutrophil density studies were performed using multi-well plate 
formats. Neutrophils were seeded at 1,000, 10,000 and 100,000 cells/well in 24-, 48- and 96-
well plate formats and stimulated as described in section 2.6.4. Neutrophil densities calculated 
according to manufacturer recommendation (Corning, 2010) are summarised in Table 4.1. 
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NETs were also qualitatively visualised using fluorescence microscopy following staining with 
Sytox green® (see section 2.6.6). 
Table 4.1: Multi-well plate formats used and neutrophil seeding cell densities. 
 
Images displayed in Figure 4.1a are representative of unstimulated and PMA stimulated 
neutrophils as seeded at different densities in a 24-well plate. Seeding 526 neutrophils/cm2 
resulted in relatively few cells being identifiable in each field of view for both PMA-stimulated 
and unstimulated conditions. Following 3 hours of PMA-stimulation, no NETs were observed. 
Seeding at 5,263 neutrophils/cm2 resulted in more cells being visible and an average of 6 
neutrophils could be seen in each field of view. Few short NET structures were also identified 
at 3 hours post PMA-stimulation. However, more numerous complex structures were visible 
with the higher seeding density (52,632 cells/cm2). Representative images obtained by seeding 
1,000, 10,000 and 100,000 cells/well in a 48-well plate are shown in Figure 4.1b. Detection and 
complexity of NET structures increased with increased cell density. The lowest density showed 
one NETosing cell in the field of view, while numerous NETosis events were observed in wells 
with higher densities (105,263 cells/cm2). Similar results were observed in the 96-well plate 
Multi-well 
plate format 
Well surface 
area (cm2) 
Volume of 
medium/well (µl) 
Cell seeding 
(cells/well) 
Cell densities 
(cells/cm2) 
24-well 1.9 600 
1,000 526 
10,000 5,263 
100,000 52,632 
48-well 0.95 400 
1,000 1,053 
10,000 10,526 
100,000 105,263 
96-well 0.32 200 
1,000 3,125 
10,000 31,250 
100,000 312,500 
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format with 1,000, 10,000 and 100,000 cells/well as shown in Figure 4.1c. The lower seeding 
density of 3,125 cells/cm2 captured relatively few cells in NETosis, while, increasing the cell 
density resulted in increased number of NET structures visible within the field of view. In the 
PMA-stimulated 312,500 cells/cm2 density wells NETs appeared as complex aggregate 
structures. Higher densities of 31,250 and 312,500 cells/cm2, showed the presence of a 
relatively small amount of NET filaments also evident in unstimulated control cells. Low 
density seeding resulted in an uneven distribution of cells within the well surfaces, which 
presented many fields of view deprived of cells (black) when observed by fluorescence 
microscopy. The autofocus setting, operating during the HCA image acquisition phase, 
becomes inoperative on black fields of view producing faulty and unreliable data. Therefore, 
based on these results, neutrophils required seeding at a minimum of 100,000 cells/well in 24- 
and 48-well for NET detection, while 10,000 cells/well was the lowest threshold suitable for 
use in the 96-well plate format.    
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a) 24-well plate  
                                           1,000 cells/well                             10,000 cells/well                                    100,000 cells/well 
Unstimulated       
Stimulated           
  
100µm
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b) 48-well plate  
                                         1,000 cells/well                             10,000 cells/well                                    100,000 cells/well 
Unstimulated        
Stimulated            
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c) 96-well plate 
                                           1,000 cells/well                             10,000 cells/well                                    100,000 cells/well 
Unstimulated         
Stimulated             
Figure 4.1: Studies for determination of neutrophil seeding densities for use in HCA in different multiwell plate formats.  
Fluorescence microscopic visualisation of Sytox green® stained neutrophils seeded at 1,000, 10,000 and 100,000 cells/well unstimulated or 
stimulated with PMA for 3 hours in a) 24 well plate, b) 48-well plate and c) 96-well plate. Images are representative of 2 independent experiments. 
Representative neutrophils are indicated with white arrows and NETs with red arrows. Scale bars are shown. 
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 Identification of a suitable NET fixation protocol for use in HCA 
Commonly reported fixation protocols suitable for use with neutrophils involve numerous wash 
steps prior to image acquisition and analysis (Elliott et al., 1995). The mechanical action applied 
during these wash steps can result in the loss of sample material, resulting in disruption of NET 
structures. The effects of these fixation procedures on NET images were analysed, and 
techniques optimised to minimise NET disruption.   
 Mechanical removal of NETs during fixation procedures 
The mechanical forces of pipetting and washing samples during the fixation protocol may also 
affect NET structures. Images of NETs before and after the washing process were subsequently 
observed to identify the effect of washing on sample integrity. Following stimulation with 
PMA, NETs were fixed by the addition of 4% PFA solution directly into the well, and after 10 
minutes incubation Sytox green® was added and 20 images per well, representing almost 
entirely the well surface, were captured with the ArrayScan (section 2.8.6). Afterwards, the 
media was removed, samples were washed twice with PBS and images were captured again. 
Figure 4.2 shows resulting images of neutrophils and NET structures following application of 
this technique. A considerable amount of NET production is apparent in images in Figure 4.2a 
as would be expected following PMA stimulation. A qualitative observation of the images 
indicated that NETs were evenly distributed and DNA filaments appeared of variable staining 
intensity, suggesting NETs are characterised by variable states of DNA condensation, as Pires 
et al. (2016) has already identified by atomic force microscopy. In Figure 4.2b images following 
the washing procedures are shown. This visibly contained fewer NETs suggesting most of NET 
structures were removed during the wash steps. 
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a)  
Pre-wash    
b) 
Post-wash  
Figure 4.2: NET structures are removed during washing procedures.  
Microscopic visualisation of Sytox green® stained neutrophils stimulated with PMA for 3 
hours. Images are representative of 20 fields of view per well in a 96-well plate and were 
acquired before and after PBS washing. Results are representative of 2 independent 
experiments. Scale bars are shown in the lower left of image box. 
  143 
 Variations of fixation protocols  
Accurate imaging of biological samples generally requires prior fixation. However, acquired 
images should provide an accurate representation for an effective application of HCA for NET 
studies. Hence, the mechanical alteration arising due to the fixation procedure needed to be 
minimised. For this reason, modifications of the fixation protocol for NETs were tested to 
identify the approach most likely to minimise loss of material. Neutrophils were stimulated with 
PMA or were unstimulated (controls) for 3 hours, prior to addition of Sytox green® and image 
captured by epifluorescence microscopy before and after the fixation procedures (see section 
2.6.6.3). Three main steps of the protocol were evaluated and tested in different sequences, 
these were: i) centrifugation of samples for 10 minutes at 1800rcf; ii) addition of 4% PFA 
solution (see section 2.6.6.1); iii) media removal and subsequent PBS washing. Images of 
unstimulated and PMA-stimulated neutrophils before and after 5 different fixation approaches 
were compared with unfixed samples. Representative images for each combination of steps are 
provided in Figure 4.3. In Figure 4.3a post-incubation samples were firstly centrifuged, 
followed by PFA addition and PBS washing after 10 minutes incubation. The mechanical force 
of the centrifugation appeared to alter NET morphology and reduce the number of NETs when 
comparing images produced before and after processing. Images shown in Figure 4.3b were 
obtained by fixing samples with PFA initially, and then incubating for 10 minutes followed by 
centrifugation and washing with PBS. Unstimulated neutrophils prior to the fixation procedure 
demonstrated the presence of NET structures, which were absent in images post-fixation. 
However, compared with PMA-stimulation, the presence of NETs in unstimulated neutrophils 
was considered a basal level of cell activation and NET production, as expected in experiments 
using peripheral blood neutrophils which circulate the body at different stages of activation. 
Images of PMA-stimulated neutrophils showed a similar amount of NET staining before and 
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after fixation. In Figure 4.3c images are representative of the centrifuged sample, then subjected 
to medium removal, and finally fixed with PFA solution. PMA-induced NET organisation and 
direction appeared altered indicating that NET material may have been mechanically removed 
by the washing procedure. Images in Figures 4.3d) & e) provide representative results obtained 
without the inclusion of the centrifugation steps. In panel d) images represent samples treated 
with PFA for 10 minutes directly after the 3-hour stimulation, followed by media removal and 
PBS washing. Images pre- and post- fixation indicated NET structures were well preserved and 
the level of DNA staining appeared to be consistent in both images. In panel e) the medium was 
initially removed, followed by treatment with PFA for 10 minutes and PBS washing. PMA-
stimulated neutrophils showed relatively high levels of NETs before the fixation procedure, 
however, after the procedure only few structures remained. Images showed in panel f) represent 
unfixed samples before and after centrifugation. Unstimulated neutrophils were not affected by 
the centrifugation step, however, PMA-stimulated samples showed an accumulation of DNA 
staining following this procedure. A qualitative evaluation of above fixation procedures 
suggested NETs were well preserved following the methods applied for images presented in 
Figures 4.3a) & d).  
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           Unstimulated                                                                               Stimulated  
                          Before                                      After                                          Before                                    After  
a)          
b)          
c)          
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            Unstimulated                                                                                 Stimulated  
                           Before                                     After                                           Before                                    After  
d)          
e)          
f)          
Figure 4.3: Assessment of fixation protocols for NET analysis.  
Visualisation of Sytox green® stained neutrophils stimulated with PMA for 3 hours or unstimulated. Images were acquired before and after the 
fixation procedures as for: a) centrifugation, adding PFA and washing; b) adding PFA, centrifugation and washing; c) centrifugation, removing 
media, adding PFA and washing; d) adding PFA, removing media and washing; e) removing media, adding PFA and washing; f) centrifugation 
only. Results are representative of 2 independent experiments. Scale bars are shown. 
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 Efficacy of the fixation protocol 
In order to study neutrophil biology and specifically NETs using HCA, samples need to be 
transported for analysis to a distant site in Manchester (UK). Therefore, the fixation protocol 
was tested to evaluate its efficacy in preserving NET samples for up to 24 hours. Neutrophils 
were stimulated with PMA or remained unstimulated (controls) for 3 hours. Subsequently, 
samples were fixed (as described in section 2.6.6.2), Sytox green® was added to samples and 
images were captured under epifluorescence microscopy at 0 and 24 hours after fixation. Figure 
4.4 shows representative images for each condition tested. Representative images of 
unstimulated neutrophils showed no visible difference between the two time-points analysed 
for both fixed and unfixed samples. However, while unfixed PMA-stimulated samples 
exhibited a higher NET presence, fixed PMA-induced NETs were unaffected in images after 
24 hours, indicating the fixation protocol successfully preserved the samples for transport.  
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                                                       Unstimulated                                                                                    Stimulated  
                                Time 0h                                    Time 24h                                     Time 0h                                    Time 24h        
Unfixed        
Fixed            
Figure 4.4: Efficacy of fixation protocol for preserving NET structures.  
Visualisation of Sytox green® stained neutrophils stimulated with PMA for 3 hours or unstimulated (negative control). Images were obtained at 
time 0 and 24 hours after application of the fixation procedures or were left unfixed. Results are representative of 2 independent experiments. Scale 
bars are shown. 
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 Poly-L-lysine effects on NET formation 
Once released into the extracellular space, NET structures become suspended in the culture 
medium and may be subjected to damage during sample processing or handling, as 
demonstrated in the above experiments (section 7.3.1). To maintain the integrity of NET 
structures and have suitable material for HCA, neutrophil NET responses were assayed 
following poly-L-lysine coating of cultureware. Poly-L-lysine is a synthetic cationic polymer 
commonly employed in tissue culture to promote cell adhesion by electrostatically bonding 
with negatively charged cells and molecules (Khademhosseini et al., 2004). Although poly-L-
lysine has applications for the non-adherent neutrophil visualisation on glass slides (Fuchs et 
al., 2007; Wang et al., 2009; Yousefi et al., 2008), there is currently a lack of knowledge on its 
effect on NET formation and NET structures. The following experiments aimed to analyse how 
the pre-treatment of cultureware with poly-L-lysine influenced neutrophil behaviour and in 
particular NET release.  
A layer of poly-L-lysine was deposited on the surface of each well prior to neutrophil seeding 
and stimulation (section 2.6.2). NETs were then produced and visualised as described in 
sections 2.6.4 & 2.6.6.3 respectively. Figure 4.5 provides images of unstimulated and 
stimulated neutrophils obtained with or without pre-treatment of wells with poly-L-lysine. A 
PMA dose-response stimulation was also applied to identify a potential threshold for neutrophil 
activation in conjunction with the polymer. Images revealed a visible increase in NETs numbers 
which correlated with PMA dosage for both untreated and poly-L-lysine treated well 
conditions. However, in poly-L-lysine pre-treated plates, NETs appeared to accumulate as flat 
structures on the bottom of the well, while without the adhesive agent NETs appeared as three-
dimensional structures distributed across several focal planes of the well.  
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                                         Unstimulated                                   25nM PMA                          50nM PMA                          100nM PMA  
No poly-L-lysine                  
Poly-L-lysine pre-treated     
Figure 4.5: Effect of poly-L-Lysine pre-treatment of cultureware for NET visualization.  
Visualisation of Sytox green® stained neutrophils stimulated with 25, 50, 100nM PMA for 3 hours or unstimulated (negative control). Comparison 
of untreated 96-well plate with poly-L-lysine pre-treated cultureware. Results are representative of 3 independent experiments. Scale bars are 
shown. 
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Inhibition of NET formation in poly-L-lysine pre-treated cultureware was further investigated 
through fluorometric quantification (section 2.6.5). As previously described, neutrophils were 
stimulated with three concentrations of PMA for 3 hours. Results obtained from both poly-L-
lysine pre-treated and untreated cultureware showed a similar trend towards dose-dependent 
NET production as determined by fluorometric analysis (Figure 4.6). However, the NET-DNA 
quantified in poly-L-lysine pre-treated wells appeared reduced by approximately 5-fold for 25 
and 50nM PMA and 3.5-fold for 100nM PMA treatment compared with NET-DNA generated 
in poly-L-lysine untreated wells. This was in contrast to the NET visualisation data, which 
indicated a similar amount of NETs were produced in poly-L-lysine pre-treated cultureware 
compared with poly-L-lysine untreated wells, and can be attributed to the differences in the 
methodologies utilised for NET analysis. 
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a) No poly-L-lysine                                                                            
 
b) Poly-L-lysine pre-treatment  
 
Figure 4.6: Effects of poly-L-lysine pre-treatment on NET quantification.  
Dose-response with fluorometric quantification of PMA stimulated NET production in 
neutrophils upon incubation in poly-L-lysine pre-treated and untreated 96-well plates. Values 
are expressed as arbitrary fluorescence units (AFU) and as mean ± SEM. Statistical 
significance calculated with Uncorrected Dunn’s test (n= 3; *p<0.05, **p<0.01). 
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 Comparison of different DNA staining approaches for image analysis of 
NETs 
Sytox green® is a DNA-binding fluorescent dye non-permeant to the outer cell wall. Once 
bound to DNA, its fluorescent signal is enhanced up to 500-fold and is visualised as a bright 
green stain (Suzuki et al., 1998). Sytox green® only stains neutrophil nuclei following cell wall 
damage, such as during cell death. Hoechst, conversely, is a fluorescent DNA dye which can 
penetrate the cell wall and stain nuclei of viable neutrophils, and is visualised as a blue 
fluorescence signal (Lakowicz et al., 1997). However, the Hoechst signal has lower intensity 
compared with Sytox green® stain, therefore it may be unsuited for staining of NETs, given 
their decondensed structures. In order to determine the difference between the two types of 
fluorescent staining for assaying NET production, unstimulated and PMA-stimulated 
neutrophils were observed using the ArrayScan (section 2.8.6). Samples were excited at 
wavelengths of 360nm and 472nm and visualised using a 490nm and 520nm filter, for Hoechst 
and Sytox green® stained DNA, respectively. Imaging with the brightfield filter was 
concomitantly employed to ensure the presence of cells within the analysed fields. 
Unstimulated neutrophils are shown in Figure 4.7a. Both Hoechst and Sytox green® appeared 
to stain nuclear DNA, however, approximately 20% of unstimulated nuclei were visible with a 
Sytox green® signal, while 100% were visible using the Hoechst stain. Conversely, in images 
of PMA-stimulated cells (Figure 4.7b) many NET filaments were visible with Sytox green® 
staining while relatively few NETs were visible using the Hoechst stain. Although the dyes 
have different properties, it appears that both have potential application for HCA of neutrophils. 
In particular, Hoechst appears appropriate for studying nuclear activation states and 
morphology in viable or NETosing cells, while Sytox green® is appropriate for NET structure 
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analysis. However, potentially, for the HCA platform, both dyes could be applied 
concomitantly for an accurate and more complete sample characterisation. 
 
              Hoechst                          Sytox green®                        Brightfield  
a) Unstimulated 
 
 
b) Stimulated     
 
Figure 4.7: Hoechst and Sytox green® neutrophil staining.  
Visualisation of Hoechst and Sytox green® stained neutrophils a) stimulated with 50nM PMA 
for 3 hours or b) unstimulated (negative control). Unprocessed images represent Hoechst 
staining on left panel, Sytox staining in the middle panel and brightfield channel on the right 
panel. Images are representative of 3 independent experiments. The scale bar shown is 
representative for all images.  
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 Discussion 
In order to develop a suitable protocol for studying NETs using HCA, neutrophils needed to be 
appropriately prepared and fixed for preservation and transportation. An appropriate fixation 
protocol, therefore, needed to be identified in which biological material especially the fragile 
NET structures was not lost.  
Initially, neutrophil cell density was investigated in different multi-well plate formats to identify 
the minimal seeding density for each format required for even cell distribution and substantial 
NET detection. The results suggested that neutrophil densities in 24-well plate had to be equal 
to or above 50,000 cells/cm2 to obtain a suitable amount of NET forming cells within the well. 
Similar to the 24-well plate format, 48- and 96-well plates required a relatively high density of 
cells, respectively 100,000 cells/cm2 and 310,000 cells/cm2 to avoid black fields of view with 
no cells and also ensure abundant NET production. These data also indicate that NET formation 
may be connected to neutrophil cell density which suggests a potential mechanism of cross-
talking among neutrophils in order to regulate NET production, which may, in turn, regulate 
the antimicrobial potential, as has already been proved for other immunity events (Bennouna et 
al., 2003). Once the adequate cell density for NET formation was established for the 96-well 
plate format, this was employed for all subsequent experiments.  
The washing stages required in the fixation procedures may affect sample integrity due to their 
mechanical actions and disruption of NET structures, as has also been identified for NETs using 
atomic force microscopy (Pires et al., 2016). Results from images captured after washing 
procedures indicated that the majority of NETs were indeed removed by the washing step. 
Clearly, NETs require careful handling and less aggressive fixation protocols in order to 
preserve their structural integrity for downstream analysis. Variations in the fixation protocol 
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were tested to identify which step most significantly affected the integrity of NET structures. 
All assayed protocol variations were analysed included the addition of PFA, a washing step and 
a centrifugation step, but they were applied in different orders. The majority of the protocols 
applied resulted in the loss of sample material or apparent alterations in NET filament structure. 
Following assessment of the results of these experiments, it was concluded that the most 
appropriate protocol consisted of careful addition of PFA directly onto stimulated NETs, thus 
the fixation agent directly interacts with NETs, potentially protecting them from further 
mechanical disruption. While such a fixation method may be sufficient for general NET 
visualization, an additional centrifugation stage for immune-staining applications is appropriate 
to ensure all NET material sediments.  
The modified fixation protocol was further tested before application to NET samples. Images 
of NETs were captured immediately following fixation and once again 24h later to identify 
whether the fixation was able to preserve NET structures over this time period. The protocol 
resulted in effective preservation of NETs compared with unfixed samples which were exposed 
to the stimulating agent for prolonged time and, hence, lead to cell damage. Indeed, images of 
unfixed unstimulated neutrophils after 24h demonstrate minimal levels of spontaneous NET 
production.  
The major issue encountered during the fixation procedure consisted of the loss of sample 
material, therefore, an adhesive agent was tested to overcome this. Poly-L-lysine acts as an 
adhesive layer which aids cells to settle and bind to cultureware. NET experiments performed 
using poly-L-lysine treated cultureware indicated that the polymer had a negative effect on NET 
formation. While images of PMA-stimulated neutrophils showed NET formation in the 
presence of poly-L-lysine treatment, NET quantification data demonstrated a considerable 
lower amounts of NET-DNA compared with experiments performed in untreated cultureware. 
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Imaged NETs demonstrated relatively flat structures formed on the bottom of the well in poly-
L-lysine pre-treated plates, supporting the assumption that they adhere to the cultureware. Data 
suggest that poly-L-lysine is unsuitable for use in fluorometric quantification of NETs, possibly 
due to the interaction between the positive charge on the polymer structure and the negative 
charges associated with NET-DNA (Liu et al., 2001), causing NETs to adhere to the layer of 
lysine and consequential inaccurate quantification. As fluorometric NET quantification has 
been used in future experiments as a positive control for NET formation, poly-L-lysine was 
deemed unsuitable for further application. 
NET filaments are relatively long and thin structures comprised of decondensed DNA which 
renders them difficult to identify with most commercially available staining approaches. The 
most common fluorescent dye used for NET assays is Sytox green® (de Buhr & von Köckritz-
Blickwede, 2016; Fuchs et al., 2007; Palmer et al., 2012a) as its signal increases up to 500 fold 
once bound to DNA. Thus, NETs appear as bright green structures in contrast to a black 
background ‘speckled’ with green cells. However, Sytox green® is unable to stain live or 
undamaged cells since the dye does not permeate the neutrophils outer cell wall. Another 
fluorescent DNA dye was tested alongside Sytox green® to investigate both cells and NETs in 
unfixed neutrophil samples. Notably, neutrophil nuclei and their features were more clearly 
visible using Hoechst staining. Unstimulated neutrophils exhibited their characteristic multi-
lobulated nuclear shape which was subsequently lost as a consequence of NET production. 
Furthermore, PMA-stimulated nuclei appeared of lager size and spherical with decreased 
intensity compared with unstimulated nuclei, a characteristic which has already been attributed 
to the early stages of NET formation and successfully employed for the quantification of 
NETosing cells (Brinkmann et al., 2012; Zhao et al., 2015). Conversely, Sytox green® only 
stained a small percentage of nuclei and in particular those with damaged outer cell walls. 
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However, PMA-stimulated NETs were clearly visible as bright filamentous structures upon 
Sytox green® staining, while Hoechst staining only highlighted faded structures. The two 
staining approaches require different excitation/emission filters, which allows their 
simultaneous application, without the risk of interference, broadening the amount of detectable 
features in a single HCA readout. While Hoechst has application for studying nuclear activation 
and nuclear morphologic changes in different conditions, simultaneous Sytox green® staining 
will serve better for studying NET structures and their release.  
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5.1 Background 
Many publications on NET analysis and their characterisation as an anti-microbial strategy 
utilise qualitative microscopic image analysis (Brinkmann et al., 2004; Fuchs et al., 2007). 
Furthermore, studies that aim to elucidate the intracellular processes leading to NET release 
and the nature of its DNA backbone utilise similar approaches (Aleyd et al., 2014; Yousefi et 
al., 2009). Three main theories, described in more details in section 2.2.3 of Introduction, 
regarding the signalling regulation of NET generation, have been proposed. The first two, 
introduced respectively by Fuchs et al. (2007) and Yousefi et al. (2009), describe NETs as 
nuclear DNA-made structures released following an ultimate fate of programmed cell death or 
as mitochondrial-derived ETs which leave the cells in a vital state. A third mechanism as been 
proposed for vital NETosis which suggested a-nuclear although functional neutrophils are left 
upon release of nuclear NETs in vesicles in response to Staphylococcus aureus (Pilsczek et al., 
2010).  
As previously described (section 2.6), frequently used NET assays are based on the 
identification of their components, including DNA or NET-related proteins, with levels 
determined by immunostaining, immunoblotting or ELISA (Palmer et al., 2012a; Urban et al., 
2009; Wang et al., 2009). These methods are relatively low-throughput, time consuming, 
expensive and currently there is lack of consistency in findings in the field. Subsequently, in 
recent years several alternative approaches have been developed for the high-throughput 
analysis of NETs (Brinkmann et al., 2012; Gavillet et al., 2015; Moussavi-Harami et al., 2016; 
Zhao et al., 2015) (as described in section 2.6.4).   
In this chapter, HCA parameters were explored and optimised in order to develop an innovative 
high-throughput approach for NET analysis. The aim was to develop an automated technique 
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that utilises quantitative imaging for the monitoring of neutrophils, their nuclei and NET-related 
responses. Furthermore, one of the key advantages of HCA compared with traditional assays is 
the potential for combining readouts acquired for protein staining intensity, subcellular protein 
localisations and independent cell information (Drake et al., 2009). Image analysis is 
subsequently performed using a bioinformatic software with built-in algorithms for a diverse 
range of biological applications (Ghosh et al.; Mandavilli; Miller et al.). Notably this technique 
has not previously been applied for neutrophils or for NET analysis.    
Research areas covered in this chapter include: i) the optimisation of pre-existing HCA 
algorithms and their application in NET analysis; ii) the development of specific algorithms for 
NET analysis; iii) the use of HCA for analysis of intracellular proteins in H400 cells and 
neutrophils; and iv) the validation of HCA for NET quantification against previously 
established NET analysis assays.  
5.2 Adapting pre-determined algorithms for NET analysis   
For appropriate image interpretation and, therefore, accurate HCA of NET structures, the 
settings of two algorithms, suitable for the analysis of extruded DNA material, already built-
into the HCS Reader software (Cellomics, ThermoFisher) were optimised and tested. NETs 
were generated as described in section 2.6.4 and fixed as per section 2.6.6.2. Neutrophil nuclei 
and NET structures were stained with Hoechst and Sytox green® as previously described in 
section 2.8.1. Images were acquired using the ArrayScan equipment (Cellomics, ThermoFisher) 
and analysed by the HCS Reader software (sections 2.8.7) applying the Compartmental 
Analysis and the Tube Formation algorithms.  
Images of neutrophils and NET recognition by each algorithm are illustrated in Figure 5.1. The 
Compartmental Analysis algorithm was designed to monitor the presence and the movements 
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of macromolecules in and between subcellular locations (as described in the Thermo Scientific 
Cellomics® Compartmental Analysis guide). The Compartmental Analysis algorithm operates 
by identifying neutrophil nuclei as circular objects which correspond to pre-determined 
parameters for both size and intensity. Subsequently the object identification settings were 
adapted to size and staining intensity based on neutrophil nuclear features, to enable the 
algorithm to recognise nuclei as small lobulated objects (coloured in pink in Figure 5.1a). 
Rejection criteria were established for the exclusion of cell debris or aggregates or objects 
located at image edges. Algorithm settings were adjusted to create a relatively wide ring around 
nuclei (shown as green circles in Figure 5.1a) and to quantify the extracellular DNA within that 
space (shown coloured in blue in Figure 5.1a).  
The Tube Formation algorithm was designed to analyse cellular structures which exhibited 
tube-like shapes (from the Thermo Scientific Cellomics® Tube Formation guide). The 
algorithm identifies neutrophil nuclei as circular objects in the image and selects as valid those 
presenting extruded DNA (circled in blue in Figure 5.1b). Selection and rejection criteria were 
optimised as previously described above for the Compartmental Analysis algorithm, with the 
exception of rejecting every nucleus lacking DNA extrusions. Subsequently the Tube 
Formation algorithm identifies, encloses and analyses extrusions of DNA in the surrounding 
extracellular space (shown in orange, green, purple and yellow in Figure 5.1b). 
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                          Acquired image                                      Algorithm recognition 
a)   
b)   
Figure 5.1: HCA algorithm recognition of neutrophils and NETs. 
Images of PMA-stimulated neutrophils stained with Hoechst and Sytox green® acquired using 
the ArrayScan. a) Application of the Compartmental Analysis algorithm for the identification 
of neutrophil nuclei (purple) and NETs (blue). b) Application of the Tube Formation algorithm 
for the identification of neutrophil nuclei (blue circles) and NETs (green, orange, yellow and 
purple). Scale bar represents 200µm and applies for all images. 
 
5.2.1 Application of the Compartmental Analysis algorithm for NET analysis 
The Compartmental Analysis algorithm allows extracellular DNA to be identified in the area 
surrounding the nuclei of activated neutrophils. The algorithm, optimised as described above, 
was applied to the analysis of NETs. Neutrophils were seeded at 10,000, 100,000 and 500,000 
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cells/well in a 96-well plate and stimulated with PMA and HOCl or were unstimulated (negative 
control) for 3 hours (as described in section 2.6.4). HCA was performed as described in section 
2.8.3 and the Compartmental Analysis algorithm was applied to determine the average DNA 
staining registered within the annular detection area around neutrophil nuclei, also termed ‘ring’ 
in the Thermo Scientific Cellomics® Compartmental Analysis guide. Results presented in 
Figure 5.2 indicate that the Compartmental Analysis algorithm identified a significant increase 
in NET areas in HOCl-stimulated neutrophils compared with unstimulated controls. However, 
the increase in the NET area was only detected with 100,000 and 500,000 cell/well densities, 
and not in the 10,000 cells/well of neutrophil densities. Interestingly, among the HOCl-
stimulated neutrophil densities the Compartmental Analysis algorithm identified significant 
differences in detected NET areas. Seeding neutrophils at 10,000 cells/well resulted in 
significantly smaller area of NETs detected than in the 100,000 and 500,000 cells/well seeding. 
These data suggest the application of the Compartmental Analysis algorithm was limited to 
HOCl-stimulated neutrophils. However, this approach was ineffective in quantifying PMA-
induced NETs (Figure 5.2). Other limitations of this software algorithm for NET detection were 
related to the lack of detection of the early time-point of NETosis and those NETs which 
extended outside the detection area or ring (annular extracellular region around nuclei).  
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Figure 5.2: NET area variation in stimulated neutrophils calculated using the 
Compartmental Analysis algorithm. 
Average of NET area detected by the Compartmental Analysis algorithm for the HCA of 
neutrophils seeded at 10,000, 100,000 and 500,000 cells/well and stimulated for 3 hours with 
PMA, HOCl or unstimulated controls. Values are calculated as pixels of staining, are expressed 
as mean ± SEM and statistical significance was calculated with Sidak’s multiple comparison 
test (n=6; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).  
 
5.2.2 Application of the Tube Formation algorithm for NET analysis 
The Tube Formation algorithm, optimised as described above (section 5.2), was applied for the 
quantification and the characterisation of NETs. Neutrophils were seeded at a range of densities 
of between 1,000 and 100,000 cells/well in a 96-well plate and stimulated with PMA or were 
unstimulated for up to 3 hours as described in section 2.6.4. HCA was performed as described 
in section 2.8.3 and the Tube Formation algorithm was applied for analysing the number of 
extruded NETs and their average size, including total NET covered area and filament length, 
under each experimental condition. Interestingly, the Tube Formation algorithm identified a 
relatively high amount of NETs which were relatively large in size in unstimulated neutrophils, 
identifying no differences compared with PMA-stimulated neutrophils at all 5 densities studied 
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(Figure 5.3a, b and c). The NET count was higher and structures were longer and wider in the 
10,000 cells/well seeding conditions compared with the other 4 seeding densities. This result 
suggested that neutrophils and NETs at this density assume a conformation and orientation 
which resulted in high values of NET units and size as registered by the Tube Formation 
algorithm. Furthermore, PMA-induced NETs are not always associated with intact nuclei, since 
nuclear decondensation and loss of the nuclear membrane occur during NETosis, and in this 
may, therefore, may escape algorithm recognition. These limitations suggest the Tube 
Formation algorithm was not suitable for NET quantification.  
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a) 
 
b) 
 
c) 
 
Figure 5.3: NET analysis as determined by the Tube Formation algorithm. 
HCA of neutrophils seeded up to 100,000 cells/well stimulated with PMA or unstimulated 
(control) for 3 hours. Analysis of a) NET numbers, b) average NET width and c) average NET 
length calculated by the Tube Formation algorithm. Values are expressed as units of staining 
and as mean ± SEM and the statistical significance was calculated with Sidak’s multiple 
comparison test (n=2; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
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5.3 Development of bespoke algorithms for NET analysis  
Alongside adapting the pre-existing algorithms of the HCS Reader software, two more 
algorithms were developed specifically for NET analysis. These algorithms, were termed “NET 
Detection” and “Nuclear Decondensation”, and were developed for the simultaneous 
monitoring of two fundamental characteristics of NETosis, respectively the release of DNA in 
the extracellular space and the preceding nuclear decondensation. In Figure 5.4 images of 
unstimulated and PMA-stimulated neutrophils are shown. Samples were isolated and 
stimulated as described in sections 2.1 & 2.6.4, and were unfixed in order to monitor cell 
integrity during NET formation. Hoechst and Sytox green® were used to stain the nuclear and 
extracellular DNA respectively (section 2.8.1). Images for Hoechst and Sytox green® staining 
were acquired independently by the ArrayScan (Figure 5.4a & b) and merged using different 
colorations (Figure 5.4c) by the HCS Reader software (sections 2.8.7). Unstimulated neutrophil 
nuclei, visible by Hoechst staining, exhibited a characteristic multilobulated shape and bright 
staining intensity indicating nuclei were in a compact state, while no NETs were visible by 
Sytox green® staining and only a few cells appeared to have a compromised plasma membrane. 
Conversely, in neutrophils stimulated for 3 hours with PMA considerable numbers of nuclei 
had lost their original morphology and exhibited an enlarged rounded conformation while the 
staining intensity visibly decreased compared with cells which had compact nuclei. Staining 
using Sytox green® indicated numerous NET filaments were visible in association with 
decondensed nuclei.  
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             a)                                                    b)                                                  c) 
Control  
PMA      
Figure 5.4: Images of nuclear decondensation related to NET formation.  
Images acquired for HCA of neutrophils unstimulated or stimulated with PMA for 3 hours. Nuclei in compact and decondensed states are visible 
in a) following Hoechst staining, while compromised cells and NETs are visible in b) following Sytox green® staining. Images of Hoechst and 
Sytox green® are merged in c) respectively in blue and green. Images are representative of 3 independent experiments. Scale bars represent 200µm 
and apply for all images.  
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5.3.1 Application of the NET Detection algorithm  
The NET Detection algorithm was also developed to provide information on NET length and 
area of extension. Neutrophils were stimulated with PMA or were unstimulated (controls) for 
up to 3 hours as described in section 2.6.4. Fixed samples were stained with Sytox green® and 
analysed by HCA (section 2.8.3). The NET Detection algorithm was designed to identify DNA 
staining areas in neutrophil images which corresponded to pre-determined parameters of size 
and intensity (Appendix I). Object identification settings were adapted to size and staining 
intensity based on NET-DNA features, therefore, the algorithm recognised all small lobulated 
objects as nuclei which were then rejected in order to exclude the nuclear DNA of intact cells 
from the analysis (circled in orange in Figure 5.5a). Algorithm settings were adjusted to identify 
filaments of extracellular DNA (green areas in Figure 5.5) and to provide information on area, 
size and intensity of those sections. Data shown in Figure 5.5.5b indicated that the NET 
Detection algorithm identified time-course increases in NETs in PMA-stimulated neutrophils 
at 3 and 4 hours, while the controls maintained values close to zero throughout the 4 hour 
period. Additional data on PMA-stimulated neutrophils indicated a time-dependent increase in 
NET area detected (Figure 5.5c), suggesting these structures increase in length and complexity 
as the stimulation is prolonged.  
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c) 
 
Figure 5.5: NET recognition and quantification by the NET Detection algorithm. 
Application of the NET Detection algorithm for the HCA of neutrophils stimulated with PMA 
or unstimulated (controls) for 3 hours. Representative images of unstimulated and PMA-
stimulated neutrophils, relative algorithm recognition (a) and time-course NET quantification 
(b). c) Time-course analysis of NET areas detected in unstimulated and PMA-stimulated 
neutrophils at up to 3 hours. Values are expressed as units of NETs and pixels of staining and 
as mean ± SEM. Scale bar represents 400µm and applies to all images shown.  
5.3.2 Application of the Nuclear Decondensation algorithm 
Alongside the algorithm for NET structure analysis, another algorithm was developed to 
acquire information on the early stages of NETosis based on monitoring changes in nuclear 
morphology and chromatin decondensation. Monitoring nuclear area and staining intensity 
provides information on the state of chromatin decondensation and, therefore, can reportedly 
be quantified as indicator of the early stages of NETosis (Zhao et al., 2015).  
The algorithm, termed “Nuclear Decondensation”, was designed to identify neutrophil nuclei 
as circular objects which correspond to pre-determined parameters for size and intensity 
(Appendix II). Object identification settings were adapted to size and staining intensity based 
on neutrophil nuclear features, therefore, the algorithm recognised small lobulated objects as 
nuclei (circled in red in Figure 5.6). Rejection criteria were established for the exclusion of cell 
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debris or aggregates or objects located at the image edges (Appendix II & circled in green in 
Figure 5.6). The Nuclear Decondensation algorithm provided a wide range of information on 
Hoechst-stained neutrophil nuclei and identified as NETosing those cells with relatively large 
areas and low signal intensity (shown in Figure 5.6) compared with controls.  
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                                     Acquired image                                                                               Algorithm recognition  
  
Figure 5.6: Images of neutrophil nuclei identification by Nuclear Decondensation algorithm. 
Representative images of PMA-stimulated neutrophil nuclei acquired with the ArrayScan and relative algorithm recognition. Nuclei are 
automatically identified and selected (red circles in the right hand image) based on morphology and intensity by the Nuclear Decondensation 
algorithm. Objects adjacent to the image edges are rejected (green circles in the right hand image). Scale bar represents 100 µm. 
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Neutrophils were stimulated with PMA or were unstimulated (controls) for 3 hours. Upon 
fixation, samples were stained with Hoechst and HCA was performed. The Nuclear 
Decondensation algorithm was applied as described above. Thresholds for nuclear areas and 
staining intensity were manually adjusted based on images of control nuclei (Appendix II). The 
algorithm determined the portion of cells with areas above, and with staining intensity below, 
the specified thresholds. Results shown in Figure 5.7a indicated the Nuclear Detection 
algorithm in unstimulated neutrophil nuclei calculated an average nuclear area of between 500 
and 700 pixels throughout the 4 hour incubation period. A similar nuclear area was calculated 
in PMA-stimulated neutrophils for up to 3 hours and increased above 1,000 pixels after 4 hours. 
Opposite trends were seen for the analysis of nuclear staining intensity. PMA-stimulated 
neutrophil nuclear intensity was constantly 200 units below the measured intensity in 
unstimulated neutrophils during the initial 3 hours of exposure to PMA and decreased to 500 
units at 4 hours (Figure 5.7b). Nuclei which presented simultaneously enlarged areas and a 
diminished nuclear intensity were considered by the algorithm as NETotic events. The graph 
presented in Figure 5.7c represents the percentage of NETotic events calculated in unstimulated 
and stimulated neutrophils related to the previously described area and intensity data. The 
percentage of NETotic events remained approximately 0% in unstimulated neutrophils, while 
in PMA-stimulated neutrophils approximately 60% of cells were determined to be in a 
NETosing state at 4 hours exposure to PMA. Interestingly, the trend for NETosing cells 
calculated with the Nuclear Detection algorithm was similar to the trend of NET release 
calculated using the NET Detection algorithm (Figure 5.5b). Taken together these data confirm 
that monitoring nuclear decondensation appears to be a valid indicator of NET forming activity 
and directly relates to NET formation.    
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Figure 5.7: Time-course of NETosis as determined using HCA. 
Data from HCA of unstimulated (PBS/green) and PMA-stimulated (red) neutrophils at up to 4 
hours. Time-course average nuclear area (a) and average nuclear intensity data (b) are combined 
to calculate the percentage of NETosing neutrophils at each time-point (c). Values are 
expressed as pixels or units of fluorescent signal and as mean ± SEM. Data represent the mean 
of two independent experiments. 
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5.4 Sub-cellular localisation of proteins 
Nuclear decondensation in neutrophils has been related to the activity of specific proteins, 
including PAD4 and NE (Li et al., 2010; Papayannopoulos et al., 2010). Tracking specific 
proteins during the NET stimulation phase provides valuable information on neutrophil 
activation and the NET release processes which still require further elucidation and may enable 
the identification of novel therapeutic approaches for NET-related diseases. 
The Compartmental Analysis algorithm, as previously described, has application for 
monitoring protein translocations in biological systems (Drake et al., 2009). However, HCA 
has not previously been applied in the localisation of neutrophil proteins. The Compartmental 
Analysis algorithm, as optimised above for neutrophil recognition, was subsequently employed 
with the aim of tracking PAD4 during the neutrophil stimulation phase. Initially however, HCA 
was applied in this thesis to study the nuclear translocation of the NF-κB transcription factor in 
oral keratinocytes, which represents a well characterised process (Milward et al., 2007). As 
HCA has already been successfully applied to the analysis of NF-κB localisation in oral 
keratinocytes (Milward et al., 2013) it was therefore utilised to validate and optimise the 
approach for the analysis of protein intracellular localisation and tracking.   
5.4.1 NF-κB nuclear translocation in H400 cells 
Bacterial products trigger a wide range of intracellular pro-inflammatory processes in H400 
cells, including the activation of NF-κB which plays a key role in regulating cytokine 
transcription and production (Perkins, 2007). In the resting state, NF-κB is located in the 
cytoplasm bound to its inhibitor IκB which is disassembled upon ubiquitination as a result of 
  179 
cellular activation. Once released, NF-κB translocates to the nucleus and binds to DNA 
promoting the transcription of several inflammation-related genes (Barnes, 1997).  
Activation of the inflammatory response in H400 cells was induced by LPS stimulation as 
described in section 2.5 of the Materials and Methods. NF-κB translocation in H400 cells was 
assessed in parallel by semi-quantitative conventional immunohistochemistry and HCA 
(sections 2.7 & 2.8.4) and data obtained using the two techniques were compared. For 
immunohistochemistry purposes H400 cells were cultured and stimulated on multi-well glass 
slide as described in sections 2.3.3. For HCA application, H400 cells were cultured and 
stimulated in black, clear bottom 96-well plates as described in sections 2.3.3 & 2.5. 
Representative images in Figure 5.8 show NF-κB staining in H400 cells unstimulated or 
stimulated with LPS for 1 hour with or without pre-treatment with celastrol. Notably, celastrol 
inhibits the intracellular pathway upstream of IκB degradation and, therefore, abrogates NF-κB 
translocation to the nucleus (Wu et al., 2009). Using both immunohistochemistry and 
immunofluorescence techniques NF-κB was shown to locate in the nuclei of LPS-stimulated 
H400 cells, while in unstimulated cells the staining was predominantly cytoplasmic. Similar to 
control samples, NF-κB staining was identified in the cytoplasm of celastrol pre-treated LPS-
stimulated H400 cells in agreement with data demonstrating the compounds inhibitory activity 
of this process (He et al., 2009).   
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Figure 5.8: Images of LPS-induced NF-κB nuclear translocation in the H400 cell line: Immunohistochemistry analysis vs HCA. 
Representative images of NF-κB nuclear translocation in H400 cells unstimulated or stimulated with LPS for 1 hour, untreated or pre-treated with 
celastrol. Immunohistochemistry images show H400 nuclei in blue and NF-κB proteins in brown, while HCA images show nuclei in blue and NF-
κB proteins in green. Images are representative of two independent experiments. Scale bars represent 50 µm. 
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Images obtained by conventional immunohistochemistry were analysed to determine the 
proportion of H400 cells positive for NF-κB nuclear localisation. The cell count was performed 
as described in section 2.7.2 and results are presented in Figure 5.9. LPS-stimulation induced 
NF-κB nuclear translocation in the majority of analysed cells, while in unstimulated conditions 
NF-κB maintained a cytoplasmic localisation. Celastrol pre-treatment of LPS-stimulated H400 
cells significantly reduced the percentage of cells positive for NF-κB nuclear localisation, 
restoring levels to those found in unstimulated H400 cells.   
 
Figure 5.9: Semi-quantitative analysis of NF-κB nuclear localisation in H400 cells as 
determined from immunohistochemistry images. 
Analysis of immunohistochemistry staining for NF-κB nuclear localisation in H400 cells 
unstimulated or stimulated with LPS for 1 hour, untreated (black bars) or pre-treated with 
celastrol (grey bars). Values are expressed as percentage of positive cells and as mean ± SEM. 
Statistical significance calculated with Tukey’s multiple comparison test (n=4; ****p<0.0001). 
 
NF-κB nuclear translocation in LPS-stimulated H400 cells was quantified by HCA with or 
without pre-treatment with celastrol and the Compartmental Analysis algorithm was applied as 
described above in section 5.2.1. Thresholds for nuclear area and staining intensity were 
manually adjusted based on images of H400 cell nuclei (Appendix III). Object identification 
and rejection settings were adapted to size and staining intensity based on H400 nuclear features 
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(Appendix III). Algorithm settings were adjusted for the subdivision of the cell into two main 
compartments which corresponded to the nucleus and cytoplasm surrounding it. The software 
subsequently identified and quantified the NF-κB staining signal within the two compartments. 
Results presented in Figure 5.10 indicated that the Compartmental Analysis algorithm 
identified a comparable number of cells for all conditions studied (Figure 5.10a). Celastrol 
treated cells presented a significantly decreased nuclear area compared with untreated cells, 
while the LPS-stimulated nuclei presented as a similar size to unstimulated nuclei (Figure 
5.10b). The decreased size of celastrol-treated nuclei may be attributed to the inhibition of NF-
κB and the consequentially reduced gene transcription since this activity has been previously 
related to nuclear morphology (Queisser et al., 2011).  
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a) 
 
b)  
 
Figure 5.10: Effect of celastrol treatment and LPS stimulation on H400 cells. 
Analysis of cell count (a) and average nuclear area (b) of H400 cells unstimulated or stimulated 
with LPS for 1 hour, untreated (black bars) or pre-treated with celastrol (grey bars). Values are 
expressed as number of cells or pixels of staining and as mean ± SEM. Statistical significance 
was calculated with Tukey’s multiple comparison test (n=2; ns=non-significant, **p<0.01).   
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In Figure 5.11 data on NF-κB nuclear translocation is presented. The Compartmental Analysis 
algorithm identified similar levels of NF-κB cytoplasmic staining between untreated and 
celastrol-treated control cells, while LPS-stimulated cells exhibited a significantly lower 
amount of cytoplasmic staining, and this was restored to control levels in celastrol pre-treated 
cells (Figure 5.11a). An opposite trend was detected for the analysis of nuclear staining (Figure 
5.11b). The NF-κB signal increased in LPS-stimulated cells compared with unstimulated cells 
which presented a similar amount of nuclear intensity as that determined with celastrol pre-
treatment of LPS-stimulated cells. Interestingly, celastrol-treated control cells presented higher 
levels or greater intensity of NF-κB nuclear staining compared with the untreated control 
condition. This suggests a partial activation of NF-κB potentially due to its anti-apoptotic 
activity, as proposed by Wright et al. (2011), in response to celastrol and relatively minor 
cytotoxicity has been identified in previous publications (Figure 4b in He et al., 2009; Figure 
1b in Sethi et al., 2007). In Figure 5.11c values of nuclear intensity are presented in relation to 
those of cytoplasmic staining for each condition. Data indicate that LPS-stimulation resulted in 
a significantly higher ratio of nuclear staining versus cytoplasmic staining compared with 
unstimulated cells. LPS-induced activation, however, was efficiently inhibited by the pre-
treatment with celastrol which exhibited levels comparable to controls for NF-κB nuclear 
staining.  
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Figure 5.11: HCA of NF-κB localisation. 
HCA of cytosolic (cyto) (a) and nuclear (b) fluorescent immunostaining signal for NF-κB and 
nuclear/cytosolic ratio (c) related to NF-κB translocation in H400 cells unstimulated or 
stimulated with LPS for 1 hour, untreated (black bars) or pre-treated with celastrol (grey bars). 
Values are expressed as units of fluorescent signal and as mean ± SEM. Statistical significance 
calculated with Tukey’s multiple comparison test (n=2; *p<0.05, ****p<0.0001). 
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5.4.2 PAD4 cellular localisation in neutrophils 
Previously experiments in murine bone marrow neutrophils (section 5.4.2) has demonstrated 
that PAD4 knockout mice were unable to produce NETs. PAD4 localises to the nuclei of 
neutrophils and has been extensively described in the literature as a key protein for regulating 
chromatin decondensation and NETosis processes (reviewed in section 2.2.1.2). In this section, 
PAD4 activation and its regulated process, histone citrullination, were investigated using HCA 
in order to characterise their association with NETosis.  
Neutrophils were exposed to PMA for up to 4 hours to induce NETosis and subsequently fixed 
with PFA as described in section 2.6.6.2. Neutrophil nuclei and NETs were stained with 
Hoechst while immunostaining was performed for PAD4 as detailed in section 2.8.2. Images 
of DNA and PAD4 staining in neutrophils were acquired on distinct channels using the 
ArrayScan (section 2.8.6) and visualised with the HCS Reader software. In Figure 5.12 the 
PAD4 staining is presented both independently and merged with the DNA signal in images of 
neutrophils stimulated for 90 minutes with PMA. The majority of neutrophil nuclei appeared 
in a condensed state as characterised by their multilobulated morphology consistently with the 
time they had been exposed to the stimulus. However, some nuclei were identified in a 
NETosing state, having lost their multilobulation and exhibited a decreased intensity. 
Interestingly, PAD4 staining was particularly intense in those areas corresponding to NETosing 
nuclei. Furthermore, PAD4 staining appeared to localise with extruded extracellular filaments 
which exhibited a morphology consistent with NET structures.     
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Figure 5.12: PAD4 staining co-localised with NETs. 
Representative images of neutrophils unstimulated or stimulated for 90 minutes with PMA. In the far left images, nuclei are in condensed (white 
arrows) and decondensed (red arrows) states. The PAD4 immunostaining signal is shown independently in the central image and merged with the 
DNA staining in the right image (PAD4 is shown in green and DNA in blue). Images are representative of 3 independent experiments. Scale bars 
represent 200µm and apply for all images.  
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Time-course localisation of PAD4 staining in neutrophil nuclei was analysed following 
stimulation for up to 4 hours with PMA or HOCl and compared with unstimulated neutrophils 
using the Compartmental Analysis algorithm. The algorithm identification and rejection criteria 
were optimised for neutrophil nuclear morphology as described in section 5.2.1. For this 
application, the algorithm settings were adjusted to identify and encircle the area surrounding 
neutrophil nuclei that corresponded with the cytoplasm (Appendix IV). The Compartmental 
Analysis, then, localised and quantified the fluorescently stained signal within the nuclear and 
the cytoplasmic areas. Images shown in Figure 5.13a demonstrate how the PAD4 staining signal 
was recognised and localised by the algorithm in HOCl-stimulated and in unstimulated 
neutrophils. Interestingly, the PAD4 signal appeared strongly associated with the nuclear DNA 
in HOCl-stimulated neutrophils, while unstimulated neutrophils presented both a nuclear and a 
cytoplasmic signal. However, the cytosolic signal in control images appeared to be located in 
close proximity of the nuclear area. Time-course data on the quantification of PAD4 nuclear 
staining in stimulated and unstimulated neutrophils are presented in Figure 5.13b. PAD4 
nuclear staining in unstimulated neutrophils remained at constant levels during all 4 hours. 
Conversely, HOCl stimulation resulted in maximum PAD4 nuclear signal after 30 minutes, 
subsequently, between 30 minutes and 2 hours, the signal decreased to relatively low levels and 
remained constant for the following 2 hours. Following PMA stimulation, the PAD4 nuclear 
signal increased in association with the time of exposure to the stimulus. Interestingly, the 
maximal levels of nuclear staining intensity were detected after 30 minutes and 4 hours 
stimulation respectively with HOCl and PMA which are both consistent with the previously 
determined exposure times required for NET production (see Figure 3.6).  
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a)                             DNA                               PAD4                    Algorithm recognition  
Control   
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Figure 5.13: PAD4 nuclear localisation in stimulated neutrophils. 
HCA of PAD4 nuclear localisation in neutrophils stimulated with PMA, HOCl or unstimulated 
for up to 4 hours. a) Representative images of neutrophils stimulated with HOCl for 30 minutes 
or unstimulated (controls). DNA and PAD4 signals are shown independently respectively in 
the left and central images. In the right hand images the algorithm identifies neutrophil nuclei 
in blue and PAD4 localisation as purple spots in the cytoplasm and red spots in the nuclei. b) 
Time-course analysis of PAD4 nuclear staining intensity in stimulated and unstimulated 
neutrophils. Images and data are representative of 3 independent experiments (n=3). Values are 
expressed as mean ± SEM. Scale bars represent 200µm and apply for all images. 
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Concurrent with PAD4 staining, citrullinated-histone 3 localisation was also investigated in 
relation to NET formation. Neutrophils were stimulated for up to 4 hours with PMA and HOCl 
and, upon fixation, immunostaining was performed simultaneously for PAD4 and citrullinated-
histone 3. The Compartmental Analysis algorithm was applied as described above. Data 
presented in Figure 5.14 show the percentage of cells that were positive for PAD4 or 
citrullinated-histone 3 nuclear staining during the course of stimulation. Time-course analysis 
of PMA-stimulated neutrophils indicated between 30% and 40% of cells were positive for 
PAD4 nuclear staining after 3 and 4 hours exposure, which was consistent with previous data 
on PAD4 localisation shown in Figure 5.13. Data for citrullinated-histone 3 nuclear staining 
showed a similar increase at 3 and 4 hours, however, only 10% of cells were shown as positive. 
A different trend was detected in HOCl-stimulated neutrophils. The percentage of cells positive 
for PAD4 nuclear staining increased to 10% after 30 minutes of stimulation, remained at 
constant levels for the following 2 hours, and then increased further to 30% after 4 hours. 
Notably, the percentage of cells positive for citrullinated-histone 3 nuclear signal increased to 
10% after 1 hour of stimulation, decreased for the following 2 hours to nearly 0%, and increased 
to 5% after 4 hours. The high percentage of cells detected as positive for PAD4 nuclear staining 
in both PMA- and HOCl-stimulated neutrophils may be a consequence of damage to nuclear 
and plasma membranes which induced loss of cellular compartments before DNA release. Since 
PAD4 has been shown to localise with NETs in the extracellular space (Figure 5.11 & Spengler 
et al., 2015), the high percentage registered at 4 hours may be related to the association of PAD4 
with NET-DNA rather than nuclear DNA.    
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PMA 
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Figure 5.14: PAD4 and citrullinated-H3 associated with DNA. 
HCA of PAD4 and citrullinated-H3 (Cit-H3) associated with DNA in neutrophils stimulated 
with PMA and HOCl for up to 4 hours. Analysis of the percentage of stimulated neutrophils 
positive for PAD4 and citrullinated-H3 association with DNA (n=3). Data are representative of 
3 independent experiments. Values are expressed as mean ± SEM. 
 
5.5 Validation of HCA for NET analysis  
Once the HCA approach had been optimised for its application for neutrophil and NET analysis, 
further validation was required in order to confirm the accuracy of the technique. Therefore, 
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approach which determines levels of extracellular NET-DNA post-MNase digestion. The HCA 
accuracy for the quantification of NETs was evaluated in time-course and cell density-related 
experiments. For HCA purposes, samples were prepared in a black, clear bottomed 96-well 
plates and fixed with PFA. Sytox green® was applied for staining NET structures and HCA 
was performed (as described in section 2.8.3) employing the NET Detection algorithm. For the 
fluorometric assay neutrophils were seeded in a clear 96-well plate and NET quantification was 
performed (as described in section 2.6.5). 
5.5.1 Time-course analysis of NET formation 
Neutrophils were isolated and stimulated with PMA for up to 3 hours as described in sections 
2.6.4. Data on time-course NET quantification performed with HCA are presented in Figure 
5.15a. Results indicated the technique detected increased NET units as early as 60 minutes after 
exposure to PMA. Subsequently, the amount of NETs further increased and reached its peak 
after 3 hours stimulation. Conversely, the algorithm identified relatively low amounts of NETs 
in unstimulated neutrophils, although this marginally increased by 90 minutes. Data obtained 
with the fluorometric quantification presented a similar trend of NET production for PMA-
stimulated neutrophils (Figure 5.15b), validating the time-course quantification determined by 
HCA. However, the fluorometric assay registered 4 times higher levels of NETs after 3 hours 
stimulation compared with the previous time-point, while fewer differences were identified by 
HCA.  
  193 
a) 
  
b) 
 
Figure 5.15: Time-course of NET quantification: HCA vs fluorometric assay. 
Time-course NET quantification in unstimulated (green) and PMA-stimulated (red) neutrophils 
up to 3 hours of stimulation. Comparison between HCA (a) and fluorometric (b) quantification. 
Values are expressed as units of fluorescent signal or arbitrary fluorescence units (AFU). Data 
represent the mean of two independent experiments ± SEM.  
 
 
5.5.2 Cell density-related NET formation  
The sensitivity of the NET Detection algorithm was evaluated using a range of neutrophil 
densities between 1,000 and 100,000 cells/well, unstimulated or stimulated with PMA for 3 
hours. The NET Detection algorithm outputs were compared with data obtained by fluorometric 
assay. The NET Detection algorithm registered significantly increased levels of NETs in PMA-
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stimulated compared with unstimulated neutrophils seeded at 50,000 cells/well and greater 
(Figure 5.16a). A similar trend of NET production was confirmed by fluorometric 
quantification, which also showed significant increases in PMA-induced NETs compared with 
controls in neutrophils seeded at 50,000 cells/well and above. However, this increase was also 
detected in as little as 5,000 neutrophils/well (Figure 5.16b). This result indicates that the HCA 
algorithm allows a sensitive and accurate NET quantification in samples with seeding densities 
above 50,000 neutrophils/well in a microplate format. 
a) 
 
b) 
 
Figure 5.16: Cell-density related NET quantification: HCA vs fluorometric assay. 
Neutrophils seeded at 5 concentrations in a 96-well plate and stimulated for 3 hours with 
PMA (grey bars) or unstimulated (black bars). NET quantification by HCA (a) and 
fluorometric assay (b). Values are expressed as units of fluorescent signal or arbitrary 
fluorescence units (AFU) and as mean ± SEM. Statistical significance calculated with 
Sidak’s multiple comparison test (n=3; **p<0.01, ****p<0.0001).   
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5.6 Discussion  
In this chapter various algorithms available for HCA were tested for neutrophil and NET 
identification and quantification. Firstly, two pre-existing algorithms were manually adjusted 
and tested for this purpose: namely “Compartmental Analysis” and “Tube Formation”. NET 
recognition occurs in two diverse manners, on one hand the Compartmental Analysis algorithm 
quantifies the DNA in a circular space surrounding the nucleus, on the other hand the Tube 
Formation algorithm quantifies DNA filaments extruded into the extracellular space. Both 
algorithms were evaluated in cell-density experiments in order to determine their accuracy.     
Analysis of NET areas registered by the Compartmental Analysis algorithm in PMA-stimulated 
neutrophils were similar to the values in control neutrophils. Conversely, HOCl-stimulation 
induced a significant increase in NET area compared with control registered in both 100,000 
and 500,000 cells/well densities. Data suggest a different type of NET release may be induced 
by the two stimuli. For instance, PMA may induce the formation of long filaments, while HOCl 
could induce a cloud-like diffusion of NETs as previously shown in the supplementary material 
(video: link3) of Brinkmann & Zychlinsky (2012). Therefore, the Compartmental Analysis 
algorithm may effectively identify cloud-like NETs and neglect extruded NET filaments. 
Moreover, seeding at low density resulted in no significant difference between the NET area 
detected for unstimulated and stimulated neutrophils, suggesting that the cell density may also 
affect the type and amount of NETs released as previously reported in section 7.2.  
The analysis performed with the Tube Formation algorithm resulted in a higher amount of 
NETs counted in unstimulated compared with PMA-stimulated neutrophils seeded at 10,000 
cells/well and above. This results may be related to the excessive formation of cell aggregates 
or to the cell assuming an elongated phenotype, as shown in Figure 3a and b of Zhao et al. 
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(2015). This type of cell morphology may be mistaken for NETosing activity by the Tube 
Formation algorithm. Furthermore, PMA-induced NETs may be extruded from multiple sites 
within the cells simultaneously or may not be associated with intact nuclei and, therefore, 
escape algorithm recognition.   
Both the Compartmental Analysis and the Tube Formation application presented limitations for 
NET analysis, therefore, two new algorithms were specifically developed for this purpose: 
namely “NET Detection” and “Nuclear Decondensation”. These algorithms targeted for two 
main features of NETosis, the extrusion of DNA filaments and the loss of nuclear 
multilobulated morphology respectively, which allows their simultaneous application to obtain 
multiparametric data on NETosis. Using dual staining with Hoechst/Sytox green®, the NET 
Detection and Nuclear Decondensation algorithm demonstrated a similar trend for NET release 
and nuclear decondensation, which indicates that the two parameters are directly related. The 
origin of NETs is somewhat controversial as some publications report mitochondrial DNA as 
the main component of these structures and that neutrophils remain viable following their 
release rather than undergoing cell death (Yousefi & Simon, 2016). However, results gathered 
with the Hoechst/Sytox green® approach and the strong stimuli employed in the present stimuli 
indicate that the association of NET production with nuclear decondensation support studies 
suggesting that these two mechanisms exist and occur as a result of different stimuli (Zhao et 
al., 2015). 
Time-course production of NETs in PMA-stimulated neutrophils was accurately measured by 
the NET Detection algorithm, as validated by the fluorometric quantification of NET-DNA. As 
expected, NET release increased with the time of exposure to the stimulus and this trend was 
confirmed by both types of quantification approach. However, differences were identified 
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between the two approaches which may be explained by the different types of quantification 
applied. On one hand, the fluorometric assay is based on fluorescent measurement of DNA in 
the supernatant and, on the other hand, HCA is applied to images of stimuli-induced NETs.  
When performing the time-course analysis of neutrophils, an interesting morphological change 
induced by PMA stimulation was observed. Images of Hoechst-stained neutrophil nuclei were 
visualised and merged with brightfield images in order to monitor cellular changes associated 
with PMA-induced nuclear changes. Unstimulated neutrophils retained a rounded and compact 
shape visible in the images as a darker ring around the orange nuclei. Conversely, as early as 
60 minutes into PMA-stimulation, the spherical shape disappeared and the cytoplasm appeared 
as an undefined area around nuclei (Figure 5.17). The altered morphology may be due to the 
activation of intracellular pathways upstream of the process of NET release. Consistently, 
similar morphology has been identified in numerous published images of stimulated neutrophils 
including Figure 1d in Brinkmann et al. (2004), Figure 2b in Fuchs et al. (2007) and Figure 1a 
in Zhao et al. (2015). This particular morphological change in neutrophils, described as 
“spreading on a surface”, has already been related to cytoskeletal activities (Girard et al., 1997). 
Furthermore, Neeli et al. (2009) demonstrated that cytoskeletal rearrangement is required for 
histone deimination and NET formation in LPS stimulated neutrophils. Therefore, the 
morphological changes observed in PMA-stimulated neutrophils and preceding NET release 
(as quantified in section 5.5.1) support the hypothesis that cytoskeletal rearrangement is an 
early stimulus-induced mechanism required for NET formation. 
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    Stimulation time (minutes): 
    0                                          60                                        90                                       120                                      180  
a)  
b)  
Figure 5.17: Time-point images of neutrophil stimulation showing altered cytoplasm appearance following PMA treatment. 
Representative HCA images of neutrophils unstimulated (a) or stimulated with PMA (b) for up to 3 hours. Hoechst-stained nuclei are shown in 
orange colouration and merged with brightfield images. Nuclei appeared in decondensed state at 180 minutes when are stimulated, while cytoplasm 
had lost the compact spherical shape in the majority of cells as early as 60 minutes after stimulation with PMA. Images are representative of two 
independent experiments. Scale bars represent 200µm and apply for all images.  
  199 
The Nuclear Decondensation algorithm provided an accurate calculation of cells in a NETosing 
state based solely on chromatin observation, which has been related to NET release in previous 
publications (Brinkmann et al., 2012; Zhao et al., 2015). This type of recognition allows the 
identification of NETosing nuclei and excludes other cell death phenotypes including necrotic 
nuclei which lose their multilobulation, however, which remain in a condensed state (Fuchs et 
al., 2007). The main advantages of monitoring nuclear decondensation are the possibility to 
study early phases of NET formation and the benefit of obtaining information on a cell-to-cell 
basis. Analysis of PMA-stimulated neutrophils demonstrated that the Nuclear Decondensation 
algorithm was effective in identifying and quantifying the portion of cells in a NETosing state. 
Results presented in Figure 5.7 are in agreement with those presented in Zhao et al. (2015) 
which proposed a modified flow cytometry method for NETosis quantification based on area 
and bright detail intensity.  
The Compartmental Analysis algorithm was successfully applied for the localisation of proteins 
in both H400 cells and neutrophils. The method was validated for nuclear translocation of NF-
κB in stimulated H400 cells by immunohistochemistry. The analysis performed on 
immunohistochemistry images and the HCA resulted in similar distributions of localisation for 
NF-κB in unstimulated and stimulated cells suggesting both techniques provide accurate and 
reliable data. NF-κB identification by immunohistochemistry and by HCA was also performed 
in neutrophils unstimulated and stimulated with PMA (data not shown). However, neither the 
immunohistochemistry staining nor the HCA identified translocation of NF-κB in the nuclei of 
neutrophils upon stimulation within the time-point observed. A previous report has identified 
nuclear translocation of NF-κB in neutrophils following 10 minutes stimulation with LPS, 
which was sustained up to 2.5 hours (McDonald et al., 1997). In the same study, PMA 
stimulation also induced NF-κB activation and nuclear translocation after 45 minutes of 
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exposure. Therefore, it is plausible that in the time-points observed, of 30 and 60 minutes post-
stimulation, NF-κB was present in the cytoplasm respectively before and after nuclear 
translocation.   
PAD4 specific activation and function in neutrophils has not been fully described, which further 
strengthens the argument raised in Yousefi & Simon (2016) which suggested that the 
citrullination process is operated by PAD2 rather than PAD4, and occurs extracellularly, rather 
than in the nucleus. HCA in stimulated neutrophils demonstrated PAD4 co-localised with 
nuclear DNA and NET filaments which suggests that PAD4 is released into the extracellular 
space bound to NETs, from where it may operate its citrullination activity as already recently 
proposed by Spengler et al. (2015) and confirmed in section 5.4.2. However, data shown in 
Figure 5.14 are a representation of PAD4 staining intensity and the strong signal registered in 
stimulated neutrophils may be related the protein activation state. Notably, previous studies 
have shown that dimerisation is required for PAD4 enzymatic activity while the monomeric 
form exhibits less activity (Liu et al., 2011). Therefore, the increased signal intensity registered 
upon stimulation suggests the enzyme was in its dimer form and its active state. Citrullinated- 
histone 3 was identified in the nuclear DNA of stimulated-neutrophils in association with 
PAD4. The registered signal, however, was relatively low compared with the PAD4 signal, 
suggesting that the citrullination activity is not proportionally related to the enzyme 
concentration in the cell. 
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11 CHAPTER 6: HIGH-THROUGHPUT 
SCREENING OF NETOSIS MODULATORS 
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6.1 Background  
Despite their important antimicrobial role at sites of infection, NETs have also been associated 
with the pathogenesis of several auto-inflammatory and auto-immune disorders. In particular, 
NET under and over-production or aberrant clearance has been proposed to play a role in the 
pathogenesis of several diseases (summarised in section 2.4). Hence, due to their potentially 
conflicting functions in human health, NETs have been described as a “double-edged sword” 
and it is apparent that a fine homeostatic balance may determine the difference between health 
and disease (Cooper et al., 2013). Consequently, the pharmacological modulation of NETosis 
offers the potential for developing novel treatments for a range of diseases (Cheng & Palaniyar, 
2013; Hahn et al., 2013). Indeed, researchers have already identified compounds that regulate 
NETosis and may therefore serve as possible treatments in auto-inflammatory/-immune 
diseases (Lapponi et al., 2013; Mcinturff et al., 2013; Yu et al., 2015). Notably, however, 
research to date has been limited as the current methods used for screening for modulators of 
NETosis lack consistency and reproducibility. An example of this is the compound Rapamycin, 
an inhibitor of the mTOR pathway, which has been found to reduce NET formation in a study 
employing LPS stimulated neutrophils (Mcinturff et al., 2013), however, in another study it 
was shown to have no effect on ionomycin and PMA induced NETosis (Gupta et al., 2014) 
raising concerns over its use.   
Chapter 8 in this thesis described the development and optimisation of a novel approach for 
HCA of neutrophils ET release. This technology has application for the screening of small 
molecule libraries and is employed in the pharmaceutical industry for drug discovery processes 
and intracellular molecular tracking (Posner, 2005; Korn & Krausz, 2007). In the current 
chapter the HCA method previously developed (see Chapter 5) was applied for High-Content 
Screening (HCS) of a pharmaceutically-derived compound library to identify modulators of 
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NETosis. The utilised library comprised 56 compounds that have previously been applied to 
cancer treatment and includes a number of immunosuppressive molecules which have been 
shown to regulate neutrophil and other immune cell functions (Dr Gareth Griffiths, Imagen 
Therapeutics - personal communication). Subsequently, the individual compounds identified 
by HCS to modulate NETosis were then characterised using low-throughput approaches to 
validate findings and further investigate their modulation of neutrophil activity.  
6.2 High-throughput screening for compounds that modulate NET production 
In order to perform HCS of the 56 member compound library, neutrophils were isolated and 
seeded in black, clear bottomed 384-well plates (as described in section 2.8.5.3). Neutrophil 
seeding and handling was performed using the robotic benchtop workstation (section 2.8.5.1). 
Individual compounds from the library were applied to the neutrophil preparations for 30 
minutes using a range of 5 concentrations pre-determined for each compound (Dr Gareth 
Griffiths, Imagen Therapeutics - personal communication and as detailed in section 2.8.5.2). 
Celastrol-treated cells were used as inhibitory controls while Benzethonium Chloride was used 
to induce cytotoxicity and to discern NETosis from other types of cell death. After 30 minutes, 
neutrophils were stimulated with PMA or were left unstimulated for 3 hours. Following 
fixation, Hoechst was applied for nuclear staining and images were acquired using the 
ArrayScan (section 2.8.6). HCA was performed using the Nuclear Detection algorithm as 
described in section 5.3.2. Image analysis was performed using two distinct methods for 
unstimulated and PMA-stimulated images. To identify whether compounds were able to induce 
NETosis in unstimulated conditions, rejection and threshold criteria for nuclear size and nuclear 
staining intensity were defined based on images of unstimulated and untreated neutrophils as 
previously described in section 5.3.2 of Chapter 5 and as listed in Appendix V. The algorithm 
subsequently identified those cells with increased nuclear size and with decreased nuclear 
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intensity. Concomitant increased size and decreased staining intensity was calculated by the 
algorithm and used as an indication of NETosing activity, which is reported in the unstimulated 
panel of Figure 6.1 using shades of grey, while control levels are shown in black. Conversely, 
in order to identify whether compounds inhibited PMA-induced stimulation, rejection and 
threshold criteria were established based on images of PMA stimulated neutrophils and 
untreated neutrophils were used as controls. In this case, the algorithm determined the 
proportion of cells with increased or decreased levels of both nuclear size and staining intensity 
compared with control cells. The NETosing activity registered in PMA-stimulated and 
untreated neutrophils are reported in shades of grey in the PMA panel of Figure 6.1; increased 
NETosis is reported in colours towards white and inhibitory activity in colours towards black. 
Celastrol treatment, used as control for inhibitory activity, resulted in a complete inhibition of 
PMA-induced NETosis and is represented in black in both panels of Figure 6.1. The HCS 
identified 17 compounds potentially inducing NETosis in unstimulated neutrophils, while 13 
compounds potentially were identified as inhibiting NETosis and 13 compounds potentially 
enhanced PMA-induced NETosis. Rapamycin and Lapatinib treatments resulted in inhibition 
at low dosages and increased NETosis at high dosages, while Bosutinib treatment resulted in 
an opposite effect. Compounds showing modulatory activity in unstimulated and PMA-
stimulated neutrophils were selected for further screening.  
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Figure 6.1: Heatmap representation of the range of activities induced by the compounds on NETosis. 
Heatmap representing the NETotitc events calculated by HCS in unstimulated and PMA-stimulated neutrophils untreated or pre-treated with 
members of the 56-compound library. Values are calculated as the mean of two independent experiments and are expressed in a grey scale where 
black represents no NET detection and white represent the maximal NETotitc activity registered in the experiment. The untreated condition is 
represented as black due to the absence of stimulation and grey represents PMA-stimulated neutrophils. 
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6.3 Selection of compounds which modulate NETosis  
Images associated with the compounds identified by the initial HCS were further analysed using 
the HCS Reader software. The nuclei in each image were analysed for false negative or false 
positive events. For instance, images captured out of focus presented nuclei with size and 
nuclear intensity inaccurately identified by the Nuclear Decondensation algorithm and were 
manually excluded from the selection process. Furthermore, nuclei were screened for 
apoptosis-related phenotypes as shown in Figure 6.2 and previously identified in neutrophils 
by Fuchs et al. (2007). Although apoptotic bodies were visible as black spots, the nuclei still 
presented similar features to NETosing activity which was misinterpreted by the algorithm and 
these were also manually excluded from the selection process.   
 
Figure 6.2: Apoptotic body detection in neutrophil nuclei. 
Representative image of apoptotic body formation (yellow arrows) in Hoechst-stained 
neutrophil nuclei following treatment with Cladrabine. Scale bar represents 100µm. 
Following an extensive literature search, those compounds that were associated with 
neutropenia or other forms of neutrophil cell death were also excluded from further study. 
Subsequently, of the 56 compounds initially screened for modulation of NETosis, 8 were 
selected for further downstream characterisation. In Figure 6.3 images of PMA stimulated and 
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compound-treated neutrophils are shown. PMA stimulated nuclei, utilised for the determination 
of nuclear size and intensity thresholds, presented characteristic NETosing morphology. 
Adjacent to this, celastrol treated neutrophils are shown, and as would be expected, these cells 
exhibited nuclei with unstimulated features which were used as controls for inhibitory activity.  
6.3.1 NETosis inducers  
Crizotinib and Ponatinib were selected as inducers of neutrophil activation since their 
application to PMA-stimulated neutrophils enhanced NETotic events to a greater level 
compared with PMA-alone treated neutrophils. Indeed, the majority of nuclei presented a 
decondensed morphology and numerous NET structures were visible in association with them.  
6.3.2 NETosis inhibitors 
Conversely, neutrophils treated with Carmustine, Erlotinib and Nilotinib, prior to PMA 
exposure, exhibited nuclear features consistent with celastrol treated cells and were, therefore, 
selected as inhibitors of NETosis.  
6.3.3 Compounds causing biphasic effects on NETosis  
Lapatinib, Bosutinib and Rapamycin displayed both inhibiting and enhancing activities when 
applied at different doses which correlated with the HCS findings. Bosutinib and Lapatinib 
were selected for further analysis, after HCS and manual screening, for their predominantly 
inhibitory activity, while Rapamycin was selected for its ability to increase PMA-induced 
stimulation.      
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                PMA                                  Celastrol                               Crizotinib                               Lapatinib                             Carmustine  
 
              Erlotinib                              Bosutinib                               Ponatinib                              Rapamycin                              Nilotinib 
 
Figure 6.3: Images of compound-treated neutrophil nuclei. 
Representative images of 3 hour PMA-stimulated neutrophil nuclei untreated or pre-treated with celastrol and the 8 compounds selected using HCS 
and manual screening applied at their highest concentration (10,000nM). Nuclei and NETs are visible following Hoechst staining. Images are 
representative of three independent experiments and are shown for comparison purposes. Scale bars represent 400µm. 
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6.4 Neutrophil dose-responses 
The 8 selected compounds were characterised further for their neutrophil modulatory activity 
using more targeted approaches. The 8 compounds were simultaneously tested in neutrophils 
from 3 donors. Isolated neutrophils were seeded in clear 96-well plates and the 8 compounds 
were applied at a range of concentrations from 1nM and 10,000nM and samples incubated for 
up to 3 hours. PMA treatment was used as a positive control for stimulation, while celastrol and 
media alone were used as a negative control and to provide baseline readouts, respectively. To 
determine whether compounds induced a neutrophil response through the activation of NOX 
complexes, intracellular and extracellular ROS production were monitored by 
chemiluminescence assay (section 2.6.3). Simultaneously, their ability to induce NETosis was 
evaluated by fluorometric quantification after 3 hours incubation (section 2.6.5).  
6.4.1 ROS production  
Neutrophil ROS production was evaluated for 3 hours following compound treatment. The 
maximum values registered within the incubation time for each treatment are presented in 
Figure 6.4. PMA stimulation effectively induced ROS production, while data indicated none of 
the 8 compound treatments induced the activation of the ROS cascade (Figure 6.4a & b). 
Celastrol treatment resulted in statistically significant lower levels of ROS compared with 
media control, suggesting the compound-driven inhibition may also suppress the normal 
metabolic activity of unstimulated cells. Similar statistically significant differences were 
detected with Bosutinib and Ponatib treatments at relatively high doses (respectively at 
10,000nM and at 1,000nM and 10,000nM), indicating the two compounds have inhibitory 
effects similar to celastrol (Figure 6.4b). 
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a) 
  
b) 
 
Figure 6.4: ROS production quantified in compound-treated neutrophils. 
ROS production in unstimulated neutrophils which were untreated or pre-treated with 10µM 
celastrol or the 8 selected compounds at concentrations ranging from 1nM to 10,000nM, or 
stimulated with 50nM PMA for 3 hours. Values are expressed as relative light units (RLU) and 
mean ± SEM. Statistical significance was calculated using the Kruskal-Wallis’s multiple 
comparison test (n= 3; *p<0.05, **p<0.01 compared with PBS control values). 
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6.4.2 NET production  
Dose-response induction of NETosis in unstimulated neutrophils was evaluated by fluorometric 
measurement of extracellular NET-DNA release following 3 hours treatment with the selected 
compounds. Among the 8 tested compounds, only Crizotinib treatment at 10,000nM induced a 
significantly higher amount of NET-DNA release compared with the unstimulated/untreated 
control (Figure 6.5a). Furthermore, Bosutinib and Ponatinib treatments at 10,000nM resulted 
in increased NET-DNA release, although the difference compared with the media control was 
not statistically significant (Figure 6.5b). The other 5 compounds exhibited similar NET-DNA 
levels to that of the untreated control indicating their application to neutrophils did not trigger 
NETosis. Notably, the data for Crizotinib and Ponatinib treatments were consistent with the 
NET-inducing activity as determined by the HCS.    
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a) 
 
b) 
 
Figure 6.5: NET production quantified in compound-treated neutrophils. 
Fluorometric NET quantification at 3 hours in unstimulated neutrophils untreated or pre-treated 
with 10µM celastrol or the 8 selected compounds using concentrations ranging from 1nM to 
10,000nM, or stimulated with 50nM PMA. Values are expressed as arbitrary fluorescence units 
(AFU) and mean ± SEM. Statistical significance was calculated with Kruskal-Wallis’s multiple 
comparison test (n= 3; *p<0.05 compared with PBS control values). 
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6.5 Dose-response inhibition of PMA-induced neutrophil activation 
The 8 selected compounds were characterised for their ability to modulate responses in PMA 
activated neutrophils from 3 donors. Neutrophils were seeded in clear 96-well plates (as 
described in section 2.1) and were treated with the selected compounds at a range of 
concentrations from 1nM to 10,000nM and incubated for 30 minutes. Neutrophil stimulation 
was subsequently induced by PMA exposure (as described in section 2.4) for up to 3 hours. 
Treatment with PMA only was utilised as the positive control, while celastrol treatment was 
used as a control for inhibitory activity. In order to identify whether compounds were able to 
inhibit or enhance the PMA-induced NOX activation, intracellular and extracellular ROS 
production was monitored by chemiluminescence assay (section 2.6.3). Simultaneously, their 
ability to inhibit or increase PMA-induced NET release was evaluated by fluorometric 
quantification after 3 hours incubation (section 2.6.5).  
6.5.1 Compound inhibition of PMA-induced ROS production  
The dose-response modulation of PMA-induced ROS release was monitored for 3 hours and 
the maximum levels of ROS production following treatment were compared with the maximum 
levels registered in untreated cells throughout the stimulation period. Data presented in Figure 
6.6 were normalised using the media-only control values in order to minimise the physiological 
differences between donors. Consistently, celastrol treatment significantly reduced PMA-
induced ROS activity. Results presented in Figure 6.6a & b show an overall dose-response 
inhibition of NOX activity following compound treatment compared with PMA-stimulated 
neutrophils, although, in general, these results were not statistically significant. Interestingly, 
Crizotinib treatment at the highest dose (10,000nM) was able to significantly reduce the amount 
of ROS produced in response to PMA stimulation (Figure 6.6a). Notably, Carmustine, 
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Bosutinib and Ponatinib treatments, all at the highest dose (10,000nM), also reduced the levels 
of PMA-induced ROS (Carmustine in Figure 6.6a, Bosutinib and Ponatinib in Figure 6.6b). 
These differences were, however, not statistically significant.  
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a) 
 
b) 
 
Figure 6.6: Compound inhibition of PMA-induced ROS. 
ROS quantification in neutrophils stimulated for 3 hours with 50nM PMA and untreated or pre-
treated with 10µM celastrol and the 8 selected compounds at concentrations of between 1nM 
and 10,000nM. Values are normalised to the media control and expressed as relative light units 
(RLU) and mean ± SEM. Statistical significance was calculated using the Kruskal-Wallis’s 
multiple comparison test (n= 3; *p<0.05 compared with PMA control values). 
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6.5.2 Compound inhibition of PMA-induced NET production 
Neutrophils were treated for 30 minutes with the selected compounds prior to stimulation with 
PMA. Compound dose-response modulation of PMA-induced NETosis was evaluated by 
fluorometric measurement of extracellular NET-DNA release following 3 hours incubation. 
Data presented in Figure 6.7 were normalised by media control values in order to minimise 
physiological differences between donors. Inhibition of NET release was identified following 
treatment with Lapatinib at 10nM and 1,000nM, Carmustine at 1nM, 10nM and 10,000nM and 
Erlotinib at 10nM and 1,000nM. Interestingly, Crizotininb treatment at the highest dosage 
(10,000nM) resulted in more than 3-fold higher DNA release, although this was not statistically 
significant, compared with the untreated control. Notably, these NETosis modulation findings 
were consistent with their activity as identified by the HCS. Statistical significance was 
identified for the inhibitory effects presented in Figure 6.7a. Celastrol treatment resulted in a 
non-statistically significant inhibition of NET-DNA release. This lack of statistical significance 
may be attributed to the donors’ physiological variability. Notably, Ponatinib appeared to 
increase the PMA-induced NET production at higher doses (10,000nM), while Rapamycin 
inhibited NET release at the lowest dose (1nM) applied (Figure 6.7b). These differences were, 
however, not statistically significant. 
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a) 
 
b) 
 
Figure 6.7: Compound inhibition of PMA-induced NETs. 
NET quantification in neutrophils stimulated for 3 hours with 50nM PMA and untreated or pre-
treated with 10µM celastrol and the 8 selected compounds at concentrations of between 1nM 
and 10,000nM. Values were normalised to the media control and expressed as arbitrary 
fluorescence units (AFU) and mean ± SEM. Statistical significance was calculated using the 
Kruskal-Wallis’s multiple comparison test (n= 3; ns=non-significant, *p<0.05, **p<0.01 
compared with PMA control values). 
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6.6 Analysis of LDH release from compound treated neutrophils 
Concomitantly, with the modulation of ROS and NET production, LDH release following the 
use of the 8 compounds at their highest doses (10,000nM) was assessed. Neutrophils were 
seeded and exposed to the 8 selected compounds for 3 hours prior to LDH measurement (section 
2.1.7.2). Neutrophils were unstimulated in order to determine baseline LDH activity, while the 
maximum LDH activity was determined following treatment with lysis buffer (as provided by 
the manufacturer). Results are presented in Figure 6.8 and indicated elevated percentage of 
LDH release were induced by Crizotinib, Bosutinib and Ponatinib treatments at their highest 
doses (10,000nM) while the other 5 compounds did not induce LDH release.   
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a) 
  
b) 
 
Figure 6.8: Assessment of neutrophil LDH release induced by the 8 compounds. 
The 8 selected compounds were assessed at their highest concentration (10,000nM) for the 
percentage of LDH release in neutrophils. a) Crizotinib, Lapatinib, Carmustine and Erlotinib 
percentage of LDH release in two donors. b) Bosutinib, Ponatinib, Rapamycin and Nilotinib 
percentage of LDH release in three donors. Values are expressed as mean of two replicates (n= 
2) ± SEM.  
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6.7 Discussion  
The automated HCA approach developed and optimised for neutrophil application in the 
previous chapter was successfully applied in the screening of a 56-compound library for the 
identification of novel modulators of NETosis. The combined high-content and manual 
screening approaches identified 8 modulators of neutrophil activity. Subsequently, Crizotinib 
and Ponatinib were identified as inducers of NETosis, while Carmustine, Erlotinib and 
Nilotinib were identified as inhibitors. Interestingly, Lapatinib was identified as an inhibitor at 
a relatively low dose and acted as an inducer at higher doses, whereas Rapamycin acted as an 
inhibitor at low doses and Bosutinib was an inducer at low doses and an inhibitor at higher 
doses.  
Notably the 8 compounds have been found to modulate multiple intracellular pathways in 
cancer cells and those relevant to neutrophil or NETosis activity are summarised in Table 6.1. 
Notably, several of these compounds have been previously associated with NETosing 
pathways. Indeed, Carmustine’s inhibitory activity has been shown to target glutathione 
reductase (An et al., 2011). This enzyme catalyzes the reduction of glutathione (GSH) from its 
oxidised state (GSSG), as described in section 2.1.3.1, and is responsible for maintaining a 
balanced redox status in neutrophils (Guerra et al., 2012). Interestingly, elevated levels of 
GSSG have been related to the hyperactivity of neutrophils from periodontitis patients (Dias et 
al., 2013) and, recently, Yan et al. (2012) demonstrated that glutathione reductase activity is 
essential for the production of murine NETs. Furthermore, Bosutinib is an inhibitor of the Src 
family kinases which have been previously identified as playing a role in regulating yeast-
induced NET production (Nanì et al., 2015). The compound Rapamycin has also been 
previously shown to regulate NETosis through the mTOR pathway and the induction of the 
hypoxia-inducible factor-1α (HIF-1α) (Mcinturff et al., 2013).  
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Compound Target of inhibition Reference 
Crizotinib 
Anaplastic lymphoma kinase 
(ALK)/Proto-oncogene 1 receptor 
(ROS1) tyrosine kinase (TK) 
(Ignatius Ou, 2011) 
Lapatinib 
Human epidermal growth factor 
receptor (HER)/ Epithelial growth 
factor receptor (EGFR) tyrosine 
kinase (TK) 
(Davis et al., 2011) 
Carmustine Glutathione reductase (GR) (An et al., 2011) 
Erlotinib Epithelial growth factor receptor (EGFR) tyrosine kinase (TK) (Smith, 2005) 
Bosutinib Src family kinases (Remsing Rix et al., 2009) 
Ponatinib 
Vascular endothelial growth factor 
receptor (VEGFR)/Fibroblast growth 
factor receptor (FGFR) tyrosine 
kinase (TK) 
(Price et al., 2013) 
Rapamycin 
Mammalian target of rapamycin 
(mTOR)/Hypoxia-inducible factor 
1α (HIF-1α) 
(Mcinturff et al., 2013) 
Nilotinib 
Platelet-derived growth factor 
receptor (PDGF-R) tyrosine kinase 
(TK) 
(Weisberg et al., 2005) 
Table 6.1: Known molecular targets of the 8 selected compounds. 
The 8 selected compounds were tested using relatively low-throughput techniques for further 
analysis of ROS production and NETosis with or without PMA stimulation. Results are 
summarised in Table 6.2. Notably, none of the 8 compounds induced ROS production in 
unstimulated neutrophils. Furthermore, Bosutinib and Ponatinib treatment resulted in 
significant lower levels of ROS compared with the media control. Similar results were observed 
in celastrol treated neutrophils, which suggests that these compounds may modulate neutrophil 
baseline metabolic activities. In support of this hypothesis is the fact that NF-κB, the cellular 
target of celastrol, has been shown to play a key role in the activation and regulation of NOX 
complexes in monocytes (Anrather et al., 2006). Subsequently, celastrol treatment may impede 
the natural assembly of NADPH oxidase in resting neutrophils therefore limiting the baseline 
production of ROS.      
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Analysis of the effect of compound treatment on PMA stimulated neutrophils indicates high 
variability amongst the 3 donor neutrophil preparations in terms of ROS and NET production. 
Graphs presented in Figure 6.9 & Figure 6.10 demonstrate the trends identified for each donor 
individually. Graph a) in both figures represents the trends identified in experiments performed 
with donors 1, 2 and 3. Although minor differences were identified between donors, the 3 trends 
were similar and, therefore, the results were statistically significant. Conversely, experiments 
performed using donors 4, 5 and 6 resulted in broad and variable biological responses following 
compound treatment and, therefore, different trends of ROS and NET production. For instance, 
when analysing PMA-induced ROS formation, donor 5 presented higher values compared with 
the other two (Figure 6.9b). Notably, however, were the strong inhibitory effects on ROS 
production caused by Bosutinib and Ponatinib treatments at relatively high doses which were 
apparent in all 3 donor samples.  
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a) Set 1 
 
b) Set 2 
 
Figure 6.9: Re-plot of data presented in Figure 6.6 showing the variability in neutrophil 
responses from different donors. 
Re-presentation of individual data points originally shown in Figure 6.6 demonstrating donor 
biological variability. Each individual trend (n=3) of activation is independently represented. 
Values are normalised to control and expressed as relative light units (RLU). 
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Even more variability was identified in the analysis of PMA-induced NET release (Figure 
6.10b). The 3 trends of neutrophil activation showed some similarities such as in the inhibition 
due to treatment with celastrol, Ponatinib (1,000nM) and Rapamycin (1nM), and the increased 
activity due to treatment with Ponatinib (10,000nM). Notably, however, most NET-DNA 
values varied considerably between donors. An example of such variability was highlighted by 
the effect of Bosutinib treatment at the high dose (10,000nM) which resulted in inhibition in 2 
donors, while induced a notable amount of NET-DNA release in the third donor. In this 
analysis, the absence of statistical significance for the differences presented in Figure 6.6 & 
Figure 6.7 is likely due to the biological variability between donors, which has been previously 
reported in other NET studies (Barrientos et al., 2013; Brinkmann et al., 2012). 
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a) Set 1  
 
b) Set 2 
 
Figure 6.10: Re-plot of data presented in Figure 6.7 showing the variability in neutrophil 
responses from different donors. 
Re-presentation of individual data points originally shown in Figure 6.7 demonstrating donor 
biological variability. Each individual trend (n=3) of activation is independently represented. 
Values are normalised to control and expressed as arbitrary fluorescence units (AFU). 
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Interestingly, Crizotinib treatment decreased the ROS activity induced by PMA stimulation. 
However, neutrophils exposed to the compound for 3 hours presented remarkably high levels 
of NET-DNA release, with and without additional PMA stimulation, compared with 
corresponding controls. Interestingly, Crizotinib, Bosutinib and Ponatinib induced DNA release 
but not ROS production suggesting an oxidant-independent activation of NETosis may be 
involved. A similar NETosis process to the aforementioned compounds has been identified with 
ionomycin treatment in studies which identified an alternative NADPH-independent pathway 
leading to NETosis and triggered by calcium influx (Parker et al., 2012a). Therefore, it is 
possible that Crizotinib, Bosutinib and Ponatinib may target an alternative NADPH-
independent pathway involved in calcium influx associated-NETosis which may overcome 
PMA-induced activation. However, whilst the compounds were selected based upon their 
induction of nuclear de-condensation, as analysed by HCS, it is not possible to exclude the 
possibility that data presented in this chapter that is based upon DNA staining, may also include 
some DNA released due to necrosis. 
Data obtained for Lapatinib, Carmustine and Erlotinib treatments indicated these compounds 
exerted a similar effect on both unstimulated and PMA-stimulated neutrophils. In particular, 
ROS production was unaffected by the treatments, while PMA-induced NETosis was 
significantly decreased compared with the untreated control. Amongst the Lapatinib and 
Erlotinib targets is the phosphorylation activity of epithelial-growth-factor-receptor tyrosine 
kinase (EGFR-TK) which may be involved in PMA-induced NET formation. EGFR-TK 
regulates many intracellular activities including ROS formation and the activation of MAPKs 
(Purdom & Chen, 2005). However, since ROS production was not affected by the compound 
treatments, the modulation by theses compound may occur downstream of NOX activation. 
This is consistent with the findings of Keshari et al. (2013) which also identified the two 
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MAPKs, p38 and extracellular signal regulated kinase (ERK), as being involved in the 
regulation of PMA-induced NETosis. Interestingly, Carmustine treatment also appeared to 
affect NETosis downstream of the production of ROS suggesting NET formation may be 
modulated by the cellular redox status which, in turn, is controlled by the enzyme glutathione 
reductase. 
Two other compounds presented similarity in their effects on unstimulated and stimulated 
neutrophils. Both Bosutinib and Ponatinib treatments efficiently reduced ROS production, 
independently of whether it was PMA-triggered or not. Their application to unstimulated 
neutrophils, however, induced a moderate NET-DNA release. In addition, Ponatinib treatment 
at high dosage was able to increase PMA-induced NET production. Since Bosutinib has among 
its targets the Src kinase family members, this data suggests they may be involved in NET 
formation (Nanì et al. 2015), and may regulate NET formation process by modulating MAPK 
activity.  
Of further note was the effect of Rapamycin treatment on PMA-stimulated NETosis. 
Application of this compound resulted in the inhibition of the release of NET-DNA which has 
previously been reported by Mcinturff et al. (2013). Interestingly, however, no inhibition was 
observed with the previously published concentration of 200nM. Its effect was only detected at 
relatively low dose (1nM) in all three donors, while higher concentrations (100nM and above) 
resulted in the compound exerting no effects on NETosis, data which is in agreement with the 
findings of Gupta et al. (2014).  
The LDH assay, as described in section 2.1.7.2 of Materials and Methods, provides a 
quantitative method for the assay of the intracellular enzyme LDH, which is released 
extracellularly following plasma membrane rupture in cellular death processes, such as necrosis 
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(Chan et al., 2013). The assay is usually applied for the analysis of compound-induced or cell-
mediated cytotoxicity, however, since NETs require membrane rupture for their extracellular 
release, in this study its application may indicate its utility as a biomarker for NETosis. Analysis 
of compound-induced LDH release upon treatment with Crizotinib, Bosutinib and Ponatinib at 
their highest dose applied (10,000nM) compared with control was assessed. These compounds 
induced DNA release which suggests the LDH identified in the supernatant could be released 
extracellularly following membrane rupture necessary for NET release. Taken together these 
results suggest LDH release could be applied along with other assays as a biomarker for 
monitoring the formation of NETs. Indeed, PMA-stimulated neutrophils presented LDH release 
levels above 50%, consistently with the NETotitc activity induced by this type of stimulation 
(Figure 6.11). Celastrol pre-treatment of PMA-stimulated neutrophils, however, decreased 
LDH release to minimal levels indicating that its detection is a consequence of NETosis.  
 
Figure 6.11: Extracellular LDH activity detected following PMA treatment of neutrophils. 
Percentage of LDH activity detected in PMA stimulated neutrophils with or without pre-
treatment with celastrol (10µM). Values are expressed as mean of two replicates (n=2) ± SEM. 
In this chapter, 8 compounds were selected for further analysis based on the initial HCS which 
indicated their modulatory activity for neutrophil ROS and NET production (Table 6.2). This 
analysis confirmed the modulatory functions of some compounds previously proposed by other 
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studies and, additionally, identified for the first time the involvement of other pathways or 
regulatory mechanisms in ROS and NET production. Subsequently, in addition to Rapamycin, 
the present study has now identified further 6 compounds which can modulate NETosis.  
Compound ROS NETs 
 Effect on unstimulated 
induction (+)/ inhibition (−) 
Effect on unstimulated 
induction (+)/ inhibition (−) 
Crizotinib none + 
Lapatinib none none 
Carmustine none none 
Erlotinib none none 
Bosutinib − + ns 
Ponatinib − + ns 
Rapamycin none none 
Nilotinib none none 
   
 Effect on PMA-stimulated  
induction (+)/ inhibition (−) 
Effect on PMA- stimulated  
induction (+)/ inhibition (−) 
Crizotinib − + ns 
Lapatinib none − 
Carmustine none − 
Erlotinib none − 
Bosutinib − ns none 
Ponatinib − ns + ns 
Rapamycin none − ns 
Nilotinib none none 
Table 6.2: Summary of individual compound effects on ROS and NET activities in 
unstimulated and PMA-stimulated neutrophils.  
(none = no effect detected; ns= non-significant) 
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12 CHAPTER 7: DISCUSSION & CONCLUSIONS  
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In the past decade, since Brinkmann et al. reported the antimicrobial properties of extracellular 
DNA filaments, the potential role for NETs in disease pathogenesis has attracted significant 
interest from researchers worldwide. NETs were originally identified as a neutrophil strategy 
for limiting the dissemination of microorganisms as for clearing infections in host tissues. Their 
antimicrobial effects were initially proposed to be fundamentally important in defending the 
body and maintaining a healthy host. However, numerous studies have demonstrated that an 
imbalance between NET production and clearance is related to tissue injury and to the 
development of certain diseases. Because of their components, structure and properties, these 
anti-microbial web-like structures have also been shown to have antigenic potential and can 
trigger an auto-immune/-inflammatory response in human. Subsequently, a better 
understanding of NET regulatory mechanisms will extend our knowledge of their role in the 
pathogenesis of a range of diseases enabling the development of novel therapeutic strategies.  
 Developing and optimising a protocol for HCA of NETs 
Several automated and high-throughput techniques have previously been proposed for NET 
analysis, however, many of those currently exhibit a number of shortcomings including 
reproducibility and the limitation to single parameter analysis. In this thesis, a protocol was 
developed and optimised for the analysis of NETosis using HCA technology. The main 
advantage of this approach is the possibility of analysing a large population of neutrophils 
contained in the experimental sample, rather than limiting analyses to a selected proportion of 
that sample population. In this study experimental conditions, that were physiologically 
relevant to periodontitis pathogenesis as well as other inflammatory diseases involving NETs, 
were characterised and evaluated. Indeed, the periodontally-related pathogens, F. nucleatum 
and P. gingivalis, are known to induce a substantial neutrophilic response in terms of ROS and 
NET production and this activation reportedly contributes to the collateral tissue damage 
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characteristic of this disease (Delbosc et al., 2011; Hirschfeld et al., 2015; Matthews et al., 
2007b). Similar results in terms of ROS production were also observed in this thesis following 
stimulation with an in vitro multispecies biofilm of oral bacteria, developed to mimic tooth 
surface colonisation and which has previously been shown to induce a substantial inflammatory 
response in oral keratinocytes (Millhouse et al., 2014). Interestingly, data from in vitro 
stimulation with oral biofilms presented in this thesis resulted in a strong response in terms of 
ROS production but with relatively poor levels of NET release. However, NET production was 
shown to be relatively high in response to challenge by a single species of heat-killed F. 
nucleatum and P. gingivalis but limited in response to pathogenic biofilms containing these two 
species, suggesting that bacterial aggregation and biofilm development may enhance bacterial 
mechanisms of evasion or regulation of NET release. Notably and consistently with this finding 
is a recent study which demonstrated that LPS from certain Gram negative bacteria is able to 
limit NET production (Pieterse et al., 2016). It is therefore conceivable that modulatory effects 
upon NET release are exerted by the different components of a complex biofilm. Furthermore, 
DNases have been shown to be released by oral bacteria as a mechanism of enhanced virulence 
by degrading the NETs released and thereby evading capture by local tissue neutrophils in the 
periodontium (Palmer et al., 2012b). Such mechanisms are likely to enable biofilm growth and 
bacterial spread and dissemination in tissues. Combined, data from these studies suggest that 
the in vivo developed oral biofilm at the gingival margin, although capable of inducing an 
inflammatory response, has evolved strategies to avoid NET capture and killing mechanisms. 
Potentially, therefore, neutrophils recruited to the site of infection and interacting with the 
pathogenic oral biofilm may employ ROS production rather than NET release to clear the 
biofilm-driven infection, which is supported by the in vitro data gathered in this thesis. In 
addition this could explain and be consistent with previous findings which identified in vitro 
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neutrophil hyper-responsiveness in term of ROS production (Matthews et al., 2007b) but did 
not detect any difference in terms of NET production in periodontitis patients compared with 
healthy individuals (White et al., 2016b). Notably, however, the in vivo presence of NETs in 
inflamed gingival tissues has been previously reported (Cooper et al. 2013), therefore, 
suggesting an alternative non-biofilm-driven mechanism in vivo for the NET response. 
Potentially, this could be underpinned by local cytokines and other immunological components 
present, which may contribute to disease development and its chronicity. Interestingly, 
inflammation chronicity in periodontitis patients is reported to be perpetuated by oral 
pathogens, such as P. gingivalis, in order for them to acquire a local source of nutrients for their 
growth (Scott & Krauss, 2012), subsequently, the direct or indirect triggering of NETs by 
virulence factors combined with bacterial evasion of NET killing may contribute to this process. 
Furthermore salivary calcium, which is reportedly relatively abundant in periodontitis patients, 
can contribute to mineralisation of the oral biofilm providing a mechanism for its physical 
protection (Miller et al., 2006; Sewon et al., 1998; Sewón et al., 1995), in addition enhanced 
calcium levels may contribute to the local priming of neutrophils for NETosis. Therefore, the 
combined process of increased biofilm protection with increased NET production in the 
inflamed periodontium may provide another bacterially-induced strategy for perpetuating 
inflammation in susceptible patients. Further studies should, therefore, explore the interaction 
between the oral biofilm, its composition and components, and neutrophils in order to elucidate 
the mechanism of NET release and its function in the pathogenesis of periodontitis.  
Disease pathogenesis has been extensively investigated using murine models. In this thesis 
PAD4 knockout mice, which are deprived of the functional form of the enzyme, were tested for 
their ability to produce NETs and compared with neutrophils derived from wild-type animals 
and humans. PAD4 knockout mice were unable to release NETs compared with controls, 
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supporting previous studies claiming that PAD4 activity is fundamental for NET formation (Li 
et al., 2010; Wang et al., 2009). However, substantial differences have been identified between 
the NETosing activation process of murine and human neutrophils, suggesting the murine 
model may not be ideally suited for studying human NET biology. Further studies should better 
characterise the biological and molecular differences between murine and human neutrophils 
to determine the relevance of murine models for the investigation of human NET-related 
biology and disease (Gentile et al., 2014).  
A suitable protocol for the preparation and preservation of NET samples was developed in this 
study to enable the use of HCA at the laboratories of Imagen Therapeutics Ltd. Interestingly, 
NET production was found to be dependent upon neutrophil density when studied in a multi-
well plate format, suggesting the involvement of a mechanism of cross-talk between cells in 
order to potentiate the NET antimicrobial response. Our previous studies have shown that 
following treatment with exogenous HOCl, a downstream product of the ROS cascade, 
relatively rapid NET release occurred (Palmer et al., 2012a), and this suggests a role for ROS 
as an intercellular signalling factor. These findings are also supported by the infection 
susceptibility identified in patients affected by leukocyte adhesion disease and CGD who are 
ROS deficient (Bunting et al., 2002; Holland, 2010) as this may in part be attributed to 
ineffective neutrophil cross-talk both in terms of ROS and NET production. Furthermore, 
potentially ineffective recruitment at the site of infection combined with aberrant neutrophil 
cross-talk may be involved in periodontitis pathogenesis due to the relatively low neutrophil 
density in tissues (Roberts et al., 2015). Further studies are however necessary to better 
understand the mechanism of intracellular communication involved in NET regulation and 
determine its role in disease pathogenesis.  
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Particular attention in this study was paid to optimising the fixative procedures required for 
sample preservation and transportation since NETs are extremely fragile structures which 
require maintenance of their integrity for accurate analysis (Brinkmann & Zychlinsky, 2012). 
The majority of fixation protocols tested here were relatively aggressive and caused loss of 
NET filaments and alterations in NET spatial organisation. This finding raises concerns with 
regards to the objectivity and validity of previously published NET findings which largely 
employed sample preparation on glass slides and used microscopic observation for analysis. 
Subsequently, this supports the need for standardisation of objective analytical protocols which 
are automated and reproducible for NET analysis (Brinkmann et al., 2012), thereby allowing 
meaningful comparison between studies. With the aim of robustly capturing NET structures on 
the well surface, poly-L-lysine pre-treatment of cultureware was assessed prior to sample 
preparation. However, the polymer contains cationic structures which may cause electrostatic 
interactions with the negatively charged extracellular DNA. This plausible interaction may 
retain NET filaments in the well and, therefore, may make its use unsuitable for application in 
fluorometric quantification assays. Indeed, the amount of NETs fluorometrically quantified in 
samples generated in poly-L-lysine treated wells was considerably lower than that detected in 
samples produced in untreated wells. Subsequently this approach was considered unsuitable for 
use in further studies which required validation of procedures by fluorometric NET 
quantification. 
Once more suitable conditions for NET analysis were identified and the fixation protocol was 
optimised for NET preservation, HCA was performed for quantifying NETosis-associated 
features. Notably the HCA platform was initially developed for drug discovery and other large-
scale biological applications, and has mainly been used for adherent cell analysis; indeed, there 
have been no previous reports using neutrophils in the HCA system. The software utilised for 
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HCA automated image analysis is provided with a number of built-in algorithms suitable for a 
wide range of biological applications. The settings of two of these algorithms, had 
characteristics that were thought appropriate for the features of NETosis. These were initially 
assessed for their ability to identify neutrophil nuclei and the quantification of NET related 
features. Subsequently, theses two algorithms, “Compartmental Analysis” and “Tube 
Formation”, were tested for their accuracy and sensitivity in quantifying NETs. However, 
results obtained using these algorithms indicated that their application for NETosis exhibited 
key limitations mostly due to the inaccurate identification of the characteristic web-like 
morphology of NETs. Two further algorithms were, therefore, specifically developed for the 
analysis of NETosis-related features and these were termed “NET Detection” and “Nuclear 
Decondensation”. These algorithms also had the advantage of being able to be applied 
simultaneously in order to provide multiparametric data and, therefore, were successfully 
utilised for the quantification of NETs and for the monitoring the activity of the PAD4 enzyme 
following PMA-stimulation. Notably, the Nuclear Decondensation algorithm quantified 
NETosing neutrophils based on changes in chromatin conformation and nuclear morphology. 
Data obtained using this algorithm were validated against other methods of NET quantification 
and supported findings that PMA induced DNA release was of a nuclear origin and subsequent 
NETosis involved rupture of the cell’s plasma membrane (Fuchs et al., 2007). These data were 
consistent with elevated extracellular LDH release also observed in this study. However, 
relevant stimuli and conditions that have been related to mitochondrial-derived NETs were not 
studied here (Yousefi et al., 2009). Therefore, future research, undertaken using HCA and 
employing mitochondrial DNA tracker dyes, could focus on the identification of biomarkers 
for distinguishing between nuclear and mitochondrial NET release following priming of 
neutrophils with GM-CSF and then stimulating with LPS or complement factor 5a, as has 
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previously been reported by Yousefi et al. (2009) for mitochondrial-NET induction. 
Furthermore, of particular interest would be the combined HCA approach for monitoring the 
parameters involved in both types of NET formation pathways including, but not limited to, 
ROS production, histone citrullination and the extracellular release of DNA. Another result 
worthy of further investigation is the altered cellular morphology identified in PMA-stimulated 
neutrophils which is proposed to be due to cytoskeleton rearrangements. HCA has application 
for this analysis and provides a suitable platform for performing multiparametric measurements 
which may identify novel aspects of this process (Nauseef & Kubes, 2016; Yousefi & Simon, 
2016). 
 Application of HCA for the identification of NETosis modulators 
The HCA method optimised for NET analysis was applied to the screening of a compound 
library with the aim of identifying modulators which could increase or reduce NET formation, 
and subsequently, therefore, have therapeutic application. The library used was originally 
developed for cancer cell treatments and was composed of a wide range of pharmaceutically 
relevant compounds with varied targets for immune cell modulation. Following the initial HCS, 
further manual screening confirmed the identification of 8 modulators of NETosis among the 
56 compounds tested. These 8 compounds were sub-categorised based on their effects on NET 
formation as being either inducers, inhibitors or biphasic modulators. Encouragingly, some of 
the compounds identified intracellular signalling which have been previously associated with 
neutrophil biology and NET formation, such as glutathione reductase, the Src and the mTOR 
pathways. These data supported the validity of the initial screening approach. Other potentially 
novel signal transduction pathways regulating NETosis were highlighted by the effects of the 
other compounds and identified roles for several receptor-associated tyrosine kinases. 
Interestingly, data presented here suggested that the MAPK pathway strongly associates with 
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NETosis. These data are consistent with the findings of a previous study (Keshari et al., 2013), 
and could represent an interesting target for the treatment of NET-related diseases, since 
MAPK-driven phosphorylation controls a wide-range of pro-inflammatory signalling 
responses. The involvement of the glutathione pathway in NETosis was identified by 
Carmustine-induced inhibition of NET formation and was consistent with findings of a previous 
study showing that the activity of glutathione reductase is required for effective NET formation 
in murine neutrophils (Yan et al., 2012). This pathway is of particular interest since it is relevant 
for neutrophil activation in several inflammatory diseases (Chapple, 1996), indeed, elevated 
levels of GSSG are associated with the hyper-responsive phenotype previously reported in 
neutrophils obtained from periodontitis patients (Dias et al., 2013). Taken together this data 
suggests that periodontitis patients may be prone to aberrant glutathione reductase activity and, 
therefore, could exhibit decreased NET production. However this was not consistent with the 
finding of a recent clinical study (White, 2015), suggesting NET production in periodontitis 
patients may be triggered by another mechanism, such as calcium influx or increased levels of 
local pro-inflammatory cytokines (Ling et al., 2015), which compensates for the decreased 
activity of glutathione reductase. Further investigation is therefore required to understand the 
molecular association between NETosis and the pathways identified by the HCS and these have 
the potential to be explored in more detail using the HCA platform. Indeed, future work could 
employ HCA for the screening of a larger and more targeted compound library, potentially 
focussing on the MAPK pathway as well as ones containing neutrophil receptor ligands. Such 
data would provide a better understanding of the regulation of NETosis and identify further 
compounds with therapeutic utility.  
The effects of the 8 compounds selected by HCS were further investigated using specific low-
throughput analysis of ROS and NET production. Compound treatment was assayed in 
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unstimulated and stimulated neutrophils. However, highly variable data were obtained using 
three different donors and this likely affected the statistical significance of the findings. Donor 
variability identified by low-throughput analysis of NETs and by previous studies (Barrientos 
et al., 2013; Brinkmann et al., 2012) may be overcome by the application of the HCA method 
in which levels of activation are standardised by baseline and maximum activation status using 
the algorithmic image analysis. Furthermore, using HCA a greater number of individual donor 
sample neutrophils could be simultaneously analysed adding to study power. This proposition 
further supports the application of HCA in the study and characterisation of NETosis.  
Although the primary function of NETs is their antimicrobial effect, their structure is also 
reported to provide a source of autoantigens in several chronic inflammatory diseases (Hakkim 
et al., 2010; Khandpur et al., 2013). NET removal, therefore, potentially plays a fundamental 
role in the clearance of this antigenic material and this may be necessary in order to prevent the 
triggering of local and systemic autoimmune responses. Subsequently, it can be postulated that 
a delicate equilibrium exists between NET formation and removal in order to ensure both the 
adequate protection against infection and, at the same time, avoiding exposing the host tissues 
to injurious NET content for a prolonged time period. Indeed, when this equilibrium is lost an 
unbalanced immune response results in inflammation and disease progression. Notably, 
ineffective NET clearance has been related to the pathogenesis of inflammatory disorders such 
as CF (Cheng & Palaniyar, 2013), while ineffective NET formation can result in pathogen 
survival and infection dissemination as reported in CGD patients (Fuchs et al., 2007). Anti-
inflammatory drugs have previously been tested on neutrophils in order to inhibit NET 
formation (Lapponi et al., 2013), however, interestingly, in this study, modulators with both 
effects, of inducing and inhibiting NETosis, were identified. The identification of compounds 
which exhibit a broad range of modulatory activity on NETosis provides the potential for 
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establishing a homeostatic balance in patients affected by NET-associated diseases. Notably, 
Crizotinib, Bosutinib and Ponatinib, were identified as NET inducers, and may therefore have 
application for treating NET-deficient patients such as those with CGD (Fuchs et al., 2007); 
indeed, data indicates that their intracellular targets modulate NET formation downstream of 
the oxidative burst machinery. Furthermore, Bosutinib and Ponatinib together with Celastrol, 
efficiently decreased baseline and PMA-induced ROS production, suggesting treatment with 
these compounds may have therapeutic application for the hyper-responsiveness of neutrophils 
from patients affected by periodontitis (Matthews et al., 2007b). Compounds identified as NET 
inhibitors, including Lapatinib, Carmustine and Erlotinib, may be employed for the treatment 
of conditions in which excess or aberrant NET production is related to disease development 
such as CF, SLE and RA (Cheng & Palaniyar, 2013; Hakkim et al., 2010; Khandpur et al., 
2013). The pathways described above, however, require further investigation to identify the 
specific molecular mechanism behind their modulation of NET production. HCA has 
application for these studies, as has been demonstrated by the PAD4 analysis reported here. 
Indeed, the effects of compounds can be further evaluated in preclinical studies in neutrophils 
derived from healthy and diseased individuals as this may help understand the physiological 
role of NETosis in the human immune response.  
 Conclusions 
 The research described in this thesis explored analytical conditions, sample processing and 
protocol optimisation to develop a novel approach for the investigation of NETosis based on 
automated High-Content Analysis (HCA). The optimised protocol was applied for the 
screening of a pharmaceutically derived library of compounds for their ability to induce or 
inhibit the process of NETosis and successfully identified 8 modulators. The modulatory 
activities of the compounds selected by HCA were tested and validated by further analysis for 
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the induction of ROS and NET production. The analysis performed in this thesis has contributed 
to the understanding of previously described molecular pathways and has suggested the 
participation of other mechanisms involved in NETosis, which may represent new targets for 
feasible therapeutic approaches in treating NET-related inflammatory disorders as proposed for 
periodontitis. 
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Figure I: Settings of the NET Detection algorithm employed in this thesis. 
Full description of the parameters of the NET Detection algorithms applied in this thesis for the 
quantification of NET by HCA.  
  272 
15 Appendix II 
 
 
  273 
 
Figure II: Settings of the Nuclear Decondensation algorithm employed in this thesis. 
Full description of the parameters of the Nuclear Decondensation algorithm applied in this 
thesis for the quantification of NET by HCA.  
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Figure III: Settings of the Compartmental Analysis algorithm employed for the 
assessment of NF-κB nuclear translocation in H400 in this thesis. 
Full description of the parameters of the Compartmental Analysis algorithm applied in this 
thesis for H400 cells and for tracking the translocation of NF-κB. 
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Figure IV: Settings of the Compartmental Analysis algorithm employed in this thesis for 
the analysis of PAD4 and citrullinated-H3 distribution in neutrophils. 
Full description of the parameters of the Compartmental Analysis algorithm applied in this 
thesis for neutrophils and for tracking PAD4 and citrullinated-H3 distribution. 
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Figure V: Settings of the Nuclear Decondensation algorithm employed in this thesis for 
the HCS of a compound library on neutrophils. 
Full description of the parameters of the Nuclear Decondensation algorithm applied in this 
thesis for screening of a compound library for the modulation of NETosis. 
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Neutrophil Extracellular Traps in 
Periodontitis: A Web of Intrigue
P.C. White1*, I.J. Chicca1,2*, P.R. Cooper1, M.R. Milward1,  
and I.L.C. Chapple1
Abstract
Neutrophil extracellular traps (NETs) represent a novel paradigm in neutrophil-mediated immunity. NETs are believed to constitute 
a highly conserved antimicrobial strategy comprising decondensed nuclear DNA and associated histones that are extruded into the 
extracellular space. Associated with the web-like strands of DNA is an array of antimicrobial peptides (AMPs), which facilitate the 
extracellular destruction of microorganisms that become entrapped within the NETs. NETs can be released by cells that remain viable 
or following a unique form of programmed cell death known as NETosis, which is dependent on the production of reactive oxygen 
species (ROS) and the decondensing of the nuclear DNA catalyzed by peptidyl arginine deiminase-4. NETs are produced in response to 
a range of pathogens, including bacteria, viruses, fungi, and protozoa, as well as host-derived mediators. NET release is, however, not 
without cost, as the concomitant release of cytotoxic molecules can also cause host tissue damage. This is evidenced by a number of 
immune-mediated diseases, in which excess or dysfunctional NET production, bacterial NET evasion, and decreased NET removal are 
associated with disease pathogenesis. Periodontitis is the most prevalent infectious-inflammatory disease of humans, characterized by a 
dysregulated neutrophilic response to specific bacterial species within the subgingival plaque biofilm. Neutrophils are the predominant 
inflammatory cell involved in periodontitis and have previously been found to exhibit hyperactivity and hyperreactivity in terms of ROS 
production in chronic periodontitis patients. However, the contribution of ROS-dependent NET formation to periodontal health or 
disease remains unclear. In this focused review, we discuss the mechanisms, stimuli, and requirements for NET production; the ability 
of NET-DNA and NET-associated AMPs to entrap and kill pathogens; and the potential immunogenicity of NETs in disease. We also 
speculate on the potential role of NETs in the pathogenesis of periodontitis.
Keywords: innate immunity, periodontal disease(s), inflammation, neutrophil biology, bacteria, host pathogen interactions








 Chapter 29 
 Characterization, Quantiﬁ cation, and Visualization 
of Neutrophil Extracellular Traps 
 Phillipa  C.  White ,  Ilaria  J.  Chicca ,  Martin  R.  Ling ,  Helen  J.  Wright , 
 Paul  R.  Cooper ,  Mike  R.  Milward , and  Iain  L. C.  Chapple 
 Abstract 
 Following the discovery of neutrophil extracellular traps (NETs) in 2004 by Brinkmann and colleagues, 
there has been extensive research into the role of NETs in a number of inﬂ ammatory diseases, including 
periodontitis. This chapter describes the current methods for the isolation of peripheral blood neutrophils 
for subsequent NET experiments, including approaches to quantify and visualize NET production, the 
ability of NETs to entrap and kill bacteria, and the removal of NETs by nuclease-containing plasma. 
 Key words  Neutrophil extracellular traps ,  Reactive oxygen species ,  Fluorescence microscopy ,  SEM , 
 Chemiluminescence ,  DNA ,  Elastase ,  Myeloperoxidase ,  Cathepsin G ,  Immunostaining 
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ABSTRACT	
The	balance	between	the	immune/inflammatory	and	regenerative	responses	in	the	diseased	pulp	is	
central	 to	 clinical	 outcome	 and	 this	 response	 is	 unique	within	 the	 body	 due	 to	 its	 environmental	
context.	Cariogenic	bacteria	invade	the	dental	hard	and	soft	tissues	triggering	molecular	and	cellular	
events	dependent	on	the	disease	stage.	Initially	odontoblasts	respond	to	bacterial	components	in	an	
attempt	to	protect	the	tooth’s	hard	and	soft	tissues	and	limit	disease	progression.	However	as	disease	
advances	 the	odontoblasts	die	 and	 cells	 central	 to	 the	pulp	 core,	 including	 resident	 immune	 cells,	
pulpal	fibroblasts,	endothelial	cells	and	stem	cells,	respond	to	the	infection	via	their	expression	of	a	
range	 of	 pattern	 recognition	 receptors	 which	 identify	 pathogen	 associated	 molecular	 patterns.	
Subsequently	 there	 is	 recruitment	 and	 activation	 of	 a	 range	 of	 immune	 cell	 types,	 including	
neutrophils,	 macrophages,	 T-	 and	 B-cells,	 which	 are	 attracted	 to	 the	 diseased	 site	 by	
cytokine/chemokine	 chemotactic	 gradients	 initially	 generated	by	 resident	 pulpal	 cells.	While	 these	
cells	aim	to	disinfect	the	tooth	their	extravasation,	migration	and	antibacterial	activity	[eg	release	of	
reactive	oxygen	species	(ROS)]	along	with	the	bacterial	toxins	cause	pulp	damage	and	impede	tissue	
regeneration	processes.	Recently	a	novel	bacterial	killing	mechanism	termed	Neutrophil	Extracellular	
Traps	(NETs)	has	been	described	which	utilises	ROS	signalling	and	results	in	cellular	DNA	extrusion.	The	
NETs	are	decorated	with	antimicrobial	peptides	(AMPs)	and	their	interaction	with	bacteria	results	in	
microbial	entrapment	and	death.	Recent	data	demonstrates	that	NETs	can	be	stimulated	by	bacteria	
associated	with	endodontic	infections	and	they	may	be	present	in	inflamed	pulps.	Interestingly	some	
bacteria	associated	with	pulpal	infections	express	DNase	enzymes	which	may	enable	their	evasion	of	
NETs.	 Furthermore,	while	NETs	aim	 to	 localize	 and	kill	 invading	bacteria	using	AMPs	and	histones,	
limiting	the	spread	of	the	infection,	data	also	indicates	that	NETs	can	exacerbate	inflammation	and	
that	their	components	are	cytotoxic.	This	 review	considers	the	potential	 role	of	NETs	within	pulpal	
infections	and	how	these	structures	may	influence	the	pulp’s	vitality	and	regenerative	responses.			
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